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Abstract
Malachite green (MG) has been used globally in aquaculture but is not registered for use in
food-producing animals in the European Union. The European Commission requested EFSA to evaluate
whether a reference point for action (RPA) of 2 lg/kg for the sum of MG and its major metabolite
leucomalachite green (LMG) is adequate to protect public health. Available occurrence data were not
suitable for a reliable exposure assessment. The hypothetical dietary exposure was calculated,
considering the RPA as occurrence value for all types of ﬁsh, ﬁsh products and crustaceans. Mean
dietary exposure across different European dietary surveys and age classes would range from 0.1 to
5.0 ng/kg body weight (bw) per day. For high and frequent ﬁsh consumers, the exposure would range
from 1.3 to 11.8 ng/kg bw per day. Both MG and LMG induced formation of DNA adducts in livers of
rats and/or mice, and of micronuclei in mice. LMG also induced cII transgene mutations in mouse liver.
MG caused a small, not dose-related, increase in thyroid gland follicular adenomas and carcinomas,
and of mammary gland carcinomas in female rats. LMG caused an increase in hepatocellular adenomas
and carcinomas in female mice. Both MG and LMG may be considered as carcinogenic and as
genotoxic in vivo. A lower 95% conﬁdence limit for a benchmark response of 10% extra risk (BMDL10)
of 13 mg/kg bw per day for hepatocellular adenomas and carcinomas was selected as reference point
for neoplastic effects. For non-neoplastic effects, a lower 95% conﬁdence limit for a benchmark
response of 5% extra risk (BMDL05) of 6 mg/kg bw per day was selected for the effect of MG on liver
weight and of LMG on body weight. The margins of exposure were 1.1 9 106 or greater for neoplastic
effects and 4.9 9 105 or greater for non-neoplastic effects. The CONTAM Panel concluded that it is
unlikely that exposure to food contaminated with MG/LMG at or below the RPA of 2 lg/kg represents
a health concern.
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of European Food Safety Authority.
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Summary
Malachite green (MG) has been used globally as a therapeutic agent in aquaculture, but it is not
registered for use in food-producing animals in the European Union (EU). However, residues of MG and
its primary metabolite leucomalachite green (LMG) have been detected in aquaculture products in
monitoring programmes in EU Member States, indicating the need for continued surveillance of ﬁsh,
ﬁsh products and crustaceans. Use of MG has not been reported in bivalve production, only in the
farming of ﬁsh and crustaceans. A minimum required performance limit (MRPL) was established for
analytical methods which were used to control the use of MG, being 2 lg/kg for the sum of MG and
LMG in meat of aquaculture products. This MRPL is used as a reference point for action (RPA) by food
control authorities.
RPAs should be low enough to exclude health risks for consumers. The EFSA Scientiﬁc Opinion,
titled ‘Guidance on methodological principles and scientiﬁc methods to be taken into account when
establishing Reference Points for Action (RPAs) for non-allowed pharmacologically active substances
present in food of animal origin’, identiﬁed an approach for establishing RPAs for various categories of
non-allowed pharmacologically active substances. Assuming that MG/LMG residues would only be
present in ﬁsh and crustaceans, this guidance would lead to a so-called toxicologically based limit of
quantiﬁcation (TBLOQ) of 0.15 or 0.30 lg/kg food (for toddlers or adults, respectively) as the basis for
the establishment of an RPA. This TBLOQ is below the current RPA of 2 lg/kg and lower than limits of
quantiﬁcation (LOQs) that are currently achievable by analytical methods used in routine monitoring.
Therefore, a compound speciﬁc risk assessment is required and the European Commission (EC) asked
the European Food Safety Authority (EFSA) to evaluate whether the existing RPA of 2 lg/kg for the
sum of MG and LMG is adequate to protect public health.
Data on occurrence of MG/LMG in food were extracted from the EC database on monitoring of
veterinary medicinal product residues and other substances in ﬁsh, ﬁsh products and crustaceans for
the years 2002–2014. There were 548 targeted samples reported as non-compliant. Data from Norway
for the years 2006–2014 were also considered. Data were also extracted from the Rapid Alert System
for Food and Feed (RASFF) database for the years 2002–2014. There were 135 notiﬁcation events
reported for MG/LMG. The notiﬁcations covered the product categories ﬁsh and ﬁsh products,
crustaceans and products thereof, farmed ﬁsh and products thereof (other than crustaceans and
molluscs) and wild-caught ﬁsh and products thereof (other than crustaceans and molluscs).
The EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) concluded that data
extracted from the EC database and the RASFF database were not suitable to carry out a reliable
human dietary exposure assessment. The CONTAM Panel calculated the hypothetical human dietary
exposure considering as an occurrence value the RPA of 2 lg/kg for all types of ﬁsh, ﬁsh products
and crustaceans. The mean hypothetical chronic dietary exposure across the different European
dietary surveys and age classes, would range from a minimum of 0.1 ng/kg body weight (bw) per
day for infants, elderly and very elderly to 5.0 ng/kg bw per day for toddlers. As there is a concern
that high and frequent ﬁsh consumers might have elevated MG/LMG dietary exposure, the exposure
for these consumers was considered separately. The 95th percentile hypothetical chronic dietary
exposure in ﬁsh consumers only, across the different European dietary surveys and age classes, would
range from a minimum of 1.3 ng/kg bw per day for adults to a maximum of 11.8 ng/kg bw per day
for toddlers.
Concentrations of MG and LMG residues in ﬁsh muscle are reduced when the muscle is subjected to
cooking conditions, such as boiling, baking and microwaving, or when stored under refrigeration,
freezing or repeated freezing/thawing conditions. The concentrations of LMG, generally, are reduced to
a lesser extent than those of MG.
There is scant information about MG and LMG kinetics in mammalian species and no data were
identiﬁed for humans. In rats, MG is rapidly absorbed and excreted mainly by the faecal route.
Available data indicate that MG undergoes biliary excretion, possibly as a glutathione (GSH) adduct. In
orally dosed rats and mice, MG is reduced to LMG and both undergo hepatic sequential
N-demethylation. An N-oxide derivative, resulting from the oxidative biotransformation of an
N-demethylated metabolite, has been identiﬁed in liver extracts from LMG-administered mice.
In ﬁsh, MG is rapidly absorbed and extensively biotransformed to LMG, which is stored in tissues
and slowly excreted. MG N-oxide and MG N-demethylated derivatives were also detected in edible ﬁsh
tissues. Persistence of MG and LMG residues in ﬁsh depends on ﬁsh species and size, MG exposure
concentration and duration, and environmental conditions including temperature and pH. In ﬁsh, MG
was detected up to about 2 months and LMG was detected up to about 9 months after cessation of
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exposure. In crustaceans (shrimp), residues of MG/LMG were no longer detectable 9 days following
treatment.
In 28-day toxicity tests, MG caused haematological effects in mice and rats, and an increase in liver
weight in male and female rats. The overall no-observed-adverse-effect level (NOAEL), based on
haematological effects in female rats, was 9.4 mg/kg bw per day. For LMG, in 28-day toxicity tests, an
increase in liver weight was found in male rats. Hepatocyte vacuolisation was found at all doses
tested, including the lowest dose of 30 mg/kg bw per day. Therefore, a NOAEL was not identiﬁed for
LMG regarding hepatotoxicity.
For LMG, a NOAEL of 10 mg/kg bw per day for fetal toxicity in rats was identiﬁed. The CONTAM
Panel noted, however, that these effects were observed at doses also causing maternal toxicity.
The positive results obtained in the in vivo micronucleus tests in mice for MG and LMG, the
increased mutations in the cII transgene in mouse liver for LMG, and the capacity of both MG and LMG
to form DNA adducts in vivo provide evidence for considering MG and LMG as genotoxic in vivo.
In long-term studies, an increase in liver weight was observed in male rats. LMG caused an
increase in relative thyroid weight in male and female rats. MG was not carcinogenic in mice, but
induced a small, not dose-related, increase in the incidence of thyroid gland follicular adenomas and
carcinomas and of mammary gland carcinomas in female rats. The CONTAM Panel concluded that MG
may be considered as carcinogenic. LMG caused an increase in hepatocellular adenomas and a small
increase in hepatocellular carcinomas in mice. In rats, LMG caused a small increase in the incidence of
mammary gland carcinomas and of thyroid gland follicular cell adenomas or carcinomas (combined).
The CONTAM Panel concluded that LMG may be considered as carcinogenic.
For humans, only one report was identiﬁed, describing a case of methaemoglobinaemia in a 3-year-old
girl following a single exposure to MG (about 2.6 mg/kg bw) in the form of an aquarium product
containing 0.075% MG. However, the composition of the product was not reported.
Regarding the mode of action, MG has been shown to induce formation of reactive oxygen species
(ROS) due to its behaviour as an electron-accepting/transferring compound. In addition, ROS can be
formed from induction of cytochrome P450-dependent monooxygenases, as well as from oxidative
biotransformation of MG itself. MG-mediated formation of ROS has been associated with MG-induced
cytotoxicity, DNA damage, apoptosis, disturbances in cell cycle progression and mitogen-activated
protein kinase signal transduction pathways and in vitro malignant transformation. In vivo, MG caused
depletion of GSH and a decrease in the activity of glutathione-S-transferases and antioxidant enzymes
that could lead to elevated levels of free radicals as indicated by increased hepatic lipid peroxidation.
LMG has been shown to inhibit thyroid peroxidase (TPO) in vitro. It can also be biotransformed by TPO
into N-demethylated derivatives that could, in turn, generate reactive metabolites. This may explain
the effects observed in the thyroid.
Because MG and LMG may be regarded as substances that are genotoxic and carcinogenic, the
derivation of a health-based guidance value is not appropriate. A lower 95% conﬁdence limit for a
benchmark response of 10% extra risk (BMDL10) for hepatocellular adenomas and carcinomas in
female mice of 13 mg/kg bw per day was selected as a reference point for neoplastic effects of MG/LMG.
Based on the effect of MG on liver weight and of LMG on body weight, the CONTAM Panel selected the
lower 95% conﬁdence limit for a benchmark response of 5% extra risk (BMDL05) of 6 mg/kg bw per
day as a reference point for the non-neoplastic effects of MG/LMG.
Due to the limited occurrence data for MG/LMG, no reliable human dietary exposure assessment
could be carried out and, therefore, the CONTAM Panel could not characterise the risk.
The CONTAM Panel evaluated whether an RPA of 2 lg/kg for the sum of MG and LMG is adequate
to protect public health. For the average consumer, the median hypothetical chronic dietary exposure
to MG/LMG across dietary surveys would result in margins of exposure (MOEs) for neoplastic effects of
about 1.1 9 107 for toddlers and 2.2 9 107 for adults, and in MOEs for non-neoplastic effects of about
4.8 9 106 for toddlers and 9.7 9 106 for adults. For high and frequent ﬁsh consumers, the median
hypothetical chronic dietary exposure to MG/LMG across dietary surveys would result in MOEs for
neoplastic effects of about 2.1 9 106 for toddlers and 3.4 9 106 for adults, and in MOEs for
non-neoplastic effects of about 9.5 9 105 for toddlers and 1.5 9 106 for adults. The CONTAM
Panel considered that these MOEs for neoplastic and non-neoplastic effects are sufﬁciently large and
do not indicate a health concern.
Overall, the CONTAM Panel concluded that it is unlikely that exposure to food contaminated with
MG/LMG at or below the RPA of 2 lg/kg represents a health concern.
The CONTAM Panel recommends that more data should be generated on the occurrence of
additional metabolites in ﬁsh and crustaceans. Further information on the fate of MG and LMG during
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food processing should be developed. In addition, knowledge concerning the toxicokinetics and
bioavailability of MG/LMG using human in vitro models should be improved. Information regarding the
potential genotoxicity of the N-demethylated metabolites should be developed, and the DNA adducts
and GSH adducts observed in rodents should be characterised.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background
Malachite green (MG; 4-{[4-(dimethylamino)phenyl](phenyl)methylidene}-N,N-dimethylcyclohexa-
2,5-dien-1-iminium chloride) is a triphenylmethane dye. The term MG is the commonly used one.
However, MG is also known as aniline green, basic green 4, diamond green B or Victoria green B. It is
widely used to colour a diverse range of materials such as textile, leather and paper products. It also
has several applications in diagnostic media.
MG has a longstanding history of use in aquaculture due to its antifungal and antiprotozoal
infection activities in ﬁsh and ﬁsh eggs. Application dosages range from 0.15 mg/L for prolonged
treatment in ponds to 100 mg/L for dipping solutions. In the European Union (EU), MG is not
registered for use in food-producing animals. Although it is not an allowed substance for use in food-
producing animals, residues of MG are regularly discovered in aquaculture products mainly imported
from third countries, demonstrating the most likely illegal use triggered by its low cost, high efﬁcacy,
large availability and lack of alternatives.
MG treatment results in residues of MG and its metabolite leucomalachite green (LMG), both
potential carcinogenic and/or genotoxic substances. In view of harmonising controls in the EU, a
reference point for action (RPA) for the sum of residues of MG and LMG is applicable at 2 lg/kg.
Based on information from the European Union reference laboratory (EURL)/National reference
laboratory (NRL) network, the analytical performance could be slightly enhanced possibly realising
detection at 1 lg/kg for the sum of MG and LMG, corresponding to the Reasonably Achievable Lowest
Limit of Quantiﬁcation in the ‘Guidance on methodological principles and scientiﬁc methods to be taken
into account when establishing Reference Points for Action (RPAs) for non-allowed pharmacologically
active substances present in food of animal origin’ (EFSA CONTAM Panel, 2013).
However, detection of residues of MG in wild-caught ﬁsh seems to indicate that MG is also an
environmental contaminant. Possible routes of contamination of the environment could include:
disposal of water containing MG used for treatment of ornamental ﬁsh, leaching of green colour from
clothes during washing and industrial spills downstream of dye manufacturing plants. Levels of
0.765 lg/kg have been reported in such cases.
In a scenario where MG/LMG residues would only be present in ﬁsh and shellﬁsh, the above-
mentioned guidance considers a toxicologically based limit of quantiﬁcation (TBLOQ) of 0.15 or
0.30 lg/kg food (based on toddler or adult exposure, respectively) as a basis for the establishment of
an RPA (EFSA CONTAM Panel, 2013). As the TBLOQ is below the RPA of 2 lg/kg, a substance-speciﬁc
risk assessment is required.
1.1.2. Findings
More than 60 notiﬁcations related to the presence of MG have been issued through the Rapid Alert
System for Feed and Food (RASFF) over the last decade. All notiﬁcations concern ﬁsh and ﬁsh
products and concern a wide variety of ﬁsh species, including ﬁsh eggs. Reported levels are usually
below 20 lg/kg but exceptions up to 7,500 lg/kg have also been reported.
1.1.3. Terms of Reference
In view of a possible review of the existing RPA for MG/LMG and taking into account that the
TBLOQ values are below what is currently analytically achievable and considering possible background
contamination, the Commission requests a risk assessment as to whether the existing RPA of 2 lg/kg
for the sum of MG and LMG is adequate to protect human health.
1.2. Interpretation of the Terms of Reference
The European Food Safety Authority (EFSA) received a request from the European Commission
(EC) for a scientiﬁc opinion on the adequacy of the RPA for MG/LMG in food to protect human health.
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The EFSA Scientiﬁc Panel on Contaminants in the Food Chain (CONTAM Panel) concluded that this
opinion should comprise:
• evaluation of the toxicity of MG and its metabolite LMG for humans, considering all relevant
toxicological endpoints and identiﬁcation of the toxicological relevance of MG and LMG present
in food;
• exposure of the EU population to MG and LMG from food, including the consumption patterns
of speciﬁc groups of the population such as high and frequent ﬁsh consumers;
• evaluation of whether the existing RPA of 2 lg/kg for the sum of MG and LMG is adequate to
protect public health.
1.3. Additional information
1.3.1. Previous assessments
MG and its major metabolite LMG have been the subject of several previous assessments by
international, European and national organisations.
1.3.1.1. International and European agencies
The EFSA Scientiﬁc Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact
with Food (AFC Panel) reviewed the toxicological information of a large number of dyes illegally
present in food in the EU (EFSA, 2005b). MG and LMG were included in the group of ‘dyes that have
been used illegally in countries outside the EU from which spices originate and dyes that have been
used in the past as food colours in other countries but withdrawn from food use following discovery of
toxicity’. The AFC Panel concluded that both compounds should be viewed as genotoxic and/or
carcinogenic.
At its 70th meeting, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluated MG
and LMG (FAO/WHO, 2009). In short-term (28 days) toxicity studies, MG caused haematological
changes and liver toxicity in male and female rats with a no-observed-adverse-effect-level (NOAEL) of
10 mg/kg body weight (bw) per day and LMG induced liver effects in male rats at all doses tested
(NTP, 2005). The increased incidence of fetal anomalies in all dose groups observed in a teratogenicity
study in rabbits (Meyer and Jorgenson, 1983), although without a consistent dose–response
relationship, raised concern regarding the potential developmental toxicity of MG. JECFA concluded,
however, that this study was inadequately conducted and reported, and that additional studies are
needed to evaluate the reproductive and developmental toxicity of MG.
JECFA concluded that MG has no genotoxic potential in conventional in vitro and in vivo assays.
LMG was negative in in vitro assays, but induced cII mutations in the liver of female Big Blue® B6C3F1
transgenic mice, whereas MG did not. MG was not carcinogenic in a long-term study in female mice,
but in female F344 rats a trend in the incidence of thyroid gland follicular cell adenomas or carcinomas
was found. In a long-term study in female mice, LMG caused a dose-related increase in the combined
incidence of hepatocellular adenomas and carcinomas. Because of the induction of cII mutations by
LMG in liver cells of female transgenic mice, JECFA concluded that a genotoxic mechanism cannot be
ruled out.
JECFA considered it inappropriate to establish an acceptable daily intake (ADI) for MG and used a
margin of exposure (MOE) approach. Due to deﬁciencies in the database, it was considered
inappropriate to derive an MOE for non-carcinogenic endpoints. It concluded that the induction of
hepatocellular adenomas or carcinomas in female mice treated with LMG was the pivotal effect for the
risk assessment, and derived a lower 95% conﬁdence limit or a benchmark response of 10% extra risk
(BMDL10) of 20 mg LMG/kg bw per day as the reference point for the MOE calculation. Because there
was no information on the conversion rate of MG to LMG in food, JECFA considered it prudent to
evaluate the sum of the residues of MG and LMG in food, expressed as LMG. Using average and high
(97.5th percentile (P97.5)) exposures (see Section 3.2.1), MOEs of about 1.3 9 105 and 3 9 104,
respectively, were calculated, which were considered to be of low concern for human health.
The European Chemicals Agency (ECHA) evaluated the same data on MG and LMG as used by
JECFA (ECHA, 2010a,b). ECHA concluded that MG may cause developmental toxicity in rabbits, but
noted that the poor quality of the study cast some doubts on the reliability of the ﬁndings. Based on
the induction of mutations in the liver of transgenic mice by LMG and the induction of DNA adducts in
the liver of rats and mice by MG and LMG, ECHA considered it prudent to presume that MG and LMG
are potential in vivo somatic cell mutagens and, based on classiﬁcation, labelling and packaging (CLP)
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criteria, a classiﬁcation of ‘Muta.2, Suspected to cause genetic defects’ was proposed for both
compounds.
In female rats, there were no signiﬁcant increases in tumour incidence caused by MG, and no
tumour ﬁndings in female B6C3F1 mice. ECHA considered the evidence as not sufﬁcient to warrant a
classiﬁcation of MG for carcinogenicity. ECHA concluded that there was limited evidence for
carcinogenicity of LMG based on tumour induction in the liver of mice and equivocal evidence of
induction of tumours in the liver of female rats. Although it was recognised that the evidence for
carcinogenicity is only weak, the possible involvement of a genotoxic action raised concerns for the
carcinogenicity of LMG. Therefore, based on CLP criteria, a classiﬁcation of ‘Carc.2, Suspected of
causing cancer’ was proposed.
1.3.1.2. National agencies
The UK Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment
(UK COM, 2004) and the UK Committee on the Carcinogenicity of Chemicals in Food, Consumer
Products and the Environment (UK COC, 2004) evaluated MG and LMG. Based on the available
conventional mutagenicity data, there was some evidence for a clastogenic potential of MG, but it was
not possible to make an adequate assessment for LMG. However, due to the formation of DNA adducts
in the liver from both rats and mice by MG, and the induction of mutations in liver DNA of female
transgenic B6C3F1 mice by LMG, it was concluded that both compounds should be regarded as in vivo
mutagens (UK COM, 2004). For MG, there was no convincing evidence for a carcinogenic effect in
female F344 rats and female B6C3F1 mice, but there was equivocal evidence of carcinogenic activity of
LMG in female F344 rats based on an increased incidence of hepatocellular adenomas or carcinomas
(combined). Taking into account the views of the UK COM (2004), it was therefore considered prudent
to regard LMG as a genotoxic carcinogen (UK COC, 2004).
The National Food Institute (NFI) of Denmark and the Technical University of Denmark (DTU)
provided a risk assessment of MG in 2007 (NFI and DTU, 2007). It was reported that in the Danish
surveillance programme up to 28 lg/kg of LMG was found in ﬁsh produced in Denmark. With an intake
of 100 g ﬁsh/day, this led to a conservatively estimated exposure of 2.8 lg LMG/day (0.048 lg/kg bw
per day for a 60-kg adult). Compared with a BMDL10 of 20 mg/kg bw per day for hepatocellular
adenomas and carcinomas in female mice, this led to an MOE of more than 4 9 105, which would be a
low concern for public health, and considered to be a low priority for risk management actions.
A health risk assessment of MG and LMG was reported by the Food Safety Commission (FSC) of
Japan (FSC, 2005). Concerning genotoxicity it was concluded that the available in vitro and in vivo
results ‘failed to provide a univocal explanation for various in vivo mutations including DNA adduct
formation and cII mutation. Nevertheless, the results obtained so far could not deny the genotoxic
potentials of MG and LMG. Further studies are required to reach a reliable conclusion’. According to the
FSC, the results of the 2-year rodent studies suggested that MG acts as a weak carcinogen in the liver
and mammary glands of female rats, and that LMG acts as a liver carcinogen in female mice and as a
weak carcinogen in liver and thyroid of rats.
Food Standards Australia New Zealand (FSANZ) investigated the risk of exposure to MG in ﬁsh
(FSANZ, 2007). Levels of MG in climbing perch of 7.8 lg/kg were found. Based on a mean ﬁsh
consumption of 100 g/day, this resulted in a dietary exposure of about 0.011 lg/kg bw per day for a
70-kg adult. Based on the data on carcinogenicity and genotoxicity, it was suggested that ‘MG is a very
low risk’, and the lowest-observed-effect level (LOEL) of 5 mg/kg bw for non-neoplastic lesions in the
rat liver was considered as the most sensitive endpoint. The estimated dietary exposure was about
450,000 times below the LOEL, and it was therefore concluded that the health risk from MG residues
in ﬁsh is extremely small.
In 2014, the Committee for Pharmacologically Active Substances and Veterinary Medicinal Products
of the German Federal Institute for Risk Assessment (BfR) published a toxicological evaluation on MG
(BfR, 2014). The Committee evaluated occurrence data on MG from ofﬁcial controls, analysis and
toxicity of MG, the applicability of the threshold of toxicological concern (TTC) concept, an assessment
based on the MOE and the appraisal by ECHA on MG. Based on a BMDL10 value of 20 mg LMG/kg bw
for hepatocellular adenomas and carcinomas in female mice and an estimated human daily exposure
of 5–50 ng LMG/kg bw, the Committee calculated MOEs of 4 9 106–4 9 105 and concluded that a
daily exposure of 50 ng LMG/kg bw is toxicologically tolerable. In addition, the Committee evaluated
the applicability of the TTC concept and concluded that MG and LMG fulﬁl the TTC criteria, which lead
to a TTC value of 0.15 lg per day for MG/LMG. In summary, the Committee stated that MG should not
be administered in food-producing animals and recommended to apply the TTC value of 0.15 lg per
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day for the health assessment of MG/LMG residues in food as this represents the more conservative
approach compared to other toxicological assessments, in particular, when taking sensitive population
groups into account.
The CONTAM Panel noted the risk assessment by l’Agence francaise de securite sanitaire des
aliments (AFSSA; currently ANSES (Agence nationale de securite sanitaire de l’alimentation, de
l’environnement et du travail)) from 2002 (AFSSA, 2002). However, since the bulk of information
regarding carcinogenicity of MG/LMG became available after 2002, no further information regarding
this risk assessment is provided in this Scientiﬁc Opinion.
1.3.1.3. Other assessments
Rauscher-Gabernig et al. (2007) assessed the risk to the Austrian population from exposure to MG
and LMG. Fish samples, mainly fresh ﬁsh produced in Austria, collected in the period 2003–2005,
contained residues almost entirely of MG. The estimated intake for high ﬁsh consumers (95th
percentile, P95), expressed as LMG, was 0.83 lg/kg bw per day for children (3–6 years of age),
0.42 lg/kg bw per day for adult women and 0.51 lg/kg bw per day for adult men. Applying a BMDL10
of 21 mg/kg bw per day for liver tumours in female mice and thyroid tumours in male rats, these
intakes resulted in MOEs of 2.5 9 104, 5 9 104 and 4.1 9 104 for these three age groups,
respectively. Therefore, the authors classiﬁed the health risk to the Austrian population from exposure
to MG and LMG as low.
Based on the maximum concentration of LMG found in wild eel caught in Germany (see
Section 3.1.1) and chronic ﬁsh consumption data, intakes of 0.27 and 3.8 ng/kg bw per day for
children and adults, respectively, were reported by Schuetze et al. (2008). Using a LOEL of 13 mg
LMG/kg bw per day for the increased incidence of neoplasms (NTP, 2005), the authors reported MOEs
of 4.9 9 107 and 3.4 9 106 for children and adults, respectively.
The application of the MOE approach to substances in food that are genotoxic and carcinogenic
was studied by a group of international scientists (Benford et al., 2010). LMG was one of the
12 compounds addressed. Available literature data suggested that only about 10–15% of ﬁsh
contained residues of LMG, and data generally did not distinguish between farmed and wild-caught
ﬁsh. Average and high (P95) dietary intakes were estimated to be 5 and 50 ng/kg bw per day,
respectively. The authors considered these intake estimates to be highly conservative because it had
been assumed that all ﬁsh consumed was contaminated at the mean LMG concentration reported in
surveillance studies. Based on a BMDL10 of 20.4 mg/kg bw per day for liver tumours (adenomas and
carcinomas combined), the MOE for average and high consumers were 4 9 106 and 4 9 105,
respectively. Therefore, it was concluded that LMG is likely to be a relatively low priority for risk
management actions, unless speciﬁc incidents result in higher levels of exposure. Identical MOEs for
LMG were reported by Renwick et al. (2010).
The risk of human exposure to LMG due to ﬁsh consumption in Taiwan was assessed by Chu et al.
(2013). They conducted a probabilistic risk assessment for three population groups, adolescents
(13–18 years), adults (19–64 years) and elderly (> 64 years), with elderly consumers having the
highest intake of LMG. Based on a BMDL10 of 18.5 mg/kg bw per day for hepatocellular adenomas and
carcinomas in female mice and probabilistic estimates of the lifetime average daily dose for mean and
high (P95) adult consumers, MOEs for these consumers were 4.8 9 106 and 4.1 9 105, respectively.
Using a cancer slope factor of 0.035 mg/kg bw per day, cancer risk estimates for this age group were
4.7 9 107 at a mean and 1.6 9 106 at a 95th percentile lifetime average daily dose. The authors
concluded that daily intake of LMG from ﬁsh consumption in Taiwan was of low priority for risk
assessment, except for those with 95th percentile high intake. The CONTAM Panel identiﬁed some
inconsistencies in the way the results were reported, and noted that had the reported point estimates
for exposure of average (13.5 ng/kg bw per day) and high adult consumers (45 ng/kg bw per day)
been used, MOEs of 1.4 9 106 and 4.1 9 105, respectively, would have resulted. However, these
results do not affect the conclusions of Chu et al. (2013).
1.3.2. Therapeutic use of malachite green in ﬁsh
Antibiotics and fungicides are used in aquaculture to prevent or treat ﬁsh diseases, which are often
caused by stress conditions (such as high ﬁsh density, hypoxia, and high nitrite and ammonia
concentrations), which impair the immune system and consequently increase susceptibility to infection.
MG was historically one of the most frequently used disinfectants in ﬁsh farming (particularly of
salmonids), and its fungicidal properties have been known since the 1930s (Foster and Woodbury,
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1936). In the 1950s, MG was used as an antiseptic against both internal and external parasites. In the
1960s, MG proved to provide the most effective treatment against protozoan ectoparasites, particularly
Ichthyophthirius multiﬁliis. The use of MG became even more widespread when it was shown to be
effective against aquatic fungi Saprolegnia spp. in ﬁsh eggs (Olah and Farkas, 1978; Alderman and
Polglase, 1984) and for the treatment of proliferative kidney disease of salmonids (Clifton-Hadley and
Alderman, 1987).
MG has previously been used globally as a therapeutic agent in aquaculture, particularly in ﬁsh and
crustacean farming. For example, it was found to be the most frequently used therapeutic product at
78 freshwater ﬁsh farms examined in Germany by Manz et al. (1991). MG has primarily been
administered via aquatic exposure either as a ﬂush treatment at a concentration of 1 mg/L or as a
bath treatment over a longer period at a lower concentration (e.g. 6 days at 0.2 mg/L for rainbow
trout; Machova et al., 1996 and 6 days at 0.5 mg/L for cyprinids; Sudova et al., 2007). MG has also
been used as a fungicide in ﬁshmeal, and consequently been demonstrated to be present in
commercial ﬁsh feed (Conti et al., 2015).
MG is not registered for use in food-producing animals in the EU (see Section 1.3.5). However, MG/LMG
residues in aquaculture products have been detected in monitoring programmes in EU Member States
(Verdon et al., 2015), indicating its continued use in certain geographic areas and the need for
continued surveillance of ﬁsh products. Use of MG has not been reported in bivalve culture, only in ﬁsh
and crustacean farming.
1.3.3. Chemistry
1.3.3.1. Malachite green
MG1 ([4-[[4-(dimethylamino)phenyl]-phenylmethylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium;
chloride; Chemical Abstract Service (CAS) No 569-64-2) is a cationic dye and consists of green crystals
with metallic lustre. It has the molecular formula C23H25N2Cl and a molecular weight of 364.91 g/mol.
The oxalate salt (CAS No 2437-29-8, molecular weight 463.50 g/mol) is also marketed. The green
colour of the compound is independent of whether it occurs with the chloride or oxalate anion.
The melting point is 158–160°C. When heated to decomposition, it emits toxic fumes of nitrogen
oxide and hydrogen chloride. MG occurs almost entirely in the ionised form at pH values of 5–9. It has
a good solubility in water and alcohols. MG is easily converted into LMG (see Section 3.3.1).
1.3.3.2. Leucomalachite green
LMG1 (4-[[4-(dimethylamino)phenyl]-phenylmethyl]-N,N-dimethylaniline; CAS No 129-73-7) consists
of an off-white to light brown powder. From alcohol and benzene, it forms needles or leaﬂets. It has
the molecular formula C23H26N2 and a molecular weight of 330.46 g/mol (Figure 1).
The melting point is 102°C. In contrast to MG, the estimated solubility of LMG in water, being
6.4 9 102 mg/L at 25°C, is very low (EPI (estimation program interface) Suite, estimated). LMG is very
soluble in organic solvents, such as ethanol, ethyl ether, ethylene glycol monomethyl ether and benzene.
1.3.4. Analytical methods
1.3.4.1. Sampling and storage
Most of the sampling of food, and of related materials, for MG/LMG testing in foods of animal origin
is undertaken in the context of the national residue monitoring plans as speciﬁed in Council Directive
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Figure 1: Chemical structure of malachite green cation (left) and leucomalachite green (right)
1 The chemical characteristics of MG and LMG were mainly taken from the Merck Index, ChemSpider and the Toxnet data bases
ChemIDplus and HSDB.
Malachite green in food
www.efsa.europa.eu/efsajournal 12 EFSA Journal 2016;14(7):4530
96/23/EC,2 with residue testing undertaken in accordance with Commission Decision 2002/657/EC3.
For details of the protocols and procedures speciﬁed for such sampling and testing, see Section 2.1.1
of this opinion.
Commission Decision 2002/657/EC states that samples shall be obtained, handled and processed in
such a way that there is a maximum chance of detecting the substance. Sample handling procedures
shall prevent the possibility of accidental contamination or loss of analytes. To achieve this goal,
samples are stored in suitable, secure, clearly identiﬁed containers and in conditions, such as frozen
storage (ﬁsh and crustaceans, water) or at refrigerated/ambient temperatures (ﬁsh feed), prior to
analysis.
1.3.4.2. Speciﬁc issues relating to (leuco)malachite green analysis
Initially, testing for residues of MG in animal tissues was by methods directed at the parent
compound, using high-performance liquid chromatography (HPLC) with ultraviolet/visible (UV/Vis)
detection. However, studies on MG showed that residues of the parent compound are less persistent
than those of the reduced metabolite LMG. Therefore, subsequent HPLC methods measured both
substances using a combination of UV/Vis detection (618 nm) for MG and ﬂuorescence detection (kex
265 nm/kem 360 nm) for LMG, or measurement of both substances as MG following oxidation of LMG
to MG. MG and LMG are the targets for residue analysis in food, while testing for the parent compound
alone is limited to samples of ﬁsh feed and water.
Because MG and LMG are sensitive to air and light, particular steps need to be taken to protect
both analytical standards and sample residues from deterioration. Addition of ascorbic acid to standard
solutions of LMG, to prevent photo-oxidative demethylation, and of acetic acid to standard solutions of
MG, to prevent transformation of MG to its carbinol form, has been applied (Hall et al., 2008; Ahn
et al., 2010) and standard solutions are normally stored in amber bottles (Mitrowska et al., 2008a;
Hurtaud-Pessel et al., 2011). In the case of sample treatment, protection from light is recommended
and steps, such as addition of hydroxylamine hydrochloride as a reducing agent/antioxidant (Hurtaud-
Pessel et al., 2011) or use of acidiﬁed acetonitrile to reduce conversion of MG to its carbinol form (Hall
et al., 2008) have been applied.
1.3.4.3. Extraction and sample clean-up
Extraction of MG/LMG from ﬁsh and crustacean samples is most often carried out using mixtures of
low pH buffer (McIlvane pH 3 or ammonium acetate buffers) and organic solvent (acetonitrile), but
also using direct extraction with organic solvents such as acetonitrile. Typically, the solvent extract is
subjected to liquid/liquid partitioning with dichloromethane or defatting by washing with hexane, and
further clean-up is achieved by the addition of adsorbents, such as alumina, basic alumina or primary/
secondary amines, to the extract or by using solid-phase extraction (SPE). For SPE, a range of
sorbents have been applied including reversed phase (such as C18 and polymeric sorbents), normal
phase (such as alumina sorbents) and cation exchange (such as propylsulfonic acid sorbents).
Depending on whether the method is a screening or conﬁrmatory method, less or more sample extract
puriﬁcation steps may be required.
Other approaches have been applied to extraction/clean-up of MG/LMG from ﬁsh and crustacean
samples, such as the Quick Easy Cheap Effective Rugged Safe (QuEChERS) technique, molecularly
imprinted polymers (MIPs) and immunoafﬁnity chromatography (IAC). The QuEChERS, or dispersive
SPE, technique involves use of a combination of salts and SPE sorbents to achieve a combined
extraction and clean-up of MG/LMG from the sample matrix. IAC involves use of MG speciﬁc antibodies
immobilised on a support material, following oxidation of residues of LMG to MG with 2,3-dichloro-5,
6-dicyano-1,4-benzoquinone (DDQ), to isolate MG/LMG from sample extracts (Xie et al., 2013). MIPs
involve use of an imprinted polymer with selectivity for both MG and LMG (Long et al., 2009) or MG
speciﬁc imprinted polymers with pre-MIP oxidation of LMG to MG using DDQ (Martınez Bueno et al.,
2010; Guo et al., 2011); the MIP is packed into a column to trap the analyte(s) from the sample
extract and allow for washing steps prior to elution of the analyte(s) from the column. In a variation
2 Council Directive 96/23/EC of 29 April 1996 on measures to monitor certain substances and residues thereof in live animals and
animal products and repealing Directives 85/358/EEC and 86/469/EEC and Decisions 89/187/EEC and 91/664/EEC. OJ L 125,
23.5.1996, p. 10–32.
3 Commission Decision 2002/657/EC implementing Council Directive 96/23/EC concerning the performance of analytical methods
and the interpretation of results. OJ L 221, 17.8.2002, p. 8–36.
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on the MIPs approach, Huang et al. (2015) describe use of a magnetic MIP to selectively enrich
MG/LMG from ﬁsh sample extracts.
In the case of water samples, some screening methods based on determination by enzyme-linked
immunosorbent assay (ELISA) (Yang et al., 2007; Xing et al., 2009) or conductive carbon black paste
electrode (Qu et al., 2012) use simple dilution of the ﬁltered sample. Other methods use solvent
extraction (Maleki et al., 2012), microwave-assisted ionic liquid extraction (Gao et al., 2013), hollow
ﬁbre liquid-phase microextraction (Zou et al., 2014), cloud point extraction (Pourreza and Elhami,
2007; An et al., 2010), direct SPE (Safarik and Safarikova, 2002; Mitrowska et al., 2008a) or
MIP-based SPE to isolate MG alone (Lian and Wang, 2012) or MG and LMG (Li et al., 2008) from water
samples.
Extraction of MG from ﬁsh feed samples was undertaken by solvent extraction with acetonitrile and
clean-up of the extract by MIP-based SPE (Li et al., 2008).
1.3.4.4. Screening methods
Screening methods should measure MG/LMG with sufﬁcient sensitivity to satisfy regulatory
requirements, currently at the minimum required performance limit (MRPL) of 2.0 lg/kg for the sum of
MG and LMG in meat of aquaculture products (Annex II of Commission Decision 2002/657/EC).
Screening methods for MG/LMG include immunoassays (ELISAs, RNA aptamer assay, biosensors),
electrochemiluminescence and HPLC.
A number of ELISAs have been developed for determination of LMG (Singh et al., 2011) and for
both MG and LMG (Yang et al., 2007; Xing et al., 2009; Xu et al., 2013) with limits of detection (LOD)
between 0.05 and 0.5 lg/kg in ﬁsh. Zhang et al. (2015) describe a chemiluminescent enzyme
immunoassay for MG with a limit of quantiﬁcation (LOQ) of 0.1 lg/kg in ﬁsh and shrimp. Commercial
ELISA kits are available for determination of both MG and LMG with reported LOD values of
0.1–0.25 lg/kg in ﬁsh and crustaceans.
As an alternative to antibodies used as the binding agents in conventional ELISAs, use of an
RNA-aptamer has been described by Stead et al. (2010); this method was capable of determining both
MG and LMG (following oxidation to MG) in salmon tissue at levels considerably lower than the MRPL
of 2 lg/kg.
Biosensor-based assays have been described, such as an electrochemical method for determination of
MG using a multiwall carbon nanotube-modiﬁed glassy carbon electrode (Yi et al., 2008) and an
electrochemical enzyme inhibition sensor on a screen-printed carbon working electrode for determination
of MG and LMG in ﬁsh, with LODs of 0.25 lg/kg (Faridah et al., 2013; Hidayah et al., 2013).
Methods based on determination by electrochemiluminescence have been described: one using
molecularly imprinted SPE for isolation of MG with an LOQ of 0.02 lg/kg (Guo et al., 2011) and
another using magnetic MIPs to isolate MG and LMG with an LOQ of 0.036 lg/kg (Huang et al., 2015).
HPLC methods for determination of MG and LMG in ﬁsh and crustacean samples may involve direct
measurement of both substances using UV/Vis (618–620 nm) and ﬂuorescence (kex 265 nm/kem
360 nm) detectors, respectively; Mitrowska et al. (2005) describe a method for carp with decision
limits (CCa4) of 0.15 and 0.13 lg/kg for MG and LMG, respectively, and detection capability (CCb5)
values of 0.37 and 0.32 lg/kg for MG and LMG, respectively, while Chen and Miao (2010) describe a
method for catﬁsh with LOD values of 0.38 and 0.10 lg/kg for MG and LMG, respectively. Where
oxidation of LMG to MG is performed, such oxidation may be undertaken pre-HPLC with DDQ or post-
column with lead oxide (PbO2) or with iodine. A number of methods using pre-HPLC derivatisation with
DDQ have been described for salmon, shrimp and catﬁsh with LOD values of 0.15–1.0 lg/kg
(Andersen et al., 2005, 2006, 2009), for ﬁsh with an LOD value of 0.15 lg/kg (Xie et al., 2013) and
for trout with CCa/CCb values of 0.16/0.39 lg/kg (Fallah and Barani, 2014). Methods involving post-
column derivatisation with PbO2 have been described for catﬁsh (Roybal et al., 1995) and for catﬁsh
and trout (Rushing and Thompson, 1997) with LOQ values of 0.5–1.5 lg/kg, for ﬁsh and prawns
with an LOD value of 1.0 lg/kg (Bergwerff and Scherpenisse, 2003; Stoev and Stoyanov, 2007),
and for ﬁsh, shrimp and shellﬁsh with CCa/CCb values of 0.14/0.24 lg/kg (Long et al., 2009).
4 CCa is the decision limit at and above which it can be concluded with an error probability of a that a sample is non-compliant
(Commission Decision 2002/657/EC).
5 CCb is the detection capability, meaning the smallest content of the substance that may be detected, identiﬁed and/or
quantiﬁed in a sample with an error probability of b (Commission Decision 2002/657/EC).
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Long et al. (2008) describe an alternative post-column oxidation procedure for LMG using an iodine
solution, giving CCa/CCb values of 0.17/0.23 lg/kg.
Most HPLC methods for water samples test only for MG with UV/Vis detection (600–618 nm) and
reported LOD values between 0.01 and 0.1 lg/L (Li et al., 2008; Lian and Wang, 2012; Maleki et al.,
2012; Gao et al., 2013; Zou et al., 2014). A method for determination of MG (CCa/CCb values of
0.03/0.08 lg/L) and LMG (CCa/CCb values of 0.03/0.07 lg/L) in water samples using UV/Vis and
ﬂuorescence detectors was described by Mitrowska et al. (2008a).
A number of methods have been described for the determination of MG, used as a dye, in meat
(Sun et al., 2013), various coloured foods (Dixit et al., 2011) and medicinal herbs (Li et al., 2015).
These methods involved microwave-assisted extraction with SPE clean-up and HPLC with UV/Vis
detection, solvent extraction with SPE clean-up and HPLC with UV/Vis detection, and use of a silver
nanoparticle wiper with surface-enhanced Raman scattering detection, respectively.
1.3.4.5. Conﬁrmatory methods
Liquid chromatography–mass spectrometry (LC–MS) is the method of choice for conﬁrmatory
analysis of MG/LMG in ﬁsh and crustaceans. Of the various mass spectrometric methods available,
liquid chromatography linked with a triple quadrupole mass detector is most commonly used, although
ion trap (Turnipseed et al., 2005; Wu et al., 2007; Andersen et al., 2009; Martınez Bueno et al., 2010)
and time-of-ﬂight (Villar-Pulido et al., 2011) detectors have also been used. Some of the published
methods for MG/LMG are multiresidue methods, also including other triphenylmethane dyes, such as
(leuco)crystal violet and/or (leuco)brilliant green (Dowling et al., 2007; Wu et al., 2007; Tarbin et al.,
2008; Andersen et al., 2009; Chen and Miao, 2010; Hurtaud-Pessel et al., 2011, 2013; Tao et al.,
2011). A method using time-of-ﬂight-mass spectrometry (TOF-MS) has been developed for multiclass
determination of residues of selected pharmacologically active substances, including MG/LMG, in
shrimps (Villar-Pulido et al., 2011).
Typical MS conditions used for the conﬁrmatory analysis of MG/LMG are positive electrospray
ionisation (ESI) with two precursor to product ion transitions being monitored for each analyte,
m/z 329 > 313, 208 for MG and m/z 331 > 239, 316 for LMG. Sample treatment, prior to liquid
chromatography–tandem mass spectrometry (LC–MS/MS) determination of the analytes, typically
involves buffer/organic solvent extraction coupled with clean-up by SPE, but extraction by automated
solvent extraction (Tao et al., 2011) or by QuEChERS (Villar-Pulido et al., 2011; Hashimoto et al., 2012;
Lopez-Gutierrez et al., 2013) and clean-up using MIPs (Martınez Bueno et al., 2010) have also been
reported.
LC–ESI–MS/MS methods for determination of MG/LMG have been applied to a variety of ﬁsh,
including catﬁsh, trout, salmon and tilapia, and to shrimps. The range of values for CCa and CCb by
these methods, for MG and for LMG, are < 0.1–0.9 and 0.1–1.2 lg/kg, respectively (van de Riet et al.,
2005; Dowling et al., 2007; Halme et al., 2007; Arroyo et al., 2009; Chen and Miao, 2010; Hurtaud-
Pessel et al., 2011, 2013; Tao et al., 2011; Ascari et al., 2012; Hashimoto et al., 2012; Xu et al., 2012;
Lopez-Gutierrez et al., 2013; Andersen et al., 2015); all with method sensitivity sufﬁcient to satisfy the
MRPL value of 2 lg/kg. A number of papers have been published on the determination of total MG in
ﬁsh, following oxidation of any LMG present in the sample to MG, post-column using PbO2 with
reported CCa/CCb values of 0.11/0.15 lg/kg (Scherpenisse and Bergwerff, 2005) and pre-LC using
DDQ with reported CCa/CCb values of 1.2/2.0 lg/kg (Tarbin et al., 2008).
LC–MS methods using an ion-trap detector have been developed for analysis of total MG in salmon
and catﬁsh, following oxidation of any LMG present in the sample to MG using DDQ, with reported
LOD/LOQ values of < 0.15/0.15 lg/kg (Turnipseed et al., 2005), 0.24/0.75 lg/kg (Andersen et al.,
2009) and 0.003/0.005 lg/kg (Martınez Bueno et al., 2010). Isotope dilution liquid chromatography/
mass spectrometry (ID-LC/MS), using deuterated and/or 13C6-MG and -LMG, has been developed for
ﬁsh, shrimp and shellﬁsh (Doerge et al., 1998; Wu et al., 2007; Ahn et al., 2010). LOD values of
0.02 lg/kg for MG and of 0.5 lg/kg for LMG are reported (Doerge et al., 1998; Ahn et al., 2010) and
CCa/CCb values of 0.08/0.13 lg/kg for MG and of 0.05/0.09 lg/kg for LMG are reported (Wu et al.,
2007). An accurate mass full-scan TOF-MS method has been applied to the analysis of shrimp, with
reported LOD values of 0.06 and 0.60 lg/kg for MG and LMG, respectively (Villar-Pulido et al., 2011).
An LC–ESI–MS/MS method has been developed for MG/LMG in water samples, following
centrifugation and preconcentration on diol SPE columns, with reported CCa/CCb values of
0.04/0.06 lg/L for MG and of 0.03/0.05 lg/L for LMG (Mitrowska et al., 2008a).
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1.3.4.6. Analytical quality assurance: performance criteria, reference materials and
proﬁciency testing
The performance criteria for methods used to test for MG/LMG are those laid down in Commission
Decision 2002/657/EC for screening and conﬁrmatory methods. Methods must have satisfactory
performance for the characteristics of speciﬁcity, trueness, ruggedness, and stability of the analyte in
standard solutions and in test matrices. The methods must be validated for recovery, repeatability,
within-laboratory reproducibility, calibration curves, CCa and CCb according to procedures speciﬁed in
the Decision, or equivalent procedures.
MG oxalate (94.3  1.4% purity) and LMG (98.8  0.8% purity) reference standards have been
prepared and are commercially available (Le Goff and Wood, 2008). Isotopically labelled materials,
such as d5-MG, d5- or d6-LMG and
13C6-LMG, are available commercially for use as internal standards.
No certiﬁed reference materials for MG/LMG are commercially available to date. A sample of salmon to
be used in an international intercomparison study was produced and the sum of MG and LMG in this
sample was determined to be 9.32  0.98 lg/kg (at the 95% conﬁdence interval) using ID-LC/MS
(Hall et al., 2008).
Several proﬁciency tests and interlaboratory studies have been reported for MG/LMG in ﬁsh. The
EURL, Anses-Fougeres (France), provides proﬁciency testing for National Reference Laboratories in
charge of control for dye residues in aquaculture products with three rounds having been organised
covering trout (2005, 2009) and prawn (2013) samples (Verdon et al., 2015). In January 2008, the
Proﬁciency Test Advisory Board, Government Laboratory, Hong Kong reported on a proﬁciency test
(APLAC T058) aimed at evaluating the testing capability of 48 participating laboratories in the
quantitative analysis of MG and LMG in swamp eels; 48% and 62% of participants had satisfactory
results (z-score ≤ 2) for the determination of MG (assigned value 28.2 lg/kg) and LMG (assigned
value 2.21 lg/kg), respectively (Wong, 2008). In the UK, the Food Analysis Performance Assessment
Scheme (FAPAS) provides samples of ﬁsh muscle containing MG and LMG for testing.6
1.3.4.7. Concluding comments
While a combination of buffer/solvent extraction, liquid/liquid partitioning and SPE is the most
commonly used sample preparation for the analysis of MG/LMG using both screening and conﬁrmatory
methods, other approaches, such as the QuEChERS technique, MIPs and IAC have been applied.
Screening methods for MG/LMG include HPLC with UV/Vis and ﬂuorescence detectors, ELISA and
biosensor methods and electrochemiluminescence, all providing sufﬁcient analytical sensitivity to meet
the MRPL of 2 lg/kg. Conﬁrmatory methods are based on various LC–MS methods and these typically
provide CCa and CCb values of < 1.0 lg/kg for a range of ﬁsh and crustaceans, again adequately
meeting the MRPL of 2 lg/kg.
1.3.5. Legislation
According7 to Article 3 of Regulation (EC) No 470/20098, any pharmacologically active substance
intended for use in the EU in veterinary medicinal products (VMPs) which are to be administered to
food-producing animals shall be subject to an opinion of the European Medicines Agency (EMA) on the
maximum residue limit (MRL), formulated by the Committee for Medicinal Products for Veterinary Use
(CVMP). The opinion consists of a scientiﬁc risk assessment and risk management recommendations.
Pharmacologically active substances, for which the opinion concludes that no MRL is needed or that a
(provisional) MRL should be established, are subsequently classiﬁed in Table 1, ‘allowed substances’, of
Regulation (EU) 37/20109. All use of other pharmacologically active substances in VMPs is not allowed.
A speciﬁc group of the non-allowed substances is the group of ‘prohibited substances’, listed in Table 2
of Regulation (EU) 37/2010. MG is not listed in Table 1 of Regulation (EU) 37/2010. Therefore,
6 http://fapas.com/proﬁciency-testing-schemes/fapas/
7 In this scientiﬁc opinion, where reference is made to European legislation (Regulations, Directives, Decisions), the reference
should be understood as relating to the most current amendment, unless otherwise stated.
8 Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community
procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin,
repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the
Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council. OJ L 152, 16.6.2009, p. 11–22.
9 Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classiﬁcation
regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1–72.
Malachite green in food
www.efsa.europa.eu/efsajournal 16 EFSA Journal 2016;14(7):4530
although not explicitly listed in Table 2, MG is not registered and not allowed for use in food-producing
animals in the EU.
Article 18 of Regulation (EC) No 470/2009 stipulates that, for substances which are not classiﬁed as
‘allowed substances’ in accordance with that Regulation, an RPA may be established to ensure the
functioning of controls for food of animal origin. Food of animal origin containing residues of such
substances at or above the RPA is considered not to comply with EU legislation. Until now, RPAs have been
based only on analytically driven MRPLs, and no consideration has been given to the toxicological proﬁle of
non-allowed substances. An MRPL of 2 lg/kg for meat of aquaculture products is speciﬁed in Annex II of
Commission Decision 2002/657/EC3, which was amended by Commission Decision 2004/25/EC10.
This MRPL refers to the sum of MG and its metabolite LMG.
Under the terms of Commission Decision 2005/34/EC11, the MRPLs listed in Annex II of Commission
Decision 2002/657/EC are currently to be used as RPAs, irrespective of the matrix tested, for the
purpose of the control of residues when analytical tests are being carried out in the framework of
import control. However, this Decision regulated imports from third countries only and did not apply to
food produced within the Union. As a number of animal products originating from Member States were
found to contain non-allowed and prohibited substances below and above the MRPLs, the EC and
the Member States agreed to also apply the approach laid down in Decision 2005/34/EC, with the
necessary changes, to food of animal origin produced within the Union. This implies, in particular, that
the MRPLs set in accordance with Commission Decision 2002/657/EC shall also be used as RPAs. This
approach, moreover, means that any detection of substances, the use of which is not authorised in the
Union, regardless of the level found, shall be followed by an investigation into the source of the
substance in question and appropriate enforcement measures shall be applied, in particular, aiming to
prevent reoccurrence in the case of documented illegal use (SANCO-E.2(04)D/521927).12
2. Data and methodologies
2.1. Data
2.1.1. Occurrence data
Data on the occurrence of MG/LMG in food are not currently collected by EFSA. The only analytical
results on MG/LMG present in the EFSA Chemical Occurrence database have been submitted by the
Czech Republic (80 samples). The Czech Republic conﬁrmed that the same data were also submitted
to the EC database on residues of veterinary medicines, relating to the national residue monitoring
plan (see below).
2.1.1.1. National residue monitoring plans
Council Directive 96/23/EC on measures to monitor certain substances and residues thereof in live
animals and animal products requires that Member States draft a national residue monitoring plan for
the groups of substances detailed in Annex I of this Directive. These plans must comply with the
sampling rules in Annex IV of the Directive.
Within Group B, Veterinary drugs and contaminants, of Annex I, Subgroup B3e Dyes, covering MG/LMG,
samples are to be taken only from aquaculture animals, their feeding stuffs, water and primary animal
products. The minimum number of samples to be collected each year is speciﬁed as a proportion of
the aquaculture production volume of the previous year. The compounds sought and the samples
selected for analysis should be selected according to the likely use of these substances. Sampling
under the national residue monitoring plan should be targeted; samples should be taken preferably at
the farm, on ﬁsh ready to be placed on the market, and either at the processing plant or at wholesale
level. Samples taken at farm level should be taken from a minimum of 10% of registered sites of
production.
Member States submit data on the occurrence of non-compliant results determined in the residue
monitoring, including for MG/LMG to the EC database on residues of veterinary medicines. Data on the
occurrence of MG/LMG in food have been extracted from the EC database on residues of veterinary
10 Commission Decision of 22 December 2003 amending Decision 2002/657/EC as regards the setting of minimum required
performance limits (MRPLs) for certain residues in food of animal origin OJ L 6, 10.1.2004, p. 38–39.
11 Commission Decision 2005/34/EC laying down harmonised standards for the testing for certain residues in products of animal
origin imported from third countries. OJ L 16, 20.1.2005, p. 61–63.
12 http://ec.europa.eu/food/fs/rc/scfcah/biological/rap16_en.pdf
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medicines. This database contains the annual sampling plan and the results from 2004 onwards
provided by all Member States. The results are reported as aggregate data. However, there is no
indication of the sample matrix tested and no concentration for the chemical residue or contaminant
detected in the sample is provided. In addition, the number of samples analysed for the individual
substances are reported by the Member States only if there is at least one non-compliant sample for
the substance in question. Where all samples are compliant, the number of samples analysed is not
reported. Furthermore, where controls are carried out at farm and processing plant, the total number
of samples recorded may refer to samples taken at either farm or processing plant, depending on
where the non-compliant samples were found, and this may be on a substance group basis rather
than on the individual substance basis. Where non-compliant samples were found at both farm and
processing plant, the number of samples represents the sum of samples taken at both sampling
points.
For the years 2002 and 2003, data on MG/LMG reported by Member States have been extracted
from the Commission Staff Working Papers on the implementation of national residue monitoring plans
in the Member States (EC, 2004, 2005). The data presented in these papers are not at the same level
of detail as found on the database for the years 2004–2014. For example, for 2003 the number of
samples analysed represents the total number of targeted samples tested for all categories of
substances, rather than the number of samples speciﬁcally tested for Subgroup B3e Dyes.
Data on the occurrence of MG/LMG in food have been considered for the period 2002–2014.13
In addition to the data submitted to the EC database on residues of veterinary medicines from
Member States, data from Norway on the occurrence of MG/LMG for the years 2006–2014 were also
considered. The latter were extracted from the annual reports ‘Monitoring program for residues of
therapeutic agents, illegal substances, pollutants and other undesirables in farmed ﬁsh (in accordance
with Council directive 96/23/EC)’ (NIFES, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015).
2.1.1.2. Rapid Alert System for Food and Feed
The CONTAM Panel considered the Rapid Alert System for Food and Feed (RASFF)14 database as
another source of information on the occurrence of MG/LMG in food.
RASFF notiﬁcations mostly concern controls at the outer European Economic Area (EEA) borders, at
points of entry or border inspection posts, when a consignment is not accepted for import into the EU.
The second largest category of notiﬁcations concerns ofﬁcial controls on the internal market. A small
number of notiﬁcations may be triggered by ofﬁcial controls in non-member countries.
After an inspection is conducted within a country and unfavourable results of the analysis are
obtained, the risk needs to be evaluated, as does the probability that the product may be present on
the market of other Member States. In the latter case, notiﬁcations are provided when non-compliant
samples for a contaminant are found, providing also quantiﬁed values. However, information on the
total number of samples analysed, the number of compliant samples, the concentrations and the type
of analysis undertaken is rarely provided.
Searches in the RASFF database were performed for the hazard category ‘residues of veterinary
medicinal products’ – hazard ‘malachite green’ or ‘leucomalachite green’ – that had been notiﬁed
between 1 January 2002 and 31 December 2014.
2.1.2. Consumption data
The EFSA Comprehensive European Food Consumption Database (Comprehensive Database)
provides a compilation of existing national information on food consumption at individual level. It was
ﬁrst built in 2010 (EFSA, 2011a; Huybrechts et al., 2011; Merten et al., 2011). Details on how the
Comprehensive Database is used are published in the Guidance of EFSA (EFSA, 2011a).
The latest version of the Comprehensive Database15 contains results from a total of 51 different
dietary surveys carried out in 23 different Member States covering 94,532 individuals.
Within the dietary studies, subjects are classiﬁed in different age classes as follows:
Infants: < 12 months old
Toddlers: ≥ 12 months to < 36 months old
Other children: ≥ 36 months to < 10 years old
13 The results for the year 2014 were extracted from the Database in December 2015.
14 http://ec.europa.eu/food/safety/rasff/
15 http://www.efsa.europa.eu/en/datexfoodcdb/datexfooddb
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Adolescents: ≥ 10 years to < 18 years old
Adults: ≥ 18 years to < 65 years old
Elderly: ≥ 65 to < 75 years old
Very elderly: ≥ 75 years old
Overall, the food consumption data gathered by EFSA in the Comprehensive Database are the most
complete and detailed data currently available in the EU. Consumption data were collected using single
or repeated 24- or 48-h dietary recalls or dietary records covering from 3 to 7 days per subject. Owing
to the differences in the methods used for data collection, direct country-to-country comparisons can
be misleading.
2.1.3. Food classiﬁcation
Consumption data were classiﬁed according to the FoodEx classiﬁcation system (EFSA, 2011b).
FoodEx is a food classiﬁcation system developed by EFSA in 2009 with the objective of simplifying the
linkage between occurrence and food consumption data when assessing the exposure to hazardous
substances. It contains 20 main food groups (ﬁrst level), which are further divided into subgroups
having 140 items at the second level, 1,261 items at the third level and reaching about 1,800
endpoints (food names or generic food names) at the fourth level.
In 2011, a new version of FoodEx, named FoodEx2 has been developed and is described in the
scientiﬁc document ‘Report on the development of a Food Classiﬁcation and Description System for
exposure assessment and guidance on its implementation and use’ (EFSA, 2011c). The last release of
FoodEx2 complements the previous hierarchical classiﬁcation system of basic codes with more detailed
food levels and gives the possibility of reporting additional information through the use of facets and
facet descriptors (EFSA, 2015).
2.1.4. Toxicokinetic and toxicological data
All data were obtained from the scientiﬁc literature as described in Section 2.2.2.
2.2. Methodologies
2.2.1. Dietary exposure assessment in humans
The CONTAM Panel considered that only chronic dietary exposure to MG had to be assessed. As
suggested by the EFSA Working Group on Food Consumption and Exposure (EFSA, 2011a), dietary
surveys with only 1 day per subject were not considered as they are not adequate to assess repeated
exposure. Similarly, subjects who participated only 1 day in the dietary studies, when the protocol
prescribed more reporting days per individual, were also excluded for the chronic exposure
assessment. Thus, for chronic exposure assessment, food consumption data were available from
35 different and most recent dietary surveys carried out in 19 different European countries present in
the latest version of the Comprehensive Database (Appendix B).
For calculating chronic dietary exposure to MG/LMG, food consumption and body weight data at
the individual level were accessed in the Comprehensive Database. Occurrence data (in this particular
case the RPA value of 2 lg/kg) and consumption data were linked at the lowest FoodEx level possible.
For each dietary survey, exposure estimates were calculated per age class. It should be noted that not
all countries provided consumption information for all age groups, and in some cases, the same
country provided more than one consumption survey. The mean and the high (95th percentile) chronic
dietary exposures were calculated by combining for all types of ﬁsh, ﬁsh products and crustaceans
(excluding aquatic molluscs) the RPA value with the average daily consumption for each food at
individual level in each dietary survey.
To calculate a more reﬁned dietary exposure to MG/LMG, the CONTAM Panel considered that the
above-mentioned foods are also consumed as part of composite dishes present in the FoodEx
classiﬁcation system. These are, for example, ﬁsh sauce, ﬁsh-based meals, soups and salads. In
addition, in the case of infants and toddlers, ﬁsh is normally consumed through ‘Ready-to-eat meals
for infants and young children’. Therefore, where it was clearly stated in the name of the meal that
this was a mixture of ﬁsh and other food items (e.g. ﬁsh and rice meal, ﬁsh and potatoes meal, etc.),
a factor of 0.5 was applied, meaning that half of the quantity reported to be consumed was
considered as referring to ﬁsh and the other half to the other food items present in the dish. All
composite dishes and ﬁsh sauce were grouped as ‘Fish composite dishes’. In the case of ‘Ready-to-eat
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meals for children’, the only FoodEx code description that refers to ﬁsh is the ‘Ready-to-eat meal for
children, meat/ﬁsh-based’. Considering that all foods classiﬁed under this code description would lead
to an overestimation of exposure to MG/LMG, the CONTAM Panel referred either to the FoodEx2 code,
where available, or the original food description to isolate only the ﬁsh-based meals and thus reﬁne
the exposure calculation.
The chronic dietary exposure to MG/LMG for high and frequent consumers of ﬁsh was calculated
taking into consideration only subjects that consumed ﬁsh among the whole population from
35 different and most recent dietary surveys carried out in 19 different European countries present in
the latest version of the Comprehensive Database.
All analyses were run using the SAS Statistical Software (SAS enterprise guide 5.1).
2.2.2. Literature search and appraisal of studies
2.2.2.1. Strategy for literature search
A comprehensive search for literature was conducted for peer-reviewed original research pertaining
to adverse health effects on (experimental) animals and humans. The search strategy was designed to
identify scientiﬁc literature dealing with toxicity, mode of action, toxicokinetics and human data on MG
and LMG. An overview of the search terms is given in Appendix A, Section A.1.
It should be noted that a narrative approach was used for those sections dealing with methods of
analysis, chemistry, occurrence and exposure as the identiﬁed papers are used only to give background
information to the reader. For methods of analysis and chemistry, recent reviews, in combination with a
limited literature search, were used to identify the scientiﬁc literature (see Appendix A, Section A.1.).
Occurrence data were only considered when the samples had been collected since 2002, because the
Member States became aware of the possible misuse of MG in aquaculture in 2002 and so control of
MG was intensiﬁed by increasing the number of samples taken (EC, 2004).
The literature search was not restricted to publications in English. A ﬁrst literature search was
performed in April 2015 for all topics (October 2015 for papers on the occurrence in foods due to
illegal use of MG as a food colouring agent). The literature search has been updated in December
2015 to identify papers dealing with toxicity, mode of action, toxicokinetics and human data on MG
and LMG. Web of Science16 and PubMed17 were identiﬁed as databases appropriate for retrieving
literature for the present evaluation. The references resulting from the literature search were imported
and saved using a software package (EndNote18), which allows effective management of references
and citations. Additionally, reviews, relevant scientiﬁc evaluations and toxicity studies by national or
international bodies were considered for the current risk assessment, i.e. AFSSA (2002), NTP (2004,
2005), UK COM (2004), UK COC (2004), FSC (2005), (NFI and DTU, 2007), FSANZ (2007), FAO/WHO
(2009), ECHA (2010a,b), and the BfR (2014). In addition, when relevant papers were identiﬁed during
the risk assessment process (e.g. from other studies or reviews), they were also considered.
The references obtained were screened using title and abstract to identify relevant literature. The
exclusion criteria used are shown in Appendix A, Section A.2.
2.2.2.2. Appraisal of studies
The information retrieved has been reviewed by the CONTAM Standing Working Group (SWG) on
non-allowed pharmacologically active substances in food and feed and their RPAs, and has been used
for the present assessment based on expert judgement. Any limitations in the information used are
documented in this scientiﬁc opinion.
Selection of the scientiﬁc papers for inclusion or exclusion was based on consideration of the extent
to which the study was relevant to the assessment and on general study quality considerations (e.g.
sufﬁcient details on the methodology, performance and outcome of the study, on dosing and route of
administration and on statistical description of the results (EFSA, 2009b)), irrespective of whether they
yielded positive, negative or null results.
Studies solely focusing on the efﬁcacy of MG as a pharmacologically active substance were
excluded from the assessment.
16 Web of Science (WoS), formerly ISI Web of Knowledge, Thomson Reuters. Available online: http://thomsonreuters.com/
thomson-reuters-web-of-science/
17 PubMed, Entrez Global Query Cross-Database Search System, National Center for Biotechnology Information (NCBI), National
Library of Medicine (NLM), Department of the National Institutes of Health (NIH), United States Department of Health and
Human Services. Available online: http://www.ncbi.nlm.nih.gov/pubmed/
18 EndNote X5, Thomson Reuters. Available online: http://endnote.com/
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2.2.3. Methodology applied for risk assessment
The CONTAM Panel applied the general principles of the risk assessment process for chemicals in
food as described by WHO (2009), which include hazard identiﬁcation and characterisation, exposure
assessment and risk characterisation. In addition to the principles described by WHO (2009), EFSA
guidance pertaining to risk assessment has been applied for this assessment. For details on the
speciﬁc EFSA guidance applied, see Appendix A, Section A.3.
3. Assessment
3.1. Occurrence data
3.1.1. Previously reported occurrence data
According to the Commission Staff Working Paper, in 2002 Member States became aware of the
possible misuse of MG in aquaculture and so control of MG was intensiﬁed by increasing the number of
samples taken (EC, 2004). Therefore, the CONTAM Panel considered occurrence data for samples that
have been collected since 2002. It should be noted that some of the studies described in this section
may also be included in the databases described in Section 3.1.2, relating to samples taken in national
residue monitoring plans. The information presented below provides examples of the occurrence of MG
and LMG in foods.
3.1.1.1. Fish and crustaceans
Bergwerff and Scherpenisse (2003) analysed trout (n = 18), eel (n = 10) and salmon products
(n = 20) collected in the Netherlands for the presence of MG/LMG residues using HPLC-UV (LOD: 1 lg/kg)
or LC–MS/MS (LOD: 0.2 lg/kg). The year of sampling was not indicated. LMG was detected in 13 trout
samples (range: 1.3–14.9 lg/kg), ﬁve eel samples (range: 1.5–9.7 lg/kg), three samples of fresh
salmon (range: 0.2–2.9 lg/kg), two smoked salmon samples (0.2 lg/kg in both samples) and in none
of the canned salmon samples.
Schuetze et al. (2008) analysed wild eel (n = 45; year of sampling not indicated) caught from
lakes, a river and a canal in Berlin, Germany. MG residues (reported as the sum of MG and LMG) were
detected in 25 samples at concentrations ranging from 0.053 to 0.765 lg/kg. The authors stated that
the occurrence could be linked directly to the presence of treated sewage discharge in the surface
waters from which the ﬁsh was caught. Samples were analysed using LC–MS/MS (LOD/LOQ:
0.02/0.04 lg/kg for MG and 0.01/0.02 lg/kg for LMG).
Samples of carp (n = 42) and rainbow trout (n = 30), collected between 2009 and 2011 from ﬁsh
farms in Croatia, were analysed for MG residues using an ELISA speciﬁc for MG (LOD/CCb:
0.31/0.68 lg/kg). MG was detected in 13 samples but at concentrations below the MRPL of 2 lg/kg
(Bilandzic et al., 2012).
Conti et al. (2015) analysed samples of sea bass (n = 15) and gilthead sea bream (n = 15)
collected from an aquaculture plant in Italy in 2013. An ELISA method with an LOD/LOQ of 0.2/0.5 lg/kg
was used. MG was detected at concentrations up to 1.21 lg/kg (mean concentration: 0.48 lg/kg).
Samples of wild European eel were collected between 2000 and 2009 in Belgium (n = 91 sites;
1 eel/site). Samples were analysed using ultra-performance liquid chromatography (UPLC)–MS/MS
(LOD/LOQ: 0.25/0.05 lg/kg). LMG and MG were detected in 74.8% and 25.3% of the samples,
respectively. Concentrations up to 9.61 and 0.96 lg/kg (mean concentrations: 0.56 and 0.07 lg/kg)
were reported for LMG and MG, respectively (Belpaire et al., 2015).
In Australia, a national survey was conducted in April–June 2005 for which 60 samples of local and
imported farmed ﬁnﬁsh were analysed. LMG was detected in 10 samples and in two of these MG was
also detected. The highest concentration detected was 880 lg/kg for LMG in ﬁsh imported from
Vietnam. Samples were analysed using LC–MS/MS (LOQ: 2 lg/kg) (FSANZ, 2005).
In the framework of a Canadian total diet study, 12 composite samples of marine, freshwater and
canned ﬁsh and shrimp were collected between 2002 and 2004. MG and LMG were analysed using
LC–MS/MS (LOD: 0.15 lg/kg for both MG and LMG). LMG was detected in two composite samples of
freshwater ﬁsh and one composite shrimp sample (0.95, 0.73 and 1.2 lg/kg) (Tittlemier et al., 2007).
Lee et al. (2010) reported on the analysis of 253 processed ﬁsh products collected from local
markets in Korea (year of sampling not indicated). Samples were analysed using HPLC-diode array
detection (DAD) (LOQ: 1.0 lg/kg) and positive results were conﬁrmed by LC–MS/MS. MG/LMG
residues were detected in one shrimp sample at a concentration of 2.6 lg/kg.
Malachite green in food
www.efsa.europa.eu/efsajournal 21 EFSA Journal 2016;14(7):4530
Samples of catﬁsh nuggets (n = 24) were analysed in the USA for the presence of MG and LMG
(year of sampling not reported). ELISA was used as the screening method (LOD: 1 lg/kg for the sum
of MG, LMG, crystal violet and leucocrystal violet, using antibodies speciﬁc for MG and crystal violet
following oxidation of the leuco metabolites). MG/LMG was not detected in any of the samples (Ozbay
et al., 2013). The same method was also used to analyse tilapia ﬁllets imported into the USA (n = 36;
year of sampling not reported), but none of the samples tested positive for MG or LMG (Babu and
Ozbay, 2013).
Samples (n = 144) of rainbow trout, collected in 2011 from ﬁsh farms in Iran, were analysed for
the presence of MG/LMG using HPLC-DAD (CCa/CCb: 0.16/0.39 lg/kg for MG). MG residues (sum of
MG and LMG) were detected in 49% of the samples at concentrations ranging from 0.3 to 146.1 lg/kg
and in 33% of the samples at the level of the MRPL or higher (Fallah and Barani, 2014).
3.1.1.2. Use of malachite green as a colouring agent
In 2005, the AFC Panel reviewed the toxicology of some dyes and MG was considered in the group
of ‘dyes that have been used illegally in countries outside the EU from which spices originate and dyes
that have been used in the past as food colours in other countries but withdrawn from food use
following discovery of toxicity’ (EFSA, 2005b). Also in the scientiﬁc literature, MG has been reported to
occur as a colouring agent in food.
Ashok et al. (2014) used micellar LC-DAD (LOD/LOQ: 100/250 lg/kg) to analyse samples of green
peas (n = 8), ice candy (n = 5) and chili sauce (n = 5) that had been collected in India (year of
sampling not reported). MG was detected in six samples of green peas (concentration range:
2,350–4,490 lg/kg), three samples of ice candy (concentration range: 2,410–4,290 lg/kg) and one
sample of chili sauce (concentration: 250 lg/kg). Similar results were reported for samples collected in
India before 2002 (Tripathi et al., 2007).
Dixit et al. (2011) collected samples of candy ﬂoss, sweetened puffed rice, cream biscuits, fruit
cakes, coloured fried peas, sugar-coated fennel, cereal/pulse-based sweets, sugar toys and starch-
based savoury products including fryums (n = 5 for each product) from a local market in India (year of
sampling not reported). Analysis was done using HPLC-UV/Vis (LOD/LOQ: 0.195–0.695/0.62–2.21 mg/L
or mg/kg). MG was detected together with auramine in one sample of fryums (concentration of the
sum: 65,560 lg/kg). The same authors reported the analysis of 2,409 samples of milk-based sweets,
non-milk/cereal-based sweets and savoury items collected in India (year of sampling not reported;
Dixit et al., 2013). MG was detected in 11 samples (0.46%) at concentrations ranging from 57,400 to
231,000 lg/kg (median: 128,500 lg/kg).
The occurrence of MG in foods available on the EU market, due to use of MG as a food colouring
agent, has not been reported. The CONTAM Panel noted the illegal use of MG as a colouring agent in
samples from different foodstuffs collected in India. However, the data pertaining to foods in India are
not considered relevant for the current risk assessment.
3.1.2. Current occurrence data
3.1.2.1. National residue monitoring plans
In the period 2002–2014, at least 21,00019 targeted samples of aquaculture products (ranging from
at least 860–2,600 per year) were analysed for Subgroup B3e Dyes in all Member States and
Norway.20 For MG/LMG, 548 targeted samples were reported to be non-compliant (levels not reported,
see Section 2.1.1). The non-compliant samples were distributed across the years as shown in Figure 2.
The highest number of non-compliant samples was reported in 2006. An explanation of the limitations
of the data is given in Section 2.1.1.
19 Number of samples analysed for MG/LMG are reported by the Member States only if there is at least one non-compliant
sample found.
20 Data from Norway were extracted from the annual reports ‘Monitoring program for residues of therapeutic agents, illegal
substances, pollutants and other undesirables in farmed ﬁsh’, available for years 2006–2013. From the total of samples
analysed during these years, no residues of MG/LMG were detected.
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3.1.2.2. Rapid Alert System for Food and Feed
In the RASFF database, there were 135 notiﬁcation events21 reported for MG/LMG in food products
for the period 2002–2014, as seen in Figure 3. The notiﬁcations covered the following product
categories: ﬁsh and ﬁsh products, crustaceans and products thereof, farmed ﬁsh and products thereof
(other than crustaceans and molluscs)22 and wild-caught ﬁsh and products thereof (other than
crustaceans and molluscs).23 The highest number of notiﬁcations (50) was reported in 2005.
3.1.3. Food processing
A study was undertaken to investigate the effects of cooking, including boiling, baking and
microwaving, on residues of MG and LMG in carp muscle (Mitrowska et al., 2007). Following exposure
of the ﬁsh in a bath containing a solution of 2 mg/L MG for 3 h, the ﬁsh were euthanised and the
muscles collected. The muscle sample from the treated ﬁsh was mixed with blank material to obtain
Figure 2: Number of non-compliant results for malachite green/leucomalachite green in aquaculture
products for the period 2002–2014
Figure 3: Number of notiﬁcation events in the Rapid Alert System for Food and Feed database for
malachite green/leucomalachite green in ﬁsh and ﬁsh products for the period 2002–201424
21 The total number of notiﬁcation events is not the sum of the total number of notiﬁcations, because one notiﬁcation event may
include more than one notiﬁcation. Notiﬁcation events include alerts, border rejections, information, information for attention,
information for follow-up and news.
22 This product category is no longer used in the RASSF database.
23 Data reported as bar graphs for ﬁve of six dosed animals.
24 In 2002, one notiﬁcation is referring to farmed ﬁsh and products thereof. In 2003, nine notiﬁcations are referring to farmed
ﬁsh and products thereof and two to wild-caught ﬁsh and products thereof. In 2010, one notiﬁcation is referring to
crustaceans and products thereof.
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average concentrations of 209.8 lg/kg MG and 142.1 lg/kg LMG. HPLC with UV and ﬂuorescence
detection was used to determine the levels of MG and LMG in the samples.
Boiling (100°C) and baking (180°C) for 15 min reduced the level of MG in carp muscle by 54%,
whereas LMG showed no measurable losses under these conditions. Microwave cooking of carp muscle
for 1 min reduced the level of MG by 61% and the level of LMG by 40%. The authors concluded that
the study suggests that MG/LMG residues in ﬁsh tissue may only be partly destroyed by high-
temperature cooking.
Another study was undertaken to investigate the effects of cooking, including boiling and
microwaving, on residues of MG in Oreochromis niloticus, tilapia (Farag et al., 2012). Of 150 samples
taken from ﬁsh farms, MG residues were detected in 28 samples at concentrations ranging from 2.4 to
35.5 lg/kg, with a mean value of 11.8 lg/kg. Aliquots of the homogenised ﬁsh muscle samples were
subjected to boiling for 15 min or to microwave cooking for 1 min. The mean concentrations of MG
determined in the treated samples were 5.6 and 4.7 lg/kg following treatment by boiling or
microwave cooking, respectively. These represent a reduction by 52.5% and 60.0% following thermal
processing of the tilapia samples; measurable levels of MG were determined in all 28 samples after
processing.
Salmon samples spiked with 35 lg/kg MG and 50 lg/kg LMG were heated at 70°C for 20 min; the
recoveries of MG and LMG following this treatment were 29  2% and 81  1%, respectively. An
incurred sample, containing 2.9 lg/kg LMG, subjected to the same treatment showed a concentration of
1.9  0.3 lg/kg, representing a recovery of 65.5% after treatment (Bergwerff and Scherpenisse, 2003).
The stability of MG and LMG in rainbow trout samples stored at refrigeration and freezer
temperatures was studied (Bergwerff and Scherpenisse, 2003). Rainbow trout samples spiked with
35 lg/kg MG and 50 lg/kg LMG were stored at 4°C for up to 4 days; a reduction of approximately
40% in MG and LMG was observed. Rainbow trout samples spiked with 50 lg/kg MG and LMG and
with 500 lg/kg MG and LMG were stored at 20°C for up to 6 months; a reduction of less than 20%
MG and of approximately 10% LMG was observed. The effect of three freeze–thaw cycles on stability
of MG and LMG in rainbow trout (spiked at 35 lg/kg and 50 lg/kg, respectively) was studied and
reductions of 24% MG and 16% LMG were observed.
In conclusion, the results of these studies indicate that the concentrations of MG residues in ﬁsh
muscle are reduced by 50% or more when subjected to normal cooking conditions, such as boiling,
baking and microwaving. The concentrations of LMG residues in ﬁsh muscle are also reduced under
these cooking conditions, but to a lesser extent. Reduction in the concentrations of MG and LMG
residues in ﬁsh muscle was also observed under refrigeration, freezing and repeated freezing/thawing
conditions; again, the reduction of MG residues was greater, generally, than that of LMG residues.
3.2. Dietary exposure assessment for malachite green in humans
3.2.1. Previously reported exposure assessments in humans
Based on data collected in the UK between 1995 and 2006, showing mean and P97.5 levels of
30.7 and 138 lg/kg ﬁsh for the sum of MG and LMG (expressed as LMG), JECFA (FAO/WHO, 2009)
estimated exposure levels of 150 and 690 ng/kg bw per day for the average and high (P97.5) intake
(assuming a portion size of 300 g for an adult of 60 kg). A very similar range of exposure was
estimated by Rauscher-Gabernig et al. (2007) for high ﬁsh consumers in the Austrian population, being
830 ng/kg bw per day for children (3–6 years of age), 420 ng/kg bw per day for adult women and
510 ng/kg bw per day for adult men. A much lower exposure of 0.27 and 3.8 ng/kg bw per day was
reported for children and adults by Schuetze et al. (2008). Also, Benford et al. (2010) arrived at a
much lower exposure of 5 (average) and 50 (P95) ng/kg bw per day, even though this was considered
to be a highly conservative estimate. Similar exposure was estimated by Chu et al. (2013), who
performed a probabilistic exposure assessment for the Taiwanese population and arrived at intake
levels of 13.5 and 45.1 ng/kg bw per day for the average and high (P95) consumer. FSANZ calculated
the exposure based on one MG level in climbing perch and arrived at an intake of 11 ng/kg bw for an
adult consuming 100 g of this ﬁsh (FSANZ, 2007). The NFI of Denmark and DTU made an assessment
on the highest observed level of 28 lg/kg ﬁsh, resulting in a highest exposure of 48 ng/kg bw per day
for a 60-kg person consuming 100 g ﬁsh (NFI and DTU, 2007).
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3.2.2. Current exposure assessment in humans
The CONTAM Panel noted the illegal use of MG as a colouring agent in samples from different foodstuffs
collected in India (see Section 3.1.1). However, in Europe the occurrence of MG in foods due to use of MG
as a food colouring agent has not been reported to date. The occurrence of MG as a colouring agent in
food is therefore not included in the current exposure assessment. As the use of MG in food-producing
animals is limited to ﬁsh and crustaceans, the CONTAM Panel considers it unlikely that MG occurs in other
foods of animal origin and the exposure assessment is therefore limited to ﬁsh and crustaceans.
Only limited occurrence data on MG and LMG in food were available for this opinion (see
Section 2.1.1 for an explanation of the limitations of the data). Therefore, the CONTAM Panel concluded
that these data are not suitable to carry out a reliable human dietary exposure assessment.
The CONTAM Panel calculated the hypothetical human chronic dietary exposure using the RPA
value of 2 lg/kg for all types of ﬁsh, ﬁsh products and crustaceans (excluding aquatic molluscs), and
the results are presented in Table 1. Therefore, it should be noted that all reference to ‘dietary
exposure’ in this and the following section is not based on actual occurrence data but refers to the
hypothetical chronic dietary exposure based on the RPA value.
The mean dietary exposure and the high dietary exposure (P95) to MG/LMG were calculated
separately for each survey and age class using consumption data recorded at individual level from the
Comprehensive Database (see Section 2.1.2). In accordance with the speciﬁcation of the EFSA
Guidance on the use of the Comprehensive Database (EFSA, 2011a), 95th percentile estimates for
dietary surveys/age classes with fewer than 60 observations may not be statistically robust and
therefore are not considered in the risk characterisation.
The median MG/LMG dietary exposure for average consumers varied between 0.4 ng/kg bw per
day in the infants group and 1.2 ng/kg bw per day in the toddlers group, across dietary surveys. The
median dietary exposure for high consumers ranged from 1.4 ng/kg bw per day in the infants group to
5.5 ng/kg bw per day in the toddlers group. The highest maximum dietary exposure for average
consumers was seen in the toddlers group, although the highest maximum dietary exposure for high
consumers was seen in the other children group.
The CONTAM Panel also noted that, for the other children group, the difference between the
maximum for the mean and for the 95th percentile dietary exposure is substantial. This can be
explained by taking into consideration the different consumption levels of ﬁsh and ﬁsh products among
the two age groups, as well as the range of ages covered by each of them. In the toddlers group
(12 months –< 36 months old), there is not a big difference between consumption at the mean and
95th percentile as the consumption of ﬁsh and ﬁsh products is relatively low in the age range covered
by this group. On the contrary, the other children group covers a wider age range (36 months to
< 10 years old) and this is why different consumption levels of ﬁsh and ﬁsh products may occur
between, for example, a 3- and a 9-year-old subject.
Table 1: Summary statistics(a) for the hypothetical chronic dietary exposure (ng/kg bw per day) to
malachite green/leucomalachite green estimated by age class for the scenario(b)
Age class Number of surveys
Hypothetical chronic dietary exposure
Minimum Median Maximum
Mean
Infants 6 0.1(d) 0.4 1.1
Toddlers 10 0.5 1.2 5.0
Other children 18 0.3 1.1 2.7
Adolescents 17 0.2 0.6 1.5
Adults 17 0.2 0.6 1.9
Elderly 14 0.1 0.7 1.9
Very elderly 12 0.1 0.7 1.8
95th percentile(c)
Infants 5 0.0(d) 1.4 5.8
Toddlers 7 3.3 5.5 6.2
Other children 18 2.3 4.7 9.1
Adolescents 17 1.6 2.7 5.7
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The dietary exposure to MG/LMG was also calculated for pregnant and lactating women based on
food consumption data originating from two surveys, one for each population group. The mean dietary
exposure estimates (0.6 ng/kg bw per day for pregnant women and 1.0 ng/kg bw per day for
lactating women) as well as the 95th percentile dietary exposure estimates (3.0 ng/kg bw per day for
pregnant women and 3.2 ng/kg bw per day for lactating women) were similar to the respective mean
and high (P95) exposures for the adults group.
3.2.3. Dietary exposure to MG/LMG for speciﬁc groups
3.2.3.1. High and frequent ﬁsh consumers
There is a concern that high and frequent consumers of ﬁsh might have elevated levels of MG/LMG
dietary exposure. To test such a hypothesis, the 95th percentile hypothetical chronic dietary exposure
from the daily consumption of ﬁsh among ‘consumers only’ was retrieved from the Comprehensive
Database for surveys in which the number of selected participants exceeded 60.
The minimum, median and maximum of the 95th percentile MG/LMG dietary exposures for ﬁsh
consumers are shown in Table 2. The dietary exposure estimations in high and frequent consumers
varied from a minimum of 1.3 ng/kg bw per day in the adults group to a maximum of 11.8 ng/kg bw
per day in the toddlers group.
High and frequent ﬁsh consumers were also present among pregnant women. The dietary exposure
to MG/LMG for high and frequent ﬁsh consumers in this population group was calculated based on
food consumption data originating from one survey. The 95th percentile dietary exposure estimate
(4.1 ng/kg bw per day for pregnant women) was similar to that for the adults group.
Age class Number of surveys
Hypothetical chronic dietary exposure
Minimum Median Maximum
Adults 17 1.6 3.0 4.9
Elderly 14 1.2 2.9 5.2
Very elderly 9 1.1 2.7 3.6
bw: body weight.
To avoid the impression of too high a precision being used, the numbers for all exposure estimates are rounded to two ﬁgures.
(a): The minimum, median and maximum of the mean and 95th percentile exposure values across dietary surveys in European
countries are shown.
(b): This scenario contains all type of ﬁsh, ﬁsh products and crustaceans (excluding aquatic molluscs) that are contaminated with
malachite green/leucomalachite green at a concentration equal to the reference point for action of 2 lg/kg.
(c): The 95th percentile estimates obtained from dietary surveys/age classes with fewer than 60 observations may not be
statistically robust (EFSA, 2011a) and therefore are not included in this table.
(d): The lower minimum for the 95th percentile exposure in comparison to the minimum for the mean exposure is due to a very
low number of infants (< 5%) consuming a high amount of ﬁsh in one survey resulting in the mean being higher than the
95th percentile in that survey.
Table 2: Summary statistics(a) for the hypothetical chronic dietary exposure (ng/kg bw per day) to
malachite green/leucomalachite green estimated by age class for ﬁsh consumers(b)
Age class
Number of
surveys
95th percentile hypothetical chronic dietary exposure in
ﬁsh consumers
Minimum Median Maximum
Infants 3 2.8 4.3 6.6
Toddlers 5 2.6 6.1 11.8
Other children 15 3.1 6.6 9.7
Adolescents 14 1.6 4.3 8.9
Adults 16 1.3 3.8 5.2
Elderly 10 1.5 3.6 5.2
Very elderly 6 2.3 3.5 4.4
bw: body weight.
(a): The minimum, median and maximum of the 95th percentile exposure values across dietary surveys (with more than
60 consumers) in European countries are shown.
(b): This scenario contains all type of ﬁsh, ﬁsh products and crustaceans (excluding aquatic molluscs) that are contaminated with
malachite green/leucomalachite green at a concentration equal to the reference point for action of 2 lg/kg.
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The 95th percentile of the dietary exposure to MG/LMG is higher in the toddlers group for the high
and frequent ﬁsh consumers, although it is not very different from that in the other children group.
However, this was the reverse of that for the dietary exposure for all population, consumers and non-
consumers. This is explained by the different percentage of ‘ﬁsh consumers-only’ between these two
age groups. The toddlers ‘ﬁsh consumers-only’ account for 41% of the toddlers’ population, whereas
the other children ‘ﬁsh consumers-only’ account for 32% of the other children population.
3.2.4. Non-dietary exposure
Additional exposure may occur from the permitted use of MG as an industrial dye for a wide range
of manufactured goods. MG is commonly used in the manufacture of silk, jute, wool, cotton, leather,
paper and acrylic products (Hidayah et al., 2013). Other uses of MG relate to its use as a biological
stain for microscopic analysis, such as for bacterial cells, and LMG may be used in forensic science to
identify the presence of blood (haemoglobin catalyses a reaction between colourless LMG and
hydrogen peroxide to produce coloured MG). Another forensic use for MG is as a powder on money,
leading to a green stain on the hands of a person handling the money.
Although the use of MG/LMG as a biological stain or in forensics is unlikely to result in substantial
exposure of the general population, its use to dye manufactured products could result in exposure,
particularly for certain groups, such as children, who might be inclined to sucking these products. In
addition, there may be release of the dye into water sources and subsequent exposure through water
and food. However, in the absence of data relating to the exposure of persons to MG from these
various sources, an assessment of human non-dietary exposure is not possible.
3.3. Hazard identiﬁcation and characterisation
3.3.1. Toxicokinetics
Despite its extensive use in the dyeing industry and in aquaculture, with the known presence of
residues in aquatic organisms, there is limited knowledge on the kinetics of MG in mammalian and
piscine species. Most of the available information is related to the biotransformation of the dye and the
form(s) under which it may accumulate in edible tissues of ﬁsh and crustaceans (FAO/WHO, 2009).
In aqueous solutions, MG is in equilibrium with a colourless hydrated derivative referred to as MG
carbinol or pseudobase (Figure 4).
The rate of carbinol formation is negligible at pH < 2, slow at pH between 2 and 8, and very fast at
pH 10 or higher, and may also increase with an increase in temperature (El Hajj Hassan et al., 2011).
According to Albert (Albert, 1979 as cited in Srivastava et al., 2004), the carbinol derivative displays a
higher liposolubility than MG and it is very likely that the dye is absorbed as MG carbinol by aquatic
organisms.
Very limited information is available concerning MG absorption and disposition in mammals. Upon a
single exposure of rats to radiolabelled MG, most of the radioactivity is found in the excreta (Law,
1994); in another study, a signiﬁcant contribution from biliary excretion was reported in rats treated
with unlabelled MG (Debnam et al., 1993).
In ﬁsh, MG is rapidly taken up mainly via the gills and both the absorption rate and peak blood
concentrations are dependent on water temperature (Poe and Wilson, 1983; Alderman and Clifton-
Hadley, 1993).
The main biotransformation reactions undergone by MG are reductive and oxidative in nature.
Reduction of MG yields the colourless derivative LMG (Figure 1, see Section 1.3.3). This reaction may
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Figure 4: Chemical structure of malachite green (MG) and MG carbinol
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be accomplished by the intestinal microﬂora (Singh et al., 1994; Henderson et al., 1997); the role
played by the gills in MG absorption and the extent of conversion of MG to LMG (see below) indicate
that MG reduction to LMG could also occur in tissues, at least in piscine species. In treated ﬁsh, MG is
rapidly cleared from the body while LMG is the predominant form in edible tissues where it may
accumulate and persist for a long time due to a very slow excretion rate (Plakas et al., 1996; Alborali
et al., 1997; Jiang et al., 2009).
No information could be retrieved concerning the nature of enzyme(s) performing the reductive
biotransformation of MG to LMG in both laboratory and target species. An in vitro study was designed
with the ﬁlamentous fungus Cunninghamella elegans, which has been used in several instances as a
model for mammalian metabolism (Cerniglia, 1997). Based on the effects of nicotinamide adenine
dinucleotide phosphate (NADPH) omission or the addition of metyrapone, a cytochrome P450 (CYP)
inhibitor, it appears that CYP is involved in the generation of LMG (Cha et al., 2001).
In vivo studies carried out in mammalian species (Culp et al., 1999) have demonstrated that the
oxidative MG pathway mainly entails the sequential N-demethylation of the dye to yield mono-, di-, tri,
and tetra-desmethyl derivatives (Figure 5); the generation of MG N-oxides could also be demonstrated
in liver (see below). The same metabolic pathway (i.e. a sequential N-demethylation) was also found
to occur for LMG in either MG- or LMG-treated rats (Culp et al., 1999). The detection of both MG-N
oxide and LMG N-demethylated metabolites in ﬁllets from MG-treated catﬁsh strongly supports the
occurrence of a similar biotransformation pathway in ﬁsh (Doerge et al., 1998).
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No papers could be found in the open literature on the identity of the enzyme(s) carrying out the
oxidative metabolism of MG and LMG in vertebrates. The cited in vitro study, utilising cultures of
C. elegans (Cha et al., 2001), provided indication of CYP involvement in the production of
N-demethylated derivatives. The same conclusions were reached in a PhD dissertation (Giuliano Albo,
2003) in which the oxidative metabolism of the dye was investigated in rat and trout liver microsomes.
The capacity of extrahepatic enzymes to perform the N-demethylation of LMG was assessed
in vitro; it could be demonstrated that, in the presence of tyrosine, iodide and H2O2, thyroid
peroxidase (TPO) was effective in the biotransformation of LMG, generating desmethyl LMG,
di-desmethyl LMG, tri-desmethyl LMG, MG itself, and MG N-oxide (Doerge et al., 1998). This pathway
has been implied in the LMG-mediated competitive TPO inhibition, which could explain the negative
effects on thyroid function (decreased thyroxine (T4) and increased thyroid-stimulating hormone
(TSH)) observed in LMG-treated rats (Culp et al., 1999).
The primary and secondary amines resulting from the sequential N-demethylation of MG and LMG
closely resemble carcinogenic amines such as gentian violet or pararosaniline (Doerge et al., 1998).
The previously mentioned isolation of MG N-oxides from liver extracts of MG-treated rats supports the
hypothesis that, similar to many carcinogenic amines, the N-demethylated metabolites may enter an
oxidative bioactivation pathway (N-hydroxylation followed by the formation of N-oxides; Figure 6)
generating reactive intermediates, which have been associated with the formation of liver- and thyroid
DNA adducts as detected by 32P-postlabelling in treated animals (Culp et al., 1999).
Little is known about the role of phase II enzymes in MG/LMG biotransformations. In MG-treated
rats, evidence has been provided concerning the formation and the biliary excretion of an
MG-glutathione (GSH) adduct (Debnam et al., 1993); however, a direct involvement of GSH-S-
transferases (GSTs) has not been demonstrated, the enzyme(s) being instead strongly inhibited by the
dye (see below). The spontaneous in vitro formation of MG adducts with GSH and other (protein)
thiols (Figure 7) has been thoroughly characterised by indirect spectrophotometric methods (Reuben
and Bruice, 1976; Debnam et al., 1993; Eldem and €Ozer, 2004), although no such studies have been
performed with MS techniques that would allow identiﬁcation of the GSH-conjugates.
A number of in vitro studies indicate that, in tissue preparations, MG is able to inhibit a number of
xenobiotic metabolising enzymes including several rat liver CYP-dependent monooxygenases and the
NADPH CYP-reductase (Beyhl, 1981) as well as hepatic rat (Debnam et al., 1993) or human (Glanville
and Clark, 1997) GSTs. The relevance of the results of such studies under in vivo conditions remains to
be established.
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3.3.1.1. Laboratory animals
In vivo studies
Rats of both sexes (n = 3) were administered a single dose of 14C-MG (2 mg/kg bw) by gavage,
and faeces and urine were collected daily. Animals were sacriﬁced after 7 days and samples of kidney,
liver, muscle and blood were taken. At that time, 14C equivalents were in the sub lg/kg range and in
the order liver > kidney > skin > muscle.23 Over the whole study period, most of the radioactivity
(mean  standard deviation (SD) = 96  6%) was recovered from the excreta; at each time point,
faecal radioactivity was largely prevailing over urinary radioactivity, accounting for more than 80% of
the cumulative 14C excretion. Due to low levels of blood and tissue radioactivity, the nature of residues
was not investigated further (Law, 1994). Biliary excretion was studied in rats with a cannulated bile
duct (number not speciﬁed) treated with MG (2–7 mg/kg bw) by the intravenous route; it was found
that MG is rapidly excreted via the bile, very likely as a GSH adduct, reaching a peak 20 min after
dosing (Debnam et al., 1993).
The nature and the amount of MG/LMG metabolites were investigated in rat and mice liver extracts
after a short-term feeding study with either MG or LMG (Culp et al., 1999). Male Fischer 344 rats and
female B6C3F1 mice (6–7 week old, n = 8 per dose group) were fed 0, 100, or 600 mg MG/kg diet or
0, 96, or 580 mg LMG/kg diet. After 28 days of feeding, animals were sacriﬁced and liver extracts
were subjected to chemical analysis by HPLC-UV and, for rats only, by HPLC in combination with
atmospheric pressure chemical ionisation–mass spectrometry (APCI–MS). With APCI–MS analysis, liver
extracts from MG fed rats showed the presence of mono-, di-, tri-, and tetra-desmethyl MG derivatives
as well as MG N-oxide and a small but measurable amount of LMG. The quantitative analysis of liver
extracts from treated rats and mice was performed by HPLC-UV. In MG-fed animals, the dye itself was
the most abundant compound followed by mono- and di-desmethyl MG and LMG, and, in the case of
rats, also mono- and di-desmethyl LMG. A dose-related increase in the concentration of MG and its
metabolites was observed. A more complex picture was observed in chromatograms from rats
administered LMG, showing not only LMG and four N-demethylated derivatives, but also MG mono-
and di-desmethyl derivatives, MG N-oxide and a little but measurable amount of MG itself.
In vitro interactions with xenobiotic metabolising enzymes
A study was designed to investigate the in vitro interactions of triphenylmethane dyes (including
MG) with hepatic xenobiotic metabolising enzymes. The incubation of MG 0.1 mM with rat liver
preparations resulted in the inhibition of different CYP-dependent monooxygenases to an extent
ranging from about 90% (aminopyrine N-demethylase) to about 50% (anisic ester O-demethylase),
while NADPH CYP-reductase was also inhibited by 30%. Most of the tested triphenylmethane dyes
inhibited the different monooxygenases to a similar extent. It was concluded that the observed dye-
mediated inhibition could be due not only to a direct interaction with the haemoprotein, but also to the
redox properties of many tested compounds – including MG – hampering the electron transfer to the
CYP-complex by NADPH CYP-reductase (Beyhl, 1981).
The interactions between MG and GSTs were investigated in rat liver preparations. The dye was
found to inhibit the tested GST classes (1-1 and 1-2) by a partial non-competitive mechanism, with a
inhibition constant (Ki) in the micromolar range; the MG–GSH adduct was believed to contribute
signiﬁcantly to the observed inhibition (Debnam et al., 1993).
3.3.1.2. Humans
No data on the toxicokinetics of MG in humans could be found in the open literature. The only
reference to human data is the in vitro capacity of human faecal microﬂora to almost completely
reduce MG to LMG (Henderson et al., 1997).
The three main human GST classes (a, l, p)25 were expressed in Escherichia coli and tested for
their sensitivity to inhibition by MG and other basic triphenylmethane dyes. All three GST classes were
inhibited by MG in a non-competitive manner displaying Ki values in the order of 0.3 lM (p), 10 lM (a)
or 70 lM (l). Despite GSH–MG adduct formation being demonstrated, the nature of the inhibitor
(adduct or free dye) was not established (Glanville and Clark, 1997).
25 Currently referred to as A, M and P (Mannervik et al., 2005).
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3.3.1.3. Fish and crustaceans
Fish
Uptake, accumulation and depuration of MG has been studied in herbivorous, omnivorous and
carnivorous freshwater ﬁsh (Parabramis pekinensis, Carassius auratus and Ophiocephalus argus,
respectively) following acute aquatic exposure (6 mg/L for 20 min) (Jiang et al., 2009). MG and LMG
concentrations were measured at six time points (0, 2, 4, 24, 96 and 240 h) in blood, muscle, liver,
kidney, gill and skin from all three ﬁsh species (and in abdominal fat of P. pekinensis, which was
present in the other two species at insufﬁcient quantities for dissection). The highest concentrations of
MG were in gill tissue of ﬁsh sampled immediately after exposure (P. pekinensis, 5.1 mg/kg;
C. auratus, 5.6 mg/kg and O. argus, 7.2 mg/kg). Most MG was rapidly converted to LMG in the ﬁsh
and depuration of LMG was slow in fat tissue, skin and gonads of the ﬁsh. The highest mean MG level
in fat in P. pekinensis was 2.4 mg/kg at 24 h, whereas LMG concentrations increased with time,
achieving a maximum concentration of 8.5 mg/kg at 240 h. Distribution of LMG in ﬁsh was dependent
on the fat content in the tissue, but not related to the different feeding habits of the ﬁsh species.
The effects of salinity and ﬁsh size on elimination of MG was investigated in tilapia (Oreochromis
spp.) by Yang et al. (2010). Small tilapia (45  10 g; mean  SD) were exposed to 0.5 mg or 2 mg
MG/L for 1 h in fresh water, or 2 mg MG/L in brackish water (15& salinity). The fourth treatment
involved large tilapia (150  20 g), which were exposed to 2 mg MG/L for 1 h in fresh water. Both MG
and LMG were rapidly eliminated from tilapia muscle tissue with elimination of MG being more rapid
than that of LMG. The elimination of both MG and LMG was faster from large ﬁsh than from small ﬁsh.
Salinity of the pond water had no apparent effect on the elimination rate of MG or LMG from small
tilapia. Higher MG and LMG concentrations were present in ﬁsh from the high exposure group (2 mg/L)
than in the low-dose group (0.5 mg/L), the elimination rates being comparable at both concentrations
such that the residues were detected for a longer time in ﬁsh exposed to 2 mg/L.
MG residues in muscle, eggs, and fry of Atlantic salmon (Salmo salar) and chinook salmon
(Oncorhynchus tshawytscha) were determined colorimetrically after repeated exposure (10–47 times)
to 1 mg/L for 1 h at ﬁsh hatcheries (Allen, 1990). Residues in eggs from treated females were
0.1–4.2 mg/kg in Atlantic salmon and 0.1–1.0 mg/kg in chinook salmon; with little relation between
the residue concentrations in the eggs and the time elapsed since the last treatment. Residues of MG
in fry from treated chinook salmon ranged from 0.14 to 1.16 mg/kg.
Kasuga et al. (1992) examined the elimination of MG from rainbow trout (Oncorhynchus mykiss)
following exposure to 1 mg/L for 1 h. Highest concentrations of MG were found in kidney
(approximately 3.4 mg/kg after 2 h) and liver (approximately 2.4 mg/kg immediately following
treatment) and lower concentrations in serum (approximately 0.8 mg/kg immediately following
treatment) and muscle (approximately 0.5 mg/kg after 4 h). MG in serum, liver and muscle gradually
decreased over time and levels were below the LOD (20 lg/kg) after 21 days. The depletion from
kidney was slow, and at the end of the study (42 days) the MG level was 0.22 mg/kg.
Machova et al. (1996) exposed rainbow trout to 0.2 mg MG/L for 6 days. Immediately after
treatment, the sum of MG and LMG concentrations in muscle, liver and skin were 0.71, 0.83 and
0.65 mg/kg, respectively. Eight weeks after exposure, MG was below the LOD (1 lg/kg) in muscle and
liver, whereas it was measurable in skin (0.011 mg/kg). The sum of MG and LMG was still detectable
in ﬁsh skin 10 months after exposure whereas after 12 months no residues were detected.
Rainbow trout (60–80 g) were exposed to MG (1 mg/L) for 1 h and then put into clean water. The
same treatment was repeated for a total of 7 days. Total tissue MG residues were determined after
LMG oxidation with PbO2 with an HPLC method (LOD: 1 lg/kg). MG concentrations in ﬁllets peaked at
about 30 days after cessation of treatment (nearly 6 mg/kg) were around 0.2 mg/kg at 90 days, and
then slowly declined reaching the LOD value (1 lg/kg) at 283 days post-treatment (Alborali et al.,
1997). Alderman and Clifton-Hadley (1993) examined the uptake, distribution and elimination of MG in
rainbow trout following exposure to 1.6 mg/L for 40 min, and water temperature maintained at either
8°C or 16°C. All three processes were temperature dependent, with rates and levels increasing with
higher water temperature. Peak MG concentrations were found in serum (13 mg/L), liver (9 mg/kg)
and kidney (8 mg/kg) immediately after exposure, at 8°C, and in kidney (34 mg/kg), liver (16.5 mg/kg)
and serum (13.5 mg/L) at 16°C. Peak MG levels in muscle were found after 90–120 h, and were
7.8 mg/kg at 8°C and 10.8 mg/kg at 16°C. Elimination half-lives of MG from tissue were 30, 13 and
4 days at 8°C, and 5.8, 5.7 and 2.9 days at 16°C for kidney, liver and muscle, respectively. Residues in
kidney above 1 mg/kg were detected after 24 days. Law (1994) exposed trout at 10°C to 2 mg
14C-labelled MG/LMG for 1 h and sampled ﬁsh at intervals until 505 h post treatment. The highest
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concentrations of residues were found in liver and kidney; residues were also found in skin. Elimination
half-lives were 28 h for MG and 197 h for LMG.
Bajc et al. (2011) examined the uptake, accumulation and depuration of MG in muscle and skin of
rainbow trout and carp. Rainbow trout was exposed to 1 mg MG/L for either 1 or 3 h, or 1.5 mg/L for
1 h. Increasing the dose of MG did not signiﬁcantly affect the residue levels in rainbow trout (0.45 and
0.53 mg MG/kg in the 1 and 1.5 mg/L groups, respectively); however, exposure duration had a major
inﬂuence. Rainbow trout exposed three times longer contained 4.5 times more MG (2.1 mg/kg) and
two times more LMG (6.0 mg/kg) 1 day after exposure compared with the trout in the 1-h bath
treatment (0.45 mg MG/kg and 2.8 mg LMG/kg). The LMG concentration in trout exposed to 1 mg
MG/L for 3 h continued to increase after removal from the treatment, reaching up to 9.7 mg LMG/kg
after 4 days. The level of MG in rainbow trout decreased rapidly and, 1 day after treatment, about
74% of total residues were in the leuco-form. Levels of MG in ﬁsh fell below the CCb (0.6 lg/kg) after
58 days in the group exposed to 1 mg/L for 1 h, and below the CCb after 142 days in the group
exposed to the same concentration for 3 h. Carp were exposed to higher concentrations of MG than
rainbow trout; 2 mg/L for 1 or 3 h, or 4 mg/L for 1 h. Nevertheless, they accumulated less MG than
rainbow trout and the elimination of LMG was slower, which may reﬂect the lower water temperature
used for carp.
Mitrowska et al. (2008b) investigated the tissue distribution and persistence of MG and LMG in carp
after exposure to 2 mg MG/L for 3 h. MG was rapidly and extensively metabolised to LMG, which was
slowly eliminated from the tissues. Higher concentrations of MG and LMG were found in the gills, liver
and kidney than in the spleen and muscle. MG was more persistent in kidney, liver and spleen (up to
112 days, LOQ: 0.5 lg/kg) than in the gills and muscle tissue (up to 56 days). LMG concentration
declined more slowly than MG in all tissues, and was still detectable in kidney and muscle 252 days
after treatment.
The residue pattern of MG and its metabolites was studied in ﬁllets from mature catﬁsh using an
LC/MS method with LODs of 0.02 and 0.5 lg/kg for MG and LMG, respectively (Doerge et al., 1998).
Fish were exposed to 1 mg/L MG oxalate for 1 h, then transferred to a tank containing clean water
and killed 24 h after dosing. The concentrations of LMG in ﬁllets were almost twice those of MG;
further metabolites were also detected including MG N-oxide and the mono-, di-, and tri-desmethyl
LMG derivatives (not quantiﬁed). In the same study, the presence of the same analytes was also
investigated in trout ﬁllets purchased from retail outlets in the UK in 1994–1995. The concentrations of
MG ranged from 0.0004 to 0.0034 mg/kg while those of LMG ranged from 0.009 to 0.096 mg/kg;
signals consistent with the presence of MG N-oxide and both mono- and di-desmethyl MG were also
observed, and in one ﬁllet sample they were estimated to be 0.035, 0.018 and 0.006 mg/kg,
respectively. The authors concluded that the occurrence of metabolites bearing the structure of
primary arylamines in ﬁsh ﬁllets might represent a potential concern for the consumer.
Plakas et al. (1996) examined the distribution of radiolabelled MG in channel catﬁsh
(Ictalurus punctatus) for 2 weeks after waterborne exposure to 0.8 mg/L for 1 h and also the effects
of pH 6, 7 or 8 on MG and LMG accumulation. Mean water quality variables were 21°C, dissolved
oxygen was 8 mg/L, and the pH was 7.1 in the control group. The peak concentrations of radioactive
residue in bile, plasma and tissue are shown in Table 3.
Table 3: Peak concentrations of radioactive residue (mg equivalents MG/kg or L) in bile, plasma and
tissue in channel catﬁsh (Plakas et al., 1996)
Tissue Concentration (mg equivalents MG/kg or L) Time after cessation of exposure (h)
Bile 101  41.2 24
Liver 33.4  7.45 0
Fat 30.3  6.39 168
Head kidney 24.6  4.86 0
Trunk kidney 22.0  5.38 0
Spleen 10.9  2.49 0
Plasma 6.36  1.51 0
Skin 3.99  0.68 0
Muscle 3.18  0.72 0
MG: malachite green.
Mean  standard deviation for ﬁve animals per time point.
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MG in plasma had an elimination half-life of 4.7 h, whereas in muscle the elimination half-life was
approximately 67 h. MG was rapidly and extensively metabolised to LMG, which was slowly eliminated
from the tissues. The rate of MG accumulation was related to pH of the exposure water. The sum of
MG and LMG concentrations was eight times higher in plasma (approximately 16 mg/L vs 2 mg/L) and
ﬁve times higher in muscle (approximately 3 mg/kg vs 0.6 mg/kg) after exposure at pH 8 compared to
MG levels in ﬁsh treated at pH 6.
The accumulation, distribution and excretion of MG and LMG were examined in channel catﬁsh
blood and tissue (muscle, liver, skin and kidney) following exposure to 7 mg MG/L for 5 min (Liu et al.,
2013). Experimental conditions were monitored daily, the average water temperature was 26.4°C and
the pH was 7.5–8.0. Peak concentrations of MG and LMG in blood were 0.118 and 0.203 mg/L after
4 and 6 h, respectively. The elimination half-lives for MG and LMG in blood were 113 and 106 h,
respectively. The peak concentration of MG in skin was 2.03 mg/kg after 4 h, in muscle 0.49 mg/kg
after 1 h, in kidney 0.27 mg/kg after 0.5 h and in liver 0.14 mg/kg after 4 h. The half-lives of MG in
muscle, skin, liver and kidney were 3.2, 4.1, 4.8 and 14.4 days, respectively. MG was not detectable in
liver after 30 days, in muscle after 45 days, and in skin or kidney after 60 days. The peak
concentration of LMG in liver of channel catﬁsh was 5.58 mg/kg after 0.5 h, in skin and muscle 1.21
and 0.87 mg/kg, respectively, after 8 h, and in kidney 0.36 mg/kg after 48 h. The half-lives of LMG in
muscle, skin, liver and kidney were 7.2, 9.6, 4.1 and 14.4 days, respectively. LMG was not detectable
in liver after 60 days, or in the other tissues at the end of the experiment, namely 90 days.
Yang et al. (2013a) examined the elimination of MG and LMG from Channel catﬁsh following the
administration of 1 mg/L to the water (analysed peak water concentration 46 lg MG/L after 24 h).
Dorsal muscle and skin were analysed for MG and LMG after 1, 3, 5, 10, 15, 30, 45, 60, 90, 120, 180,
210, 240, 270, 300, 330 and 360 days following exposure. One day after exposure, the peak
concentrations of MG in muscle and skin tissue were 42.77  5.26 and 6.36  0.11 lg/kg,
respectively, and elimination half-lives were 57.8 days and 31.5 days, respectively. The peak
concentrations of LMG in muscle (502.3  20.43 lg/kg) occurred 3 days after exposure whereas the
highest concentration in skin (125.3  12.8 lg LMG/kg) occurred after 1 day. Elimination half-lives for
LMG were 33.0 and 38.5 days for muscle and skin, respectively.
The elimination of MG and LMG was studied for 100 days in glass eels (Anguilla anguilla) following
exposure to 0.1 mg MG/L for 24 h (Bergwerff et al., 2004). The highest mean MG concentration in eel,
4.35  0.59 mg/kg (mean  SD) was found 6 h after treatment commenced. The LMG levels in eel
were relatively high (> 0.1 mg/kg) from about 2 h after treatment, with a maximum LMG concentration
of 0.83  0.23 mg/kg occurring after 3 days. LMG was eliminated slowly from eel and residues remained
100 days after exposure (0.015 mg/kg).
Crustaceans
The accumulation and elimination of MG was studied in Paciﬁc white shrimp (Litopenaeus vannamei)
following exposure to 0.15 mg/L for 2 h (Yang et al., 2013b). Experimental conditions were: water
temperature: 28–33°C, pH: 7.8–7.9, salinity: 28&, dissolved oxygen: 6.83–7.11 mg/L. Peak
concentrations of MG and LMG were found immediately after exposure (0.273 and 0.519 mg/kg,
respectively). MG was eliminated rapidly from the shrimp, and was below the LOD (0.5 lg/kg) after
3 days, whereas LMG elimination was slower, being below the LOD after 9 days. Similarly, Chen et al.
(2013) found peak levels of MG and LMG in Paciﬁc white shrimp muscle and head immediately after
exposure to 0.2 mg/L for 2 h (0.02 mg MG/kg and 0.079 mg LMG/kg, and 0.185 mg MG/kg and
0.392 mg LMG/kg in muscle and head, respectively). Experimental conditions were: water temperature:
25–30°C, pH: 7.7–7.8, salinity: 28&, dissolved oxygen: 6.7–7.2 mg/L. Both MG and LMG elimination were
more rapid from head than muscle tissue, and LMG was eliminated from both tissues more slowly than
MG (MG was below the LOD (0.5 lg/kg) in shrimp head after 3 days and in muscle after 4 days, whereas
LMG was below the LOD in shrimp head after 5 days and in muscle after 7 days. The difference in results
from the two studies may be accounted for by the different life stage used in the two experiments; Yang
et al. (2013b) used shrimp seed of approximately 0.9 cm, whereas Chen et al. (2013) conducted their
study on prawns of approximately 4–5 cm and weight of 1.33–2.41 g. Consequently, the whole animals
were analysed for MG and LMG in the former trial, whereas the latter examined concentrations in head
and muscle tissue separately.
Exposure to LMG through feed
Seel-audom et al. (2013) examined the accumulation and effects of diet-borne LMG in Nile Tilapia
(O. niloticus) fed experimental diets containing nominal concentrations of 0, 0.1, 0.5 or 2.5 mg LMG/kg
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(measured values 0.104, 0.510, and 2.2 mg/kg) for 28 days. The concentrations of LMG in liver and
muscle were 0, 0.0119, 0.0483, 0.231 mg/kg in liver and 0, 0.0068, 0.0262, and 0.0917 mg/kg in
muscle, respectively.
3.3.1.4. Accumulation in edible tissue
Maximum levels of MG in edible tissue of ﬁsh, i.e. in muscle, occur immediately after exposure
whereas peak levels of LMG tend to occur later (hours to days) depending on the ﬁsh species, the MG
exposure concentration and duration, and environmental conditions such as temperature and pH.
Limited studies on crustaceans (shrimp) indicate that levels of both MG and LMG fell below the LOD
(0.5 lg/kg) after some days following treatment.
3.3.1.5. Conclusions
There is limited knowledge on the kinetics of MG and its metabolites in mammalian and piscine
species, the published studies being mostly focused on occurrence of the parent compound and its
derivatives in tissues. The main metabolite is LMG, the reduced form of MG, which is slowly excreted and
may be stored in ﬁsh edible tissues for a long time after exposure. An oxidative pathway, likely mediated
by CYPs and other (per)oxidases, has been demonstrated entailing the sequential N-demethylation of
both compounds. This results in the formation of N-demethylated metabolites (structurally similar to
carcinogenic amines), which have been found to occur in ﬁsh ﬁllets. Apart from the likely spontaneous
generation of a MG–GSH adduct, which is reported to undergo biliary excretion in rats, no information
could be found on the involvement of other conjugation reactions in MG/LMG biotransformation.
3.3.2. Toxicity in experimental animals
3.3.2.1. Acute toxicity
For female Sprague–Dawley rats an oral median lethal dose (LD50) for MG-oxalate (purity not
given) of 520 mg/kg bw (95% conﬁdence limits 433–624 mg/kg bw) was reported by Meyer and
Jorgenson (1983). Observed effects included depression, prostration, emaciation, coma and death.
The oral LD50 for MG-oxalate (purity ≥ 90%) in Wistar rats was 275 mg/kg bw. No sex differences
were observed. Major acute effects were hyperaemia and atonia of the intestinal walls, often in
association with dilatation of the gastrointestinal tract (Clemmensen et al., 1984).
3.3.2.2. Repeated dose toxicity
Groups of male and female B6C3F1 mice (8/sex per dose group) received a diet containing 0, 25,
100, 300, 600 or 1,200 mg MG/kg diet (corresponding to 0, 4, 18, 50, 100 or 220 mg/kg bw per day
for males and 0, 5, 20, 65, 120 or 250 mg/kg bw per day for females) for 28 days. Purity of MG was
≥ 94%. Female mice at the highest dose showed a decrease in ﬁnal body weight (to about 92% of
controls). Feed consumption was not affected. Signiﬁcant but small decreases (< 7%) in erythrocyte
count, haemoglobin and haematocrit were found in females at 120 and 250 mg/kg bw per day and in
males in the highest dose group. Reticulocytes were signiﬁcantly increased in females at doses of
65 mg/kg bw per day and higher, but in males at the highest dose only. No signiﬁcant
histopathological changes were observed (Culp et al., 1999; NTP, 2004).
MG-oxalate (purity ≥ 90%) was administered to groups of male and female Wistar rats (8/sex per
dose group) in the diet at concentrations of 0, 10, 100 or 1,000 mg MG-oxalate/kg diet for 28 days.
Age of the animals was not reported, but body weights at the start of the experiment ranged from 170
to 250 g. These concentrations correspond to doses of 0, 1.2, 12 and 120 mg MG-oxalate/kg bw per
day (equivalent to 0, 0.9, 9.4 and 94.5 mg MG/kg bw per day) when applying a default factor of
0.12 for a subacute study (EFSA Scientiﬁc Committee, 2012). No clinical signs were seen at 0.9 or
9.4 mg MG/kg bw per day, but hyperactivity and a signiﬁcant reduction in body weight gain and in
food consumption (none of these parameters quantiﬁed) were observed at 94.5 mg MG/kg bw per day
in both sexes. High-dose females showed small haematological changes: an increase in lymphocytes, a
decrease in neutrophils and a decrease in haematocrit. In high-dose males, a signiﬁcant increase in
plasma urea was noted (Clemmensen et al., 1984).
Male and female Fischer 344 rats (8/sex per dose group) were administered a diet containing 0, 25,
100, 300, 600 or 1,200 mg MG/kg diet (purity ≥ 94%) (corresponding to 0, 3, 12, 40, 70 or 175 mg/kg
bw per day for males and 0, 3, 12, 40, 75 or 190 mg/kg bw per day for females) for 28 days.
A decrease in mean body weight (to about 80% of the control for females and to 87% of the control
for males) was found at the highest dose. Final body weight was signiﬁcantly reduced for females at
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75 and 190 mg/kg bw per day for females and at 175 mg/kg bw per day for males. Feed consumption
was generally similar to that of the controls. Absolute and relative liver weights were signiﬁcantly
increased in females from 40 mg/kg bw per day onwards and in males in the two highest dose groups.
Histopathological examination revealed an increased incidence of hepatocyte cytoplasmic vacuolisation
in male rats in the two highest dose groups, 1/8 and 4/8, respectively, compared to 0/8 in the control
and other groups, and of 7/8 in the highest dose females, compared to 0/8 in the control and other
groups. No further details on this effect were provided. In both sexes, there was a signiﬁcant
increasing trend in the activity of gamma-glutamyl transferase (GGT), being 4.2-fold greater in high-
dose females than in the controls. Red blood-cell parameters (erythrocyte count, haemoglobin and
haematocrit) showed a small (< 5%), but signiﬁcant, decrease in females of the highest dose group.
Male rats showed a small (< 3%), but signiﬁcant, decrease in mean erythrocyte haemoglobin at
40 mg/kg bw and higher, however without a consistent dose–response relationship. No effect on
reticulocytes was observed in male and female rats (Culp et al., 1999; NTP, 2004).
Male and female Fischer 344 rats (8/sex per dose group) were fed a diet containing 0 or 1,200 mg
MG/kg diet (equivalent to approximately 0 or 200 mg/kg bw per day) for 4 or 21 days (purity ≥ 94%).
Triiodothyronine (T3) levels were signiﬁcantly higher in treated females at 21 days than in controls,
and T4 levels were signiﬁcantly lower in females at 4 and 21 days. There were no signiﬁcant changes
in T3 and T4 levels for males and no signiﬁcant changes in TSH for either sex (Culp et al., 1999;
NTP, 2004).
Groups of female B6C3F1 mice (8/dose group) were fed a diet containing LMG (purity ≥ 99%) at
concentrations of 0, 290, 580 or 1,160 mg/kg diet for 28 days. These concentrations correspond to
doses of about 0, 60, 110 or 220 mg/kg bw per day. Final body weight and absolute and relative
kidney weight were signiﬁcantly decreased in the two highest dose groups. Feed consumption was
lower in all dose groups, on average about 80–90% of the controls, but without a dose–response
relationship. All mice at the high dose had scattered dead or degenerated cells in the transitional
epithelium of the urinary bladder. Many of the cells lacked nuclei, and when visible, the nuclei were
condensed or fragmented, suggesting apoptosis (Culp et al., 1999; NTP, 2004).
LMG (purity ≥ 99%) was administered to male Fischer 344 rats (8/dose group) in the diet at
concentrations of 0, 290, 580 or 1,160 mg/kg diet (corresponding to 0, 30, 60 or 115 mg/kg bw per
day) for 28 days. Final body weight was signiﬁcantly decreased in the high-dose group. Feed
consumption was on average about 10% lower in the two highest dose groups, compared to the
controls. Small (< 6%) but signiﬁcant decreases of haemoglobin, haematocrit and the erythrocyte
count were observed in the high-dose group. A signiﬁcant increase in the GGT activity and
phosphorous level was observed in the high-dose group. Absolute liver weight increased with dose,
but the increase was signiﬁcant at the high-dose only. A signiﬁcant dose-related increase in relative
liver weight was found in all groups. A dose-related increase in hepatocyte cytoplasmic vacuolisation
was observed (0/8, 2/8, 5/8, 7/8 for control, low- , mid-, and high-dose groups, respectively), being
signiﬁcant in the mid- and high-dose group. This effect was not further characterised. Upon
histological examination, also apoptotic follicular epithelial cells in the thyroid gland were observed at
the two highest doses (2/8 in the 60 and 2/8 in the 115 mg/kg bw per day groups), and there was
evidence of follicular epithelium regeneration (Culp et al., 1999; NTP, 2004).
Male Fischer 344 rats (8/dose group) were fed a diet containing 0 or 1,160 mg LMG/kg diet
(equivalent to approximately 0 or 200 mg/kg bw per day) for 4 or 21 days (purity of LMG ≥ 99%).
There was a signiﬁcant decrease in T4 and a signiﬁcant increase in TSH levels at days 4 and
21 compared to the controls. T3 levels were not affected (Culp et al., 1999; NTP, 2004).
Conclusion
Information on the repeated dose toxicity of MG and LMG in mice and rats was conﬁned to 28-day
toxicity tests only. MG caused haematological effects in mice and rats and an increase in absolute liver
weight in male and female rats. The overall NOAEL, based on haematological effects in female rats,
was 9.4 mg/kg bw per day. LMG decreased body weight and induced histopathological changes in the
bladder of mice at the highest dose (220 mg/kg bw per day). In male rats, absolute liver weight was
increased at the highest dose, but the incidence of hepatocyte cytoplasmic vacuolisation was increased
at all doses tested. Consequently, no NOAEL can be identiﬁed for LMG.
3.3.2.3. Immunotoxicity
No immunotoxicity studies with oral administration were identiﬁed.
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3.3.2.4. Developmental and reproductive toxicity
MG oxalate (purity not given) was administered by gavage to groups of 20 pregnant New Zealand
white rabbits at doses of 0, 5, 10 or 20 mg MG oxalate/kg bw per day from day 6 through 18 of
gestation (Meyer and Jorgenson, 1983). Intubation errors led to loss of four animals in both the low-
and high-dose groups. Body weight loss occurred in dams of the two highest dose groups. The body
weights of the progeny of the treated rabbits were less than those of the controls (37.1, 34.2, 35.8
and 35.2 g for control, low-, mid- and high dose, respectively), but differences were only signiﬁcant at
the low- and high dose. Fetal toxicity was shown at all three dose levels. There were signiﬁcant
increases in preimplantation losses, but actual data on this parameter were not reported by the
authors. Based on the reported data for total number of corpora lutea and total number of
implantation sites, the CONTAM Panel calculated that the preimplantation loss was 8%, 19%, 20% and
17% for control, low-, mid- and high dose, respectively. At all three dose levels, the average number
of resorptions per dose was signiﬁcantly increased (0.8, 2.1, 2.3 and 3.8 for control, low-, mid- and
high dose, respectively) and the average number of live fetuses per dose was signiﬁcantly decreased
(7.3, 4.9, 5.2, 5.2 for control, low-, mid- and high dose, respectively). According to the authors, early
resorptions accounted for most of the dead implants, but detailed information was not provided. An
increased incidence in skeletal malformations (incomplete ossiﬁcation of caudal vertebrae and
malformed skulls) was observed in all treated groups (20%, 36%, 38% and 38% for control, low-,
mid- and high dose, respectively). In treated animals, enlargement of the liver and heart and
haemorrhaging of the bladder was also observed, but without a dose–response relationship. The
CONTAM Panel considered this study to be of limited value, because of the losses sustained during
gavage of the animals, the inadequate reporting and the lack of a consistent dose–response
relationship for the observed fetal toxicity and skeletal and visceral malformations.
LMG (Purity 99.0%) was administered orally (by gavage) to groups of 24 female Sprague–Dawley
rats of 11–12 weeks of age, mated with males of the same strain (Wan et al., 2011). Administration of
LMG was once daily from day 6–15 of gestation, at doses of 0, 10, 80 or 160 mg/kg bw per day. At
doses of 80 and 160 mg/kg bw per day, LMG induced maternal toxicity, which consisted of a severe
reduction in maternal weight and feed consumption compared to the controls. The number of corpora
lutea per dam, number of implants per dam, and preimplantation losses per dam were not affected by
LMG, but post-implantation losses per dam and the number of dams with resorptions were signiﬁcantly
increased in the highest dose group. Fetal body weight and placental weight were signiﬁcantly
decreased at 160 mg/kg bw per day only. In the treated groups, the incidences of fetuses (and litters)
with external abnormalities were not signiﬁcantly different from those in the control group. LMG
induced a dose-related increase in the incidence of fetuses (reported as 8.8%, 13.8%, 36.6% and
72.3% for the control, low-, mid- and high dose, respectively) and litters (reported as 34.8%, 58.3%,
73.7% and 100% for the control, low-, mid- and high dose, respectively) with skeletal abnormalities.
The predominant skeletal abnormalities were bipartite ossiﬁcation of the thoracic centrum (reported as
11%, 19%, 41% and 45% of the fetuses for the control, low-, mid- and high dose, respectively).
These effects were signiﬁcant at doses of 80 mg/kg bw per day and higher. The CONTAM Panel noted
that the number of fetuses with skeletal abnormalities for each litter was not reported. In the high-
dose group (160 mg/kg bw per day), LMG also induced a signiﬁcant increase in the number of fetuses
and litters (%) with visceral abnormalities, particularly hydronephrosis, compared with the controls.
Based on the observed effects, a NOAEL of 10 mg/kg bw per day for maternal and fetal
developmental toxicity in rats could be identiﬁed.
The developmental toxicity of MG has also been studied in a model with zebraﬁsh (Danio rerio)
embryos. Exposure of zebraﬁsh embryos to MG concentrations of 0.125, 0.15 or 0.175 mg/L for 14 h
signiﬁcantly altered cardiovascular development causing growth retardation through blocking of the
activation of the vascular endothelial growth factor receptor 2. In contrast, exposure up to 0.875 mg
LMG/L for 14 h did not affect zebraﬁsh embryo growth (Jang et al., 2009).
Minta and Wilk-Zasadna (2007) studied potential embryotoxic activity of MG and LMG in an in vitro
model using micromass cultures of rat embryonic mesenchyme limb and midbrain cells. Embryonic
mesenchyme limb and midbrain cells cultured at high density were exposed to 0.002, 0.005, 0.013,
0.032, 0.080, 0.200, and 0.500 lg/mL MG and 0.03, 0.12, 0.49, 1.95, 7.81, 31.25, and 125 lg/mL
LMG. After 5 days of incubation, the viability and differentiation were determined. From the dose–
response curves, the concentrations (lg/mL) that produced 50% inhibition of viability/proliferation
(IC50-P) and 50% reduction of differentiation (IC50-D) were calculated. Embryotoxicity was classiﬁed
according to the prediction model described by Genschow et al. (2002). MG and LMG induced
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dose-dependent inhibition of cell survival and differentiation in both cell cultures. MG was
approximately 200–300 times more potent than LMG. The reduction of cell survival and differentiation
were observed at similar concentrations. IC50-P values ranged from 0.02–0.08 and 5–17 lg/mL for MG
and LMG, respectively. According to the prediction model, MG was classiﬁed as strongly embryotoxic in
mesenchyme limb cells (IC50-D = 0.02 lg/mL) and midbrain cells (IC50-D = 0.05 lg/mL), whereas LMG
was classiﬁed as weakly embryotoxic in mesenchyme limb cells (IC50-D = 15.6 lg/mL) and strongly
embryotoxic in midbrain cells (IC50-D = 3.7 lg/mL).
Conclusion
Both MG and LMG induced developmental effects. MG caused fetal toxicity and skeletal
malformations in rabbits at all doses tested (5–20 mg/kg bw per day). However, the CONTAM
Panel noted that these effects did not show a consistent dose–response relationship, probably due to
the small dose range of the study. For LMG, a NOAEL of 10 mg/kg bw per day for fetal toxicity in rats
was identiﬁed, although there is no speciﬁc information on the individual litters. The CONTAM
Panel noted, however, that these effects of LMG were observed at doses also causing maternal toxicity.
3.3.2.5. Neurotoxicity
No neurotoxicity studies with oral administration were identiﬁed.
3.3.2.6. Genotoxicity
The in vitro and in vivo genotoxicity studies for MG and LMG are summarised in Tables 4 and 5,
respectively.
Bacterial reverse mutation assays (Ames test) of MG were performed with Salmonella Typhimurium
strains TA97, TA98, TA100, TA102, TA104, TA1535 and TA1537. Because MG is highly toxic to bacteria,
it was tested only at low doses, with a few exceptions. In one study, MG was mutagenic only in TA98
in the presence of S9 (Clemmensen et al., 1984). In later studies, the compound was tested at doses
up to 10 lg/plate only, due to its antibacterial activity, and did not show any mutagenic activity
(Fessard et al., 1999; NTP, 2004). LMG showed no mutagenic activity at doses up to 2,000 lg/plate
(Fessard et al., 1999).
Assessment of the in vitro mutagenicity of MG or LMG in the Chinese hamster ovary (CHO)
hypoxanthine–guanine phosphoribosyltransferase (HPRT) locus assay gave negative results, with and
without S9 activation (Fessard et al., 1999). Due to severe cytotoxicity, evaluation of the mutagenicity
of MG was restricted to very low concentrations (up to 0.05 lg/mL and 1 lg/mL without and with
metabolic activation, respectively). LMG was less cytotoxic than MG and mutagenicity of LMG was
evaluated at concentrations of 5–100 lg/mL.
In CHO cells, the capacity of MG and LMG to induce DNA damage was determined by the Comet
assay (Fessard et al., 1999). When tested without metabolic activation, MG induced an increase in
DNA strand breaks at concentrations ≥ 3 lg/mL, at which loss of viability ranged from 20% to 30%.
The signiﬁcance of the positive result observed at the 10 lg/mL dose is questionable due to a 70%
loss of viability at this dose. After metabolic activation, DNA damage was observed at concentrations
(15–20 lg/mL) where cell viability was reduced by less than 20%. In the same study, LMG tested at
concentrations of 5–500 lg/mL did not induce DNA damage or loss of viability (Fessard et al., 1999).
MG-induced DNA strand breaks were reported also in Syrian hamster embryo (SHE) cells after
exposure to 0.0125–0.1 lg/mL (Bose et al., 2005). In the same study, the authors observed
MG-mediated cell cycle arrest and induction of apoptosis. Panandiker et al. (1994) showed an
association of MG-induced DNA strand breaks with the formation of free radicals in SHE cells. Several
studies showed that MG induces malignant transformation in vitro in SHE cells (Panandiker et al.,
1993; Mahudawala et al., 1999). Au and Hsu (1979) reported no evidence of MG-induced
chromosomal aberrations in vitro in cultured CHO cells.
In vivo genotoxicity studies for MG and LMG include chromosomal aberration and micronucleus
assay, forward mutation assays, lacI and cII transgene mutation assays with rodents and
32P-postlabelling studies of liver DNA adduct formation. No increase in micronucleated erythrocytes
was observed in bone marrow of mice administered a single dose of 37.5 mg/kg bw MG oxalate by
gavage (Clemmensen et al., 1984).
In rat bone marrow cells, following three intraperitoneal injections of MG chloride at doses ranging
from 1,094 to 8,750 mg/kg bw, a very small but signiﬁcant increase in micronuclei frequency was
observed only at a dose of 4,375 mg/kg bw (NTP, 2004). As the frequency of micronucleated
polychromated erythrocytes (PCEs) was not signiﬁcant at a dose of 8,750 mg/kg and no bone marrow
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toxicity was detected at this dose, the test in rats was judged to be negative overall. No increase in
micronuclei was observed in peripheral blood normochromatic erythrocytes (NCEs) or PCEs of male
and female mice after 28 days of exposure to MG chloride in feed (up to 1,200 mg/kg; approximately
250 mg/kg bw per day) (NTP, 2004).
MG also did not induce increase in micronucleated NCEs or PCEs in female Big Blue® B6C3F1 mice
that received 450 mg/kg MG in the diet for 4 or 16 weeks (Mittelstaedt et al., 2004). On the contrary,
Donya et al. (2012) reported a dose- and time-dependent increase in chromosomal aberration in bone
marrow and spermatocytes in Swiss albino male mice treated daily by gavage with up to 543 mg
MG/kg bw for 7, 14, 21 and 28 days. In the same study, the authors reported also dose- and time-
dependent increase in sister chromatid exchanges in bone marrow and DNA fragmentation in liver
cells. Induction of chromosomal aberrations, micronuclei formation and DNA damage in bone marrow
have also been observed in Swiss albino female mice treated by gavage with 4 mg MG/kg bw for
30 days (Das et al., 2013).
A peripheral blood micronucleus test with LMG was performed in female B6C3F1/Nctr BR mice after
28 days of exposure to 290, 580, or 1,160 mg LMG/kg in feed. Signiﬁcant increases in the frequency
of micronucleated NCEs were observed in the 290 and 580 mg/kg groups. The increase of
micronucleated PCEs was not signiﬁcant (NTP, 2004). In female Big Blue® B6C3F1 mice that received
204 or 408 mg LMG/kg in the diet for 4 or 16 weeks, LMG did not induce an increase in
micronucleated NCEs or PCEs (Mittelstaedt et al., 2004).
It has been shown that exposure to MG (100 or 600 mg/kg feed) for 28 days induces the
formation of DNA adducts in liver of male F344 rats and female B6C3F1 mice (Culp et al., 1999).
Under the same exposure conditions, LMG induced the formation of DNA adducts in rat, but not in
mouse liver (Culp et al., 1999). A dose-related increase in DNA adduct levels in liver has been reported
also in female Big Blue rats® fed a diet containing 9–543 mg LMG/kg for 4 weeks (Culp et al., 2002;
Manjanatha et al., 2004). Because the results are based on 32P-postlabelling analysis, without further
characterisation of the nature of adducts, the CONTAM Panel noted that these adducts are not
necessarily MG/LMG metabolites bound to DNA.
When livers of female Big Blue® rats treated with 273 and 543 mg LMG/kg were analysed for lacI
transgene mutations at 4, 16, and 32 weeks post-exposure, a signiﬁcant increase (2.9-fold) in lacI
mutant frequency was observed only in the livers of rats fed 543 mg LMG/kg for 16 weeks (Culp et al.,
2002). However, molecular analysis of 80 of these liver lacI mutants revealed that 21% (17/80) were
clonal in origin and that the majority (55/63) of the independent mutations were base pair
substitutions involving guanine (G)-cytosine (C) to adenine (A)-thymine (T) transitions, similar to those
found for control rats, suggesting that LMG is not a mutagen in the livers of female rats (Manjanatha
et al., 2004). In the same female Big Blue® rats orally exposed to LMG, the analysis of the induction of
HPRT mutations in lymphocytes also showed negative results (Manjanatha et al., 2004).
In another study, transgenic female Big Blue® B6C3F1 mice were given feed with MG (450 mg/kg)
or LMG (204 and 408 mg/kg) for 4 and 16 weeks (Mittelstaedt et al., 2004). An increase in the liver
cII transgene mutant frequency was observed after a 16-week treatment with 408 mg LMG/kg,
indicating that LMG is an in vivo mutagen in transgenic female mouse liver. Molecular analyses of
mutations from mice fed LMG had increased frequencies of G ? T and A ? T transversions. Statistical
evaluation indicated that the spectrum of mutations for LMG-treated mice is signiﬁcantly different from
the controls. MG did not increase the mutation frequency of the cII transgene in the liver and neither
MG nor LMG increased the HPRT mutation frequency in lymphocytes at either time point (Mittelstaedt
et al., 2004).
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Conclusion
The results for genotoxicity studies with MG and LMG are summarised in Table 6. MG and LMG are
not bacterial mutagens and also do not induce mutations in mammalian cells in vitro. However, it
should be noted that because MG is highly toxic to bacteria it was tested only at low doses, with a few
exceptions. In mammalian cells in vitro, MG induced DNA strand breaks, while LMG was inactive. A
single report indicates that MG is not clastogenic in vitro. In vivo clastogenicity studies gave conﬂicting
results for MG and LMG. Two short-term exposure bone marrow micronucleus assays with MG in mice
and rats gave negative results, and two long-term exposure (28 days and 16 weeks) peripheral blood
micronucleus assays in mice were also negative. Two other studies reported positive results for MG in
the bone marrow micronucleus and chromosomal aberration assays in mice after long-term exposures
(28 and 30 days). LMG was weakly positive in one long-term exposure peripheral blood micronucleus
assay in mice, while negative results were reported in another study. Neither MG- nor LMG induced
HPRT mutations in mice or rat spleen lymphocytes. Formation of DNA adducts was induced by MG in
liver of rats and mice and by LMG in liver of rats, but not in liver of mice. However, characterisation of
the nature of these adducts was not performed. No clear evidence for MG-induced cII transgene
mutations in mouse liver was obtained. LMG increased mutation frequency of the cII transgene in
mouse liver, with a unique mutational spectrum of increased G ? T and A ? T transversions.
However, LMG did not induce lacI transgene mutations in rat liver.
JECFA concluded that MG has no genotoxic potential in conventional in vitro and in vivo assays and
that LMG was negative in in vitro assays, but induced cII mutations in the liver of female Big Blue®
B6C3F1 transgenic mice (FAO/WHO, 2009). However, at the time of that report the positive in vivo
micronucleus and chromosomal aberration studies (Donya et al., 2012; Das et al., 2013) with MG were
not available. ECHA (ECHA 2010a,b) evaluated the same data for MG and LMG as were used by JECFA.
Based on the evidence that MG induced formation of DNA adducts in the liver of rats and mice and
that LMG induced formation of DNA adducts in liver of rats and mutations in the liver of transgenic
mice, ECHA presumed that MG and LMG may be potential in vivo somatic cell mutagens. Both
compounds were classiﬁed as Muta.2 (suspected to cause genetic defects).
The CONTAM Panel concluded that: (a) the positive results obtained in the in vivo micronucleus
tests in mice for MG and LMG, (b) the increased mutations in the cII transgene in mouse liver for LMG,
and (c) the capacity of both MG and LMG to form DNA adducts in vivo provide evidence for
considering MG and LMG as genotoxic in vivo.
3.3.2.7. Chronic toxicity and carcinogenicity
Groups of 48 female B6C3F1 mice were fed diets containing 0, 100, 225 or 450 mg MG/kg for
104 weeks (NTP, 2005; Culp et al., 2006). These dietary concentrations correspond to doses of
approximately 0, 15, 33 or 67 mg/kg bw per day. The purity of MG was about 87%, with identiﬁed
impurities of LMG (7.5%), N-desmethyl MG (3.8%) and N-desmethyl LMG (0.5%). There were no
effects on body weight or on the survival rate of female mice, but absolute kidney weights were
decreased in the mid- and high-dose groups. No treatment-related neoplasms were observed.
Groups of 48 female F344 rats were fed diets containing 0, 100, 300 or 600 mg MG/kg for
104 weeks (NTP, 2005; Culp et al., 2006), equivalent to average doses of 0, 7, 21 or 43 mg/kg bw per
day. The purity of MG was about 87% (for impurities, see above). Body weights were decreased,
particularly in the mid- and high-dose groups, being approximately 90% (mid dose) and 88% (high
dose) of the control group weight at the end of the experimental period. In these groups, a small
Table 6: Summary of genotoxicity testing results
In vitro In vivo
Bact.
Mammalian
cells
Mice Rats
Mut DSB CA Mut DSB CA MN
Mut.
HPRT
Mut.
transgen
DNA
adducts
DSB CA MN
Mut.
HPRT
Mut.
transgen
DNA
adducts
MG N P N N P P N/P N N P – – N – – P
LMG N N – N – – N/(P) N P N – – – N N P
CA: chromosomal aberration; DSB: DNA strand breaks; HPRT: hypoxanthine–guanine phosphoribosyltransferase; LMG: leucomalachite green;
MG: malachite green; MN: micronucleus; Mut: mutations; Mut. trans: mutations in transgenic animals; N: negative result; P: positive result;
(P): weakly positive; –: not tested.
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decrease in feed consumption was observed during the ﬁrst year of the study compared to that of the
control group. The survival rate was not affected. A small increase in the incidence of thyroid gland
follicular cell adenoma or carcinoma was observed (0/46, 0/48, 3/47 and 2/46 for control, low-, mid-
and high-dose groups, respectively). According to the NTP technical report (NTP, 2005), the incidence
of thyroid gland follicular carcinoma was 0/46, 0/48, 2/47 and 1/46 for control, low-, mid- and high
dose, respectively. The incidence of mammary gland carcinoma was increased in the high-dose group
(2/48, 2/48, 1/48 and 5/48 for control, low-, mid- and high-dose groups, respectively). A dose-related
increase in the incidence of hepatocellular adenomas was observed in female rats fed MG (1/48, 1/48,
3/48 and 4/48 for control, low-, mid- and high-dose groups, respectively), being signiﬁcant only in the
high-dose group.
Groups of 48 female B6C3F1 mice were fed diets containing 0, 91, 204 or 408 mg LMG/kg (purity
about 99%) for 104 weeks (NTP, 2005; Culp et al., 2006). These dietary concentrations are equivalent
to average doses of approximately 0, 13, 31 or 63 mg/kg bw per day. Body weight and survival rate
were not affected by treatment with LMG, but a decrease in relative kidney weights was observed in
all dose groups, however without a consistent dose–response relationship. The only neoplastic ﬁnding
was a dose-related increase in the incidence of hepatocellular adenomas or carcinomas (3/47, 6/48,
6/47 and 11/47 for control, low-, mid- and high-dose groups, respectively), reported as signiﬁcant in
the high-dose group. The data reported by NTP (2005) indicated that hepatocellular adenomas formed
the largest part of these tumours, and that only a low number of malignant liver tumours were found
– the incidence of hepatocellular carcinomas alone was 0/47, 0/48, 1/47 and 2/47 for control-, low-,
mid- and high-dose groups, respectively.
Male and female F344 rats (48 per sex) were fed diets containing 0, 91, 272 or 543 mg LMG/kg
(purity about 99%) for 104 weeks (NTP, 2005; Culp et al., 2006). These dietary concentrations are
equivalent to average doses of 0, 5, 15 or 30 mg/kg bw per day for males and 6, 17, or 35 mg/kg bw
for females. Reduced body weights were found in both sexes, particularly in the mid- and high-dose
groups, with body weights at termination of the experiment being approximately 92% (mid dose) and
87% (high dose) of the control group for males, and approximately 89% (mid dose) and 77% (high
dose) of the control group for females. In mid- and high-dose males and females, a small decrease in feed
consumption was observed throughout the study, compared to that by the control group. The survival
rate was not affected. The absolute (and relative) liver weights of males were signiﬁcantly increased in
the mid- and high-dose groups. For females, only the relative liver weight was signiﬁcantly increased
in the mid- and high-dose groups. The incidence of hepatic cytoplasmic vacuolisation was increased in
female rats (5/48, 5/48, 19/48, 22/48 for control, low-, mid- and high-dose groups, respectively). No
further details on this effect were provided. In male and female rats, follicular cysts in the thyroid were
found in the high-dose group, accompanied by an increase in relative thyroid weight. Both sexes also
showed a low, not dose-related, increase in incidence of thyroid gland follicular cell adenomas or
carcinomas (females 0/46, 1/46, 2/47, 1/48 and males 0/47, 2/47, 1/48, 3/46 for control, low-, mid- and
high-dose groups, respectively). Female rats had an increased incidence of mammary gland adenomas or
carcinomas: 0/48, 2/48, 3/48, 4/48 for control, low-, mid- and high-dose groups, respectively. The NTP
(2005) report showed that the incidence of mammary gland adenomas was 0/48, 1/48, 1/48 and 2/48
and of mammary gland carcinomas 0/48/, 1/48, 2/48 and 2/48 for the control, low-, mid- and high-dose
groups, respectively. Male rats had a dose-related increasing trend in interstitial cell adenomas of the
testis (37/48, 42/47, 43/48, 45/47 for control, low-, mid- and high-dose groups, respectively).
Conclusion
The long-term studies evaluated above were all aimed at investigating the carcinogenic effects of
MG and LMG and included a full histological assessment. Haematological and clinical chemical analyses
were not included in these studies. MG was not carcinogenic in mice. In rats, a small, not dose-
related, increase in the incidence of thyroid gland follicular adenomas and carcinomas and of
mammary gland carcinomas was observed. Based on these observations in rats, the CONTAM
Panel concluded that MG may be considered as carcinogenic.
LMG caused an increase in hepatocellular adenomas and a small increase in hepatocellular
carcinomas in mice. In rats, LMG caused a small increase in the incidence of mammary gland carcinomas
and of thyroid gland follicular cell adenomas or carcinomas (combined). Based on these observations in
mice and rats, the CONTAM Panel concluded that LMG may be considered as carcinogenic.
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3.3.3. Observations in humans
There is very limited information on the effects of MG/LMG in humans. Only one case report on
intoxication with MG was identiﬁed.
A 3-year-old girl (17.3 kg bw) ingested about 45 mg MG (in the form of an aquarium product
containing 0.075% MG) corresponding to a dose of about 2.6 mg/kg bw. She was admitted to the
hospital half an hour after ingestion of the aquarium product with signs of cyanosis, including blue
face, arms, hands, legs and feet. Blood analysis revealed that oxygen saturation was 47.4% and
methaemoglobin level was 50.6%. She was treated with an infusion of methylene blue and, two and a
half hours after ingestion of MG, the methaemoglobin level decreased to 6.5%. The child was
observed for an additional 20 h, but symptoms did not return (Spiller et al., 2008).
3.3.4. Mode of action
MG is a conjugated iminium triphenylmethane dye available as the oxalate or hydrochloride salt.
Due to its iminium structure, MG may behave as an electron-accepting/transferring compound leading
to the formation of oxygen radical species that can affect a number of cellular processes (e.g.
mitochondrial respiration) and result in GSH depletion (reviewed by Kovacic and Somanathan, 2014).
In common with other electrophilic triphenylmethane dyes, it is also accepted that, at physiological pH,
MG may form adducts with GSH, proteins and protein related nucleophiles (e.g. human serum
albumin; see Section 3.3.1), possibly resulting in the inhibition of enzyme activities (Eldem and €Ozer,
2004; Tacal and €Ozer, 2004). In addition, MG and LMG may enter a CYP-mediated oxidative pathway
yielding primary and secondary amine metabolites; in common with other aromatic amines, such
metabolites may undergo further oxidation giving rise to unstable intermediates (-NHOH) and
NO-derivatives (see Section 3.3.1), which have been linked with lipid peroxidation and DNA damage in
cell cultures (Panandiker et al., 1992). Under in vitro conditions, LMG competitively inhibits TPO activity
resulting in the impairment of tyrosine iodination and T4 formation (Doerge et al., 1998), with the
potential for impairment of thyroid function. Chronic inhibition of thyroid hormone synthesis results in
prolonged growth stimulus from TSH that can lead to thyroid follicular cell tumours. In vitro
TPO-mediated LMG oxidation has also been demonstrated (see Section 3.3.1), so it cannot be
excluded that the resulting reactive metabolites may display genotoxic activity at the thyroid level.
The MG-related cytotoxicity was correlated with effects on xenobiotic metabolising enzymes, lipid
peroxidation and antioxidant status. SHE cells were exposed to increasing MG concentrations
(0, 0.025, 0.05 and 0.1 lg/mL for 24 h, corresponding to 0, 0.0685, 0.137, and 0.274 lM,
respectively). Compared to untreated controls, there was a concentration-related increase in both
aryl-hydrocarbon hydroxylase (using benzo(a)pyrene as the substrate) and aminopyrine N-demethylase
activities, reaching 181% and 295% of the control values, respectively. The rise in CYP-mediated
monoxygenases was matched by a concurrent increase in lipid peroxidation (as measured by the
amount of malondialdehyde produced), in catalase (CAT) activity, and in cytotoxicity expressed as
relative plating efﬁciency. Results show that MG is able to induce CYP-dependent monooxygenases and
they support the hypothesis that the observed cytotoxic effects might be related to an increase in the
generation of reactive oxygen species (ROS), possibly including those derived from the (enhanced)
oxidative biotransformation of MG itself (Panandiker et al., 1992). Further studies conﬁrmed that
exposure of SHE cells to MG-induced generation of free radicals (detected with electron spin resonance
spectroscopy) and that it is associated with induction of lipid peroxidation and DNA damage
(Panandiker et al., 1994). The study also showed that treatment of SHE cells with the antioxidant
enzymes CAT and glutathione peroxidase (GPx) decreased MG-induced lipid peroxidation and DNA
damage.
In mice, intraperitoneal exposure to 100 lg MG/mouse per day (equivalent to 4 mg/kg bw per day)
for 30 days caused an increase in the levels of serum alanine aminotransferase (ALT) and aspartate
aminotransferase (AST), indicators of liver injury, and an increase of hepatic lipid peroxidation,
determined in terms of thiobarbituric acid reactive substances, an indicator of oxidative stress (Das et al.,
2013). In the liver, MG caused depletion of reduced GSH and decrease in the activity of GST and of the
antioxidant enzymes superoxide dismutase (SOD), CAT and GPx, which could lead to elevated levels of
free radicals as indicated by increased lipid peroxidation. The CONTAM Panel noted that, under the same
exposure conditions, MG also induced chromosomal aberrations and micronuclei in bone marrow and
DNA strand breaks in lymphocytes (see Section 3.3.2.6). The same study showed that pre- or
cotreatment of MG exposed mice with diphenylmethyl selenocyanate protects against MG-induced
hepatotoxicity; this was reﬂected in lower levels of serum aminotransferases ALT and AST, lower levels of
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hepatic lipid peroxidation and higher levels and activities of detoxifying and antioxidative enzymes, as well
as a moderate reduction in DNA damage compared to mice treated with MG alone. These results indicate
a possible involvement of MG-induced oxidative stress in the mechanism of in vivo MG genotoxicity.
In isolated rat mitochondria, MG inhibited respiratory rates supported by succinate (a Complex II
electron donor) while no inhibition of N,N,N8,N8-tetramethyl-p-phenylenediamine-supported respiration
was observed, indicating that MG does not affect mitochondrial complex IV. MG promoted a dissipation
of the mitochondrial membrane potential, accompanied by mitochondrial swelling, which was
prevented by ethylene glycol tetraacetic acid (EGTA), Mg2+ and cyclosporin A, demonstrating that it
induced mitochondrial permeability transition. This mitochondrial permeabilisation was induced by
respiratory inhibition, attributable to cytochrome c release that was caused by the oxidation of NAD(P)
H promoted by MG (Kowaltowski et al., 1999). These results indicate that MG could induce apoptosis
via an intrinsic pathway.
Majeed et al. (2014) studied MG-induced cytotoxicity, genotoxicity, apoptosis and oxidative stress
in vitro in ﬁsh cell lines (Channa striata kidney (CSK) and gill (CSG) cell lines). Cells were exposed to
0.001–10 lg/mL MG for 48 h. The viability was signiﬁcantly reduced at concentrations ≥ 1 lg/mL. MG
treatment for 48 h resulted in the distortion of mitochondrial shape and disorganisation of
mitochondrial distribution in both CSK and CSG cell lines. The acridine orange/ethidium bromide
staining showed that, at low concentration range (0.001–0.1 lg/mL), both early and late apoptotic
cells occurred, while at higher concentrations the late apoptotic and necrotic cells were observed. A
signiﬁcant dose-dependent increase in DNA damage was observed at concentrations ≥ 0.1 lg/mL.
Additionally, DNA electrophoretic mobility experiments, that were carried out to study the binding
effect of MG to double-stranded DNA, showed that MG is capable of strong binding to linear double-
stranded DNA, subsequently causing DNA degradation. In these cell lines, exposure to MG also
induced signiﬁcant increases in lipid peroxidation, and reductions in GSH and CAT activity, conﬁrming
the involvement of oxidative stress in MG-induced toxicity.
Induction of apoptosis and differential gene expression has been studied in human hepatoma
HepG2 cells (Kim et al., 2008). Exposure of HepG2 cells to 0.0523, 0.867 and 1.202 lM MG
concentrations, corresponding to the 10% inhibitory concentration (IC10), IC20 and IC30, respectively,
for 48 h resulted in the induction of late apoptosis and necrosis in a dose-dependent manner. The
gene expression pattern of selected apoptosis-related genes showed upregulation of tumour necrosis
factor, p53, while expression of bax and caspase 3 were not changed. This result would indicate the
involvement of an extrinsic (death receptor mediated) pathway in MG-induced apoptosis.
Pierrard et al. (2012) studied the mechanism of MG-induced toxicity by proteomic analysis (two-
dimensional difference gel electrophoresis) in primary cultured peripheral blood mononuclear cells
(PBMCs) from the Asian catﬁsh, Pangasianodon hypophthalmus. The analysis showed that
109 proteins displayed signiﬁcant changes in abundance in PBMC during 48 h exposure to MG. The
data suggest that low concentrations of MG (1 and 10 ng/mL) could induce disturbances of
mitochondrial metabolic functions, impairment of signal transduction and normal cell division,
stimulation of DNA repair and disorganisation of the cytoskeleton.
A comparative in vitro cytotoxicity study of MG and LMG showed striking differences in their toxicity
(Stammati et al., 2005). The compounds were tested in two human cell lines: HEp-2 cells derived from
a human carcinoma of the larynx and Caco-2 cells derived from a human colon carcinoma. HEp-2 cells
were exposed to 0.26, 1.4, 2.6 or 4.0 lM MG or 30, 150, 300 or 610 lM LMG and Caco-2 cells were
exposed to 0.1, 1, 10, 25, 50 or 100 lM MG or 25, 50, 75 or 100 lM LMG for 24 h. Cytotoxicity was
measured by neutral red uptake, total protein content, lactate dehydrogenase leakage, tetrazolium
conversion and proliferation capability by the colony forming ability test (CFA). MG produced a clear
dose-dependent inhibition of the viability of HEp-2 and CaCo-2 cells, whereas LMG showed only a small
inhibition of CFA at the highest tested concentration in HEp-2 cells.
MG has been shown to induce morphological transformation of SHE cells exposed to 0.025, 0.05 and
0.1 lg/mL MG (Panandiker et al., 1993). It has been shown that in normal SHE cells, MG induces arrest
in the G2/M phase of the cell cycle after 16 h of exposure, whereas in MG-treated transformed cells no
such effect was observed indicating that in MG-transformed SHE cells the G2/M cell cycle checkpoint is
abrogated (Rao et al., 1998). From the clone of MG-transformed cells, an immortalised MG-transformed
cell line was established that showed increased DNA synthesis (determined by BrdU incorporation),
increased levels of proliferating cell nuclear antigen (PCNA) and increased levels of p53 and bcl-2
proteins (Mahudawala et al., 1999). These MG-transformed cells exhibited higher expression and
phosphorylation levels of vimentin, which has the role to link the nucleus to the plasma membrane
possibly contributing to communication and transport between the cell surface and the nucleus
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(Mahudawala et al., 2000). A further study showed that in normal SHE cells MG induced time- and dose-
dependent apoptosis, while in MG-transformed SHE cells induction of apoptosis by MG was marginal and
was associated with over expression of p53 and bcl-2 proteins (Rao et al., 2000). Subcutaneous injection
of these MG-transformed immortalised cells to nude mice resulted in the development of tumours that
were transplantable and were histopathologically identiﬁed as sarcomas (Mahudawala et al., 1999).
The studies of changes in the cell signalling cascades during the MG-induced transformation of SHE
cells, focusing on the mitogen-activated protein (MAP) kinase signal transduction pathway, showed
that early changes associated with MG-induced malignant transformation of SHE cells are
hyperphosphorylation of extracellular regulated kinases (ERK) and decreased phosphorylation of Jun
N-terminal kinases (JNK), while no changes were observed in total ERK and JNK or in total and
phosphorylated p38 (Bose et al., 2004, 2005). The study of the expression proﬁle of these MAP kinases in
MG-transformed cells, compared to normal SHE cells, showed decreased levels of phosphoactive ERK2
and JNK1 and 10-fold increased levels of phosphoactive p38 kinase (Bose et al., 2006).
Ashra and Rao (2006) studied MG-induced DNA damage, cell cycle arrest and the role of protein
kinases Chk1, Chk2, Cdc2, Cdc25C, 14-3-3 and Cyclin B1 in normal and MG-transformed SHE cells.
Exposure to MG caused DNA damage in both types of SHE cells, while cell cycle arrest in the G2/M
phase was detected only in normal cells. Normal cells exposed to MG showed a decrease in Chk1 and
an increase in Chk2, whereas in the MG-transformed cells an increase in phosphorylated Chk1 and a
decrease in Chk2 were observed. Also, the levels of expression of Cdc25C, 14-3-3 and Cyclin B1 were
elevated in normal cells, but decreased in MG-transformed cells. The study indicates that abrogation of
G2/M checkpoint control during the transformation of SHE cells by MG is associated with elevated
phosphorylation of Chk1 and decreased phosphorylation of Chk2 and decreased levels of Cyclin B1.
MG has been reported to act as a tumour promoter on the development of hepatic pre-neoplastic
lesions (Fernandes et al., 1991; Rao and Fernandes, 1996). In male Wistar rats that were pretreated
with the hepatocarcinogen N-nitrosodiethylamine (DEN; 200 mg/L in drinking water for a period of
1 month) followed by the treatment with MG (25, 50 and 100 mg/L in drinking water for 7 months)
signiﬁcantly higher numbers of GGT-positive foci, total GGT activity and the induction of glycogen-
deﬁcient islands were observed compared to animals treated with DEN alone. In subsequent
mechanistic studies, it has been shown that in DEN-induced pre-neoplastic lesions, MG enhanced
tyrosine phosphorylation, deregulated expression of cell cycle regulatory proteins cyclin D1 and B1 and
their associated kinases (cdk4 and cdc2), elevated the level of PCNA, and stimulated DNA synthesis
(Sundarrajan et al., 2000, 2001; Gupta et al., 2003).
MG (base, purity not given) was tested in an uterotropic assay for its estrogenic or antiestrogenic
potency in groups of six ovariectomised C57BL/6J mice of 6 weeks of age. MG was administered orally
by gavage at doses of 0, 3, 10, 30 or 100 mg/kg bw per day for 7 consecutive days at 24 h intervals,
alone or in combination with ethynyl oestradiol (EO). Judged by the effect on uterus weight in
combination with EE, MG exhibited a small, but signiﬁcant, antiestrogenic effect at a dose of 100 mg/kg
bw per day (Ohta et al., 2012).
Conclusion
MG has been shown to induce formation of ROS due to its behaviour as an electron-accepting/
transferring compound. In addition, ROS can be formed from induction of CYP-dependent
monooxygenases, as well as from oxidative biotransformation of MG itself. These types of effects have
been shown to be related to cytotoxicity, DNA damage, induction of apoptosis, disturbances in cell
cycle progression and MAP kinase signal transduction pathways and in vitro malignant transformation.
In vivo, MG caused depletion of reduced GSH and decrease in the activity of GSTs and of the
antioxidant enzymes SOD, CAT and GPx, which could lead to elevated levels of free radicals as
indicated by increased hepatic lipid peroxidation. Therefore, the increased incidence of adenomas and
carcinomas observed in MG/LMG-exposed rodents may be explained by increased induction of ROS.
However, the formation of reactive metabolites causing adducts and mutations is also a possible
mechanism for the observed genotoxic effects (see Section 3.3.2.6).
LMG has been shown to inhibit TPO in vitro, being also biotransformed by TPO into N-demethylated
derivatives that could, in turn, generate reactive metabolites. This might explain the reported
increased incidence of thyroid gland follicular cell adenoma or carcinoma in female rats in the
carcinogenicity study by NTP (2005).
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3.3.5. Consideration of critical effects, dose–response assessment and derivation
of a health-based guidance value
3.3.5.1. Neoplastic effects
For both MG and LMG, long-term carcinogenicity studies are available (see Section 3.3.2.7). The
CONTAM Panel concluded that MG may be considered as carcinogenic in rats and LMG in both mice
and rats. No information was identiﬁed on the carcinogenicity of MG or LMG in humans. For the
selection of the reference point for neoplastic effects, the CONTAM Panel focused on those organs in
which malignant tumours had been observed.
MG induced thyroid gland follicular cell adenomas or carcinomas and mammary gland carcinomas in
female F344 rats, but in female B6C3F1 mice no treatment-related neoplasms were observed (NTP,
2005; Culp et al., 2006). Based on positive results in the in vivo micronucleus tests in mice and the
capacity to form DNA adducts in vivo, the CONTAM Panel considered MG to be genotoxic in vivo.
Therefore, MG may be regarded as a substance which is genotoxic and carcinogenic.
LMG induced hepatocellular adenomas or carcinomas in female B6C3F1 mice and, in female F344
rats, induced thyroid gland follicular cell adenomas or carcinomas and mammary gland adenomas or
carcinomas. Based on positive results in the in vivo micronucleus tests in mice, positive results in cII
transgene mutations in mouse liver, and the capacity to form DNA adducts in vivo, the CONTAM
Panel considered LMG to be genotoxic in vivo. Therefore, LMG may be regarded as a substance which
is genotoxic and carcinogenic.
Based on these conclusions regarding the genotoxicity and carcinogenicity of MG and LMG, the
CONTAM Panel concluded that the derivation of a health-based guidance value (HBGV) for these
compounds is not appropriate, and decided to apply an MOE approach for the risk characterisation.
The CONTAM Panel evaluated the following tumour data from the carcinogenicity studies performed
by NTP, for BMD analysis (see Table 7):
• LMG induced hepatocellular adenomas and carcinomas in female mice. The CONTAM Panel noted
the low increase (< 10%) of tumour incidence in the treated groups compared to the control
group. The EFSA Scientiﬁc Committee indicated that a BMR of 10% is the ‘lowest statistically
signiﬁcant increased incidence that can be measured in most studies, and would normally require
little or no extrapolation outside the observed experimental data’ (EFSA, 2005a). Therefore, the
CONTAM Panel concluded that using the data on carcinomas alone would result in an increase of
the uncertainty regarding the reference point and considered the data not to be suitable for
calculating a BMDL10. Instead, the CONTAM Panel used the combined data on adenomas or
carcinomas in female mice for BMD analysis (see Appendix C, Section C.1). Based on these data,
the CONTAM Panel derived a lowest BMDL10 of 13.1 mg/kg bw per day.
• MG and LMG induced mammary gland adenomas and carcinomas in rats. The CONTAM
Panel noted the low increase (< 10%) of tumour incidence in the treated groups compared to
the control group considering both substances separately or combined. For the same reason as
mentioned above, the CONTAM Panel concluded that using the data on mammary gland
adenomas and carcinomas would result in an increase of the uncertainty regarding the
reference point and considered the data not to be suitable for calculating a BMDL10.
• The data on thyroid gland follicular cell adenomas and carcinomas induced by MG and LMG in
rats were not used for BMD analysis because of the lack of a consistent dose–response
relationship.
The CONTAM Panel selected the BMDL10 value of 13 mg/kg bw per day (rounded ﬁgure) derived
for LMG. As both the RPA and the data on occurrence of MG and LMG in ﬁsh and crustaceans are
expressed for MG/LMG, and consequently, the exposure is estimated for MG/LMG, the CONTAM
Panel used the selected BMDL10 value as a reference point for the neoplastic effects of MG/LMG.
The CONTAM Panel noted that JECFA also selected the incidence of hepatocellular adenomas and
carcinomas (combined) in female mice induced by LMG as the pivotal effect for the risk assessment.
JECFA calculated BMDL10 values ranging from 18.5 to 31.2 mg/kg bw per day and selected a BMDL10
of 20 mg LMG/kg bw per day as the reference point for the risk characterisation of neoplastic effects.
The CONTAM Panel also noted that JECFA used 15 mg/kg bw per day as the dose for the low-dose
group, while in the current risk assessment a dose of 13 mg/kg bw per day, which is the dose
reported in the NTP study, is used (NTP, 2005).
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3.3.5.2. Non-neoplastic effects
For the evaluation of non-neoplastic effects, 28-day, long-term (104 weeks) and reproductive and
developmental toxicity studies are available for both MG and LMG (see Section 3.3.2).
The CONTAM Panel evaluated the following data on non-neoplastic effects for deriving a reference
point:
• The data on post-implantation loss and skeletal abnormalities caused by LMG (Wan et al.,
2011) in rats were considered not suitable for deriving a reference point due to the maternal
toxicity observed at doses causing fetal toxicity. In addition, there is a lack of separate data for
each litter and therefore a BMD analysis cannot be adjusted for litter effects. However, the
CONTAM Panel identiﬁed from these data a NOAEL of 10 mg/kg bw per day.
• Increases in relative liver weight observed in 28-day and long-term studies caused by MG and
LMG in rats were not considered an appropriate endpoint due to the observed decrease in
body weight.
• Increases in absolute liver weight in rats observed in a 28-day study with MG and in a long-
term study with LMG were considered suitable for BMD analysis (see Appendix C, Sections C.2
and C.3). BMDL05 values of 5.9 and 7.2 mg/kg bw per day, respectively, were derived.
• Decreases in body weight observed in a long-term study with LMG in male and female rats and
with MG in female rats were considered suitable for BMD analysis (see Appendix C, Section C.4).
A lowest BMDL05 value (for female rats) of 5.8 mg/kg bw per day was derived for LMG.
• In a 28-day study with male rats, LMG increased the incidence of hepatocyte cytoplasmic
vacuolisation in a dose-related manner in all treated groups. In a similar study with MG, the
same effect was found in male rats, but only at higher dose levels. In long-term studies,
hepatocyte cytoplasmic vacuolisation was only observed in female rats in the two highest dose
groups, but without a clear dose–response relationship. The CONTAM Panel noted that this
effect indicated that the liver was a target organ for toxicity, but because information on the
nature and the severity of the effect was lacking, its relevance could not be judged and the
data were considered not to be suitable for deriving a reference point.
• The CONTAM Panel noted an increase in reticulocytes and a small decrease in the levels of
haemoglobin, haematocrit and erythrocytes in a 28-day study with MG in male and female
mice treated at high doses (from 120 mg/kg bw per day onwards for females and at 220 mg/kg
bw per day for males), which indicate mild anaemia. Because the biological relevance of such
small effects is unclear, the CONTAM Panel considered the data not to be suitable for deriving
a reference point.
• Overall for MG, a NOAEL of 9.4 mg/kg bw per day was identiﬁed for haematological effects in
rats.
Based on the effect of MG on liver weight and of LMG on body weight, the CONTAM Panel selected
the BMDL05 value of 6 mg/kg bw per day (rounded ﬁgure), as a reference point for the non-neoplastic
effects of MG/LMG. The CONTAM Panel noted that this value is higher than the acute dose that caused
adverse effects in a case of intoxication of an infant. However, the composition of the product was not
reported and this is further addressed in Section 3.5.
3.4. Risk characterisation
Exposure of ﬁsh and crustaceans to MG results in residues of MG and its metabolite LMG occurring
in tissue. Only limited occurrence data on MG/LMG in food were available for this opinion (see
Section 3.1.2). The CONTAM Panel concluded that these data are not suitable to carry out a reliable
human dietary exposure assessment. Therefore, the CONTAM Panel cannot characterise the risk of
actual exposure to MG/LMG.
3.4.1. Evaluation of whether a reference point for action of 2 lg/kg for the sum
of MG and LMG is adequate to protect human health
To evaluate whether or not an RPA of 2 lg/kg for the sum of MG and LMG is adequate to protect
human health, the CONTAM Panel calculated the hypothetical chronic dietary exposure to MG/LMG
from all type of ﬁsh, ﬁsh products and crustaceans, with the exclusion of aquatic molluscs, assuming
that all products would be contaminated at the level of the RPA.
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The CONTAM Panel selected a BMDL10 value of 13 mg/kg bw per day, derived for LMG, as
reference point for the risk characterisation of neoplastic effects caused by MG/LMG.
The median hypothetical chronic dietary exposure to MG/LMG across dietary surveys for the
average consumer would be 1.2 and 0.6 ng/kg bw per day for toddlers (the highest exposed
population group) and adults, respectively. The minimum and maximum hypothetical chronic dietary
exposures across dietary surveys for the average consumer would be 0.5 and 5.0 ng/kg bw per day,
respectively, for toddlers and 0.2 and 1.9 ng/kg bw per day, respectively, for adults (see Table 1).
When comparing the median hypothetical chronic dietary exposure to MG/LMG across dietary
surveys for the average consumer with the BMDL10 of 13 mg/kg bw per day for neoplastic effects, the
MOE would be about 1.1 9 107 for toddlers and 2.2 9 107 for adults. For the minimum and maximum
hypothetical chronic dietary exposures across dietary surveys for the average consumer, the MOEs for
toddlers would be about 2.6 9 107 and 2.6 9 106, respectively, and for adults would be about
6.6 9 107 and 6.9 9 106, respectively.
As there is a concern that high and frequent consumers of ﬁsh might have elevated levels of MG/LMG
dietary exposure, a scenario for these consumers was elaborated. For high and frequent ﬁsh consumers,
the median hypothetical chronic dietary exposure to MG/LMG across dietary surveys would be 6.1 and
3.8 ng/kg bw per day for toddlers and adults, respectively. The minimum and maximum hypothetical
chronic dietary exposures across dietary surveys would be 2.6 and 11.8 ng/kg bw per day,
respectively, for toddlers and 1.3 and 5.2 ng/kg bw per day, respectively, for adults (see Table 2).
When comparing, for high and frequent ﬁsh consumers, the median hypothetical chronic dietary
exposure to MG/LMG across dietary surveys with the BMDL10 for neoplastic effects, the MOE would be
about 2.1 9 106 for toddlers and 3.4 9 106 for adults. For the minimum and maximum hypothetical
chronic dietary exposures across dietary surveys, the MOEs for toddlers would be about 5.0 9 106 and
1.1 9 106, respectively, and for adults would be about 1.0 9 107 and 2.5 9 106, respectively.
For substances that are both genotoxic and carcinogenic, the EFSA Scientiﬁc Committee proposed
that an MOE of 10,000 or higher, if based on the BMDL10 from an animal carcinogenicity study, would be
of low concern from a public health point of view (EFSA, 2005a). Considering that the calculated MOEs
for carcinogenicity would be of the order of 106 and higher, they do not indicate a health concern.
For non-neoplastic effects, the CONTAM Panel identiﬁed a BMDL05 of 6 mg/kg bw per day for
the effect on body weight and liver weight caused by MG/LMG.
When comparing the median hypothetical chronic dietary exposure to MG/LMG across dietary
surveys for the average consumer with the BMDL05 of 6 mg/kg bw per day for non-neoplastic effects,
the MOE would be about 4.8 9 106 for toddlers and 9.7 9 106 for adults. For the minimum and
maximum chronic hypothetical dietary exposures across dietary surveys for the average consumer, the
MOEs for toddlers would be about 1.2 9 107 and 1.2 9 106, respectively, and for adults would be
about 2.9 9 107 and 3.1 9 106, respectively.
When comparing, for high and frequent ﬁsh consumers, the median hypothetical chronic dietary
exposure to MG/LMG across dietary surveys with the BMDL05 for non-neoplastic effects, the MOE
would be about 9.5 9 105 for toddlers and 1.5 9 106 for adults. For the minimum and maximum
hypothetical chronic dietary exposures across dietary surveys, the MOEs for toddlers would be about
2.2 9 106 and 4.9 9 105, respectively, and for adults would be about 4.5 9 106 and 1.1 9 106,
respectively.
The CONTAM Panel noted that MOEs larger than 100 are often considered to be of low concern for
threshold effects (FAO/WHO, 2009). Considering that the calculated MOEs for the effects on body
weight and on liver weight would be of the order of 105 or higher, they are considered sufﬁciently
large and do not indicate a health concern for non-neoplastic effects.
Overall, the CONTAM Panel concluded that it is unlikely that exposure to food contaminated with
MG/LMG at or below the RPA of 2 lg/kg represents a health concern.
3.5. Uncertainty analysis
The CONTAM Panel concluded that the lack of representative occurrence data on MG/LMG in food
precludes a reliable human dietary exposure assessment. The CONTAM Panel made exposure scenarios
by calculating the hypothetical human chronic dietary exposure using the current RPA of 2 lg/kg for
all types of ﬁsh, ﬁsh products and crustaceans (excluding aquatic molluscs) as a hypothetical
occurrence value for average consumers and for high and frequent consumers of ﬁsh. This is in
agreement with the request to evaluate if the RPA is low enough to protect human health. These
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scenarios represent highly unlikely situations and, as they consider that all selected food products are
simultaneously contaminated with MG/LMG at the RPA, are likely to grossly overestimate the exposure.
The risks from MG and LMG are evaluated based on their potential genotoxic and carcinogenic
properties. The data on the genotoxicity of MG and LMG contain a number of contradictions. Both
compounds were negative in standard in vitro genotoxicity tests. In vivo, both compounds induced
DNA adducts that were detected by the 32P-postlabelling technique, without further characterisation of
the nature of these adducts. In the in vivo genotoxicity tests, only LMG showed a weak mutagenic
effect. There were also indications for clastogenic effects of MG and LMG but, overall, the evidence is
rather weak. In addition, it is not clear whether the mechanism of genotoxicity is due to the formation
of speciﬁc MG- and LMG-induced DNA adducts or via the generation of ROS.
The CONTAM Panel concluded that MG and LMG may be considered as carcinogenic and genotoxic
compounds. MG/LMG did cause liver, mammary and thyroid tumours, but for some of these tumour
types only small (less than 10% of the animals) and/or non-dose-related increases of the incidence
were observed. Reliable dose–response modelling was only feasible when combining the incidence of
hepatocellular carcinomas and adenomas. However, only some of the adenomas may develop into
carcinomas. Furthermore, there are indications that tumours might develop because of the tumour
promoting capacity of MG. The relatively low tumour incidence adds to the uncertainty of the BMD-
modelling. Overall, considering MG and LMG as carcinogenic and genotoxic compounds as well as
including adenomas in the modelling may result in an overestimation of the risk.
The CONTAM Panel identiﬁed only one case report indicating that a single exposure to malachite
green at a dose of about 2.6 mg/kg bw caused methaemoglobinaemia. This dose is below the selected
BMDL05 of 6 mg/kg bw per day for non-neoplastic effects. However, the CONTAM Panel noted that MG
was ingested in the form of an aquarium product containing only 0.075% MG and that the
composition of the product was not reported. The presence of other compounds causing
methaemoglobinaemia cannot be excluded and, therefore, the study cannot be used for the risk
assessment.
N-demethylated metabolites with potential genotoxic activity have been detected in tissues of rats
and ﬁsh exposed to MG/LMG. These metabolites are not included in the RPA and this may result in an
underestimation of the risk for humans.
No information regarding the potential formation of degradation products of MG/LMG during food
processing was identiﬁed. This lack of information adds to the uncertainty.
Overall, the CONTAM Panel considered that the impact of the uncertainties on the risk assessment
of human exposure to MG/LMG through the consumption of food is substantial. Both the exposure
scenario and the hazard characterisation are overestimated and therefore the approach taken is likely
to overestimate the risk.
4. Conclusions
4.1. General
• Malachite green (MG) is a triphenylmethane dye that is used to colour materials such as paper
and textiles.
• MG has been widely used as a therapeutic agent for ﬁsh and crustaceans due to its antifungal
and antiprotozoal activity. However, in the European Union, MG is not registered for use in
food-producing animals.
• Residues of the parent compound are less persistent than those of the reduced metabolite
leucomalachite green (LMG).
4.1.1. Analytical methods
• Screening and conﬁrmatory methods are usually designed to measure both substances
independently or to measure both substances as MG, following oxidation of LMG to MG.
• Screening methods for MG/LMG include immunoassays (ELISA, RNA aptamer assay,
biosensors), electrochemiluminescence and HPLC-UV/Vis and/or ﬂuorescence detection, with
detection capability values typically ≤ 0.5 lg/kg.
• LC–MS (typically tandem mass spectrometry) is the method of choice for conﬁrmatory analysis
of MG/LMG in ﬁsh and crustaceans.
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4.2. Occurrence/exposure
• Data on occurrence of MG/LMG in food were extracted from the European Commission
database on monitoring of veterinary medicinal product residues and other substances in ﬁsh,
ﬁsh products and crustaceans for the years 2002–2014. There were 548 targeted samples
reported as non-compliant. Data from Norway for the years 2006–2014 were also considered.
• Data were extracted from the RASFF database for the years 2002–2014. There were 135
notiﬁcation events reported for MG/LMG. The notiﬁcations covered the product categories ﬁsh
and ﬁsh products, crustaceans and products thereof, farmed ﬁsh and products thereof (other
than crustaceans and molluscs), and wild-caught ﬁsh and products thereof (other than
crustaceans and molluscs).
• The CONTAM Panel concluded that data extracted from the European Commission database
and the RASFF database were not suitable to carry out a reliable human dietary exposure
assessment.
• The CONTAM Panel calculated the hypothetical human dietary exposure considering as an
occurrence value the RPA of 2 lg/kg for all types of ﬁsh, ﬁsh products and crustaceans.
• The mean hypothetical chronic dietary exposure across the different European dietary surveys
and age classes, would range from a minimum of 0.1 ng/kg bw per day for infants, elderly and
very elderly to 5.0 ng/kg bw per day for toddlers.
• As there is a concern that high and frequent ﬁsh consumers might have elevated MG/LMG
dietary exposure, the exposure for these consumers was considered separately. The 95th
percentile hypothetical chronic dietary exposure in ﬁsh consumers only, across the different
European dietary surveys and age classes, would range from a minimum of 1.3 ng/kg bw per
day for adults to a maximum of 11.8 ng/kg bw per day for toddlers.
4.3. Food processing
• Concentrations of MG and LMG residues in ﬁsh muscle are reduced when the muscle is
subjected to cooking conditions, such as boiling, baking and microwaving, or when stored
under refrigeration, freezing or repeated freezing/thawing conditions. The concentrations of
LMG, generally, are reduced to a lesser extent than those of MG.
4.4. Hazard identiﬁcation and characterisation
4.4.1. Toxicokinetics
• There is scant information about MG and LMG kinetics in mammalian species and no data were
identiﬁed for humans.
• In rats, MG is rapidly absorbed and excreted mainly by the faecal route. Available data indicate
that MG undergoes biliary excretion, possibly as a GSH adduct.
• In orally dosed rats and mice, MG is reduced to LMG and both undergo hepatic sequential
N-demethylation.
• An N-oxide derivative, resulting from the oxidative biotransformation of an N-demethylated
metabolite, has been identiﬁed in liver extracts from LMG-administered mice.
• In ﬁsh, MG is rapidly absorbed and extensively biotransformed to LMG, which is stored in
tissues and slowly excreted. MG N-oxide and MG N-demethylated derivatives were also
detected in edible ﬁsh tissues.
• Persistence of MG and LMG residues in ﬁsh depends on ﬁsh species and size, MG exposure
concentration and duration, and environmental conditions including temperature and pH. In
ﬁsh, MG was detected up to about 2 months and LMG was detected up to about 9 months
after cessation of exposure.
• In crustaceans (shrimp), residues of MG/LMG were no longer detectable 9 days following
treatment.
4.4.2. Toxicity studies
• In 28-day toxicity tests, MG caused haematological effects in mice and rats and an increase in
liver weight in male and female rats. The overall NOAEL, based on haematological effects, in
female rats was 9.4 mg/kg bw per day.
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• For LMG, in 28-day toxicity tests, an increase in liver weight was found in male rats.
Hepatocyte vacuolisation was found at all doses tested, including the lowest dose of 30 mg/kg
bw per day. Therefore, a NOAEL was not identiﬁed for LMG regarding hepatotoxicity.
• For LMG, a NOAEL of 10 mg/kg bw per day for fetal toxicity in rats was identiﬁed. The CONTAM
Panel noted, however, that these effects were observed at doses also causing maternal toxicity.
• The positive results obtained in the in vivo micronucleus tests in mice for MG and LMG, the
increased mutations in the cII transgene in mouse liver for LMG, and the capacity of both MG
and LMG to form DNA adducts in vivo provide evidence for considering MG and LMG as
genotoxic in vivo.
• In long-term studies, an increase in liver weight was observed in male rats. LMG caused an
increase in relative thyroid weight in male and female rats.
• MG was not carcinogenic in mice. However, MG induced a small, not dose-related, increase in
the incidence of thyroid gland follicular adenomas and carcinomas and of mammary gland
carcinomas in female rats. The CONTAM Panel concluded that MG may be considered as
carcinogenic.
• LMG caused an increase in hepatocellular adenomas and a small increase in hepatocellular
carcinomas in mice. In rats, LMG caused a small increase in the incidence of mammary gland
carcinomas and of thyroid gland follicular cell adenomas or carcinomas (combined). The
CONTAM Panel concluded that LMG may be considered as carcinogenic.
4.4.3. Observations in humans
• Only one report was identiﬁed, describing a case of methaemoglobinaemia in a 3-year-old girl
following a single exposure to MG (about 2.6 mg/kg bw) in the form of an aquarium product
containing 0.075% MG. However, the composition of the product was not reported.
4.4.4. Mode of action
• MG has been shown to induce formation of ROS due to its behaviour as an electron-accepting/
transferring compound. In addition, ROS can be formed from induction of CYP-dependent
monooxygenases, as well as from oxidative biotransformation of MG itself.
• MG-mediated formation of ROS has been associated with MG-induced cytotoxicity, DNA
damage, apoptosis, disturbances in cell cycle progression and MAP kinase signal transduction
pathways and in vitro malignant transformation.
• In vivo, MG caused depletion of GSH and a decrease in the activity of GSTs and antioxidant
enzymes that could lead to elevated levels of free radicals as indicated by increased hepatic
lipid peroxidation.
• LMG has been shown to inhibit TPO in vitro. It can also be biotransformed by TPO into
N-demethylated derivatives which could, in turn, generate reactive metabolites. This may
explain the effects observed in the thyroid.
4.4.5. Considerations of critical effects, dose–response modelling and
possibilities for derivation of a health-based guidance value
• Because MG and LMG may be regarded as substances that are genotoxic and carcinogenic, the
derivation of a health-based guidance value is not appropriate. A BMDL10 for hepatocellular
adenomas and carcinomas in female mice of 13 mg/kg bw per day was selected as a reference
point for neoplastic effects of MG/LMG.
• Based on the effect of MG on liver weight and of LMG on body weight, the CONTAM
Panel selected the BMDL05 value of 6 mg/kg bw per day as a reference point for the
non-neoplastic effects of MG/LMG.
4.5. Risk characterisation
• Due to the limited occurrence data for MG/LMG, no reliable human dietary exposure assessment
could be carried out and, therefore, the CONTAM Panel could not characterise the risk.
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4.5.1. Evaluation of whether an RPA of 2 lg/kg for the sum of MG and LMG is
adequate to protect public health
• For the average consumer, the median hypothetical chronic dietary exposure to MG/LMG
across dietary surveys would result in margins of exposure (MOE) for neoplastic effects of
about 1.1 9 107 for toddlers and 2.2 9 107 for adults, and in MOEs for non-neoplastic effects
of about 4.8 9 106 for toddlers and 9.7 9 106 for adults. The CONTAM Panel considered that
these MOEs for neoplastic and non-neoplastic effects are sufﬁciently large and do not indicate
a health concern.
• For high and frequent ﬁsh consumers, the median hypothetical chronic dietary exposure to
MG/LMG across dietary surveys would result in MOEs for neoplastic effects of about 2.1 9 106
for toddlers and 3.4 9 106 for adults, and in MOEs for non-neoplastic effects of about
9.5 9 105 for toddlers and 1.5 9 106 for adults. The CONTAM Panel considered that these
MOEs for neoplastic and non-neoplastic effects are sufﬁciently large and do not indicate a
health concern.
• Overall, the CONTAM Panel concluded that it is unlikely that exposure to food contaminated
with MG/LMG at or below the RPA of 2 lg/kg represents a health concern.
5. Recommendations
• Data regarding the occurrence of additional metabolites in ﬁsh and crustaceans should be
generated.
• Further information on the fate of MG and LMG during food processing should be developed.
• Knowledge concerning the toxicokinetics and bioavailability of MG/LMG using human in vitro
models should be improved.
• Information regarding the potential genotoxicity of the N-demethylated metabolites should be
developed.
• The DNA adducts and GSH adducts observed in rodents should be characterised.
Documentation provided to EFSA
The following original study report submitted to WHO for the risk assessment of malachite green by
the Joint FAO/WHO Expert Committee on Food Additives (JECFA) in 2008 was made available by the
data owner:
1) Law FCP, 1994. Total Residue Depletion and Metabolic Proﬁle of Selected Drugs in Trout. US
Food and Drug Administration, Contract number 223-90-7016. Study conducted at Simon
Fraser University, Burnby, British Columbia, Canada. Submitted by the United States Food
and Drug Administration.
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AST aspartate aminotransferase
bw body weight
BfR German Federal Institute for Risk Assessment
BMD benchmark dose
BMD05 benchmark dose for a response of 5% extra risk
BMDL benchmark dose lower conﬁdence limit
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BMDL05 lower 95% conﬁdence limit for a benchmark response of 5% extra risk
BMDL10 lower 95% conﬁdence limit for a benchmark response of 10% extra risk
BMDU05 upper 95% conﬁdence limit for a benchmark response of 5% extra risk
BMR benchmark response
C cytosine
CA chromosomal aberration
CAS Chemical Abstracts Service
CAT catalase
CCa decision limit
CCb detection capability
CFA colony forming ability test
CHO Chinese hamster ovary
CLP classiﬁcation, labelling and packaging
CONTAM Panel EFSA Scientiﬁc Panel on Contaminants in the Food Chain
CSG Channa striata gill
CSK Channa striata kidney
CVMP Committee for Veterinary Medicinal Products
CYP cytochrome P450
DAD diode-array detection
DDQ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone
DEN N-nitrosodiethylamine
DSB DNA strand breaks
DTU Technical University of Denmark
ECHA European Chemicals Agency
EEA European Economic Area
EGTA ethylene glycol tetraacetic acid
ELISA enzyme-linked immunosorbent assays
EMA European Medicines Agency
EO ethynyl oestradiol
EPI estimation program interface
ERK extracelluar regulated kinases
ESI electrospray ionisation
EURL European Union Reference Laboratory
FAO Food and Agriculture Organization
FAPAS Food Analysis Performance Assessment Scheme
FSANZ Food Standards Australia New Zealand
FSC Food Safety Commission
FW freshwater
G guanine
GGT gamma-glutamyl transferase
GPx glutathione peroxidase
GSH glutathione
GST glutathione-S-transferase
HBGV health-based guidance value
HPRT hypoxanthine–guanine phosphoribosyltransferase
HPLC high performance liquid chromatography
i.p. intraperitoneal
IAC immunoafﬁnity chromatography
IC inhibitory concentration
IC50-D concentration causing 50% reduction of differentiation
IC50-P concentration causing 50% inhibition of viability/proliferation
ID-LC/MS isotope dilution liquid chromatography/mass spectrometry
JECFA Joint FAO/WHO Expert Committee on Food Additives
JNK Jun N-terminal kinases
Ki inhibition constant
LC–MS liquid chromatography–mass spectrometry
LC–MS/MS liquid chromatography–tandem mass spectrometry
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LD50 median lethal dose
LMG leucomalachite green
LOD limit of detection
LOEL lowest-observed-effect level
Log Kow octanol/water partition coefﬁcient
LOQ limit of quantiﬁcation
LPO lipid peroxidation
MAP mitogen activated protein
MG malachite green
MIP molecularly imprinted polymer
MN micronucleus
MOE margin of exposure
MRL maximum residue limit
MRPL minimum required performance limit
Mut mutations
N negative result
NADPH nicotinamide adenine dinucleotide phosphate
NCBI National Center for Biotechnology Information
NCE normochromatic erythrocytes
NFI National Food Institute
NIH Department of the National Institutes of Health
NLM National Library of Medicine
NOAEL no-observed-adverse-effect level
NRL national reference laboratory
P positive result
p.o. per os (orally)
PBMC peripheral blood mononuclear cells
PbO2 lead oxide
PCE polychromated erythrocytes
PCNA proliferating cell nuclear antigen
QuEChERS Quick Easy Cheap Effective Rugged Safe
RASFF Rapid Alert System for Food and Feed
ROS reactive oxygen species
RPA reference point for action
SD standard deviation
SHE Syrian hamster embryo
SOD superoxide dismutase
SPE solid-phase extraction
SWG Standing Working Group
T thymine
T3 triiodothyronine
T4 thyroxine
TBLOQ toxicologically based limit of quantiﬁcation
TOF-MS time-of-ﬂight mass spectrometry
TPO thyroid peroxidase
TrxR thioredoxin reductase
TSH thyroid-stimulating hormone
TTC threshold of toxicological concern
UPLC ultra-performance liquid chromatography
UV ultraviolet
UV/Vis ultraviolet/visible
VMP Veterinary medicinal product
WHO World Health Organization
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Appendix A – Identiﬁcation and selection of evidence relevant for the risk
assessment of malachite green and leucomalachite green in food
A.1. Search for scientiﬁc literature
A.1.1. Chemistry and methods of analysis
A search for recent reviews was conducted to identify papers on chemistry and methods of analysis
by using the following search string in Web of Science and PubMed:
Used search string: TOPIC: ((“malachite green” OR “leucomalachite green”)) AND TOPIC:
((chemistry OR analysis OR determination OR detection OR ELISA OR immune* OR GC OR GC-MS OR
HPLC OR LC-MS OR ICP-MS)) AND TOPIC: review; Timespan=last ﬁve years
From this search, four reviews were identiﬁed:
Liu MingYang; Xiao ShanShan; Yu Bing; Yang ChunGuang; Zhao JonhHong; Jin Yan; Zhu ChengYun,
2015. Research progress of the residue determination of triphenymethane dyes in aquatic product.
Journal of Food Safety and Quality Volume: 6 Issue: 1 Pages: 35–40.
Hidayah, N.; Abu Bakar, F.; Mahyudin, N. A.; Faridah S; Nur-Azura M.S.; Zaman M.Z., 2013.
Detection of malachite green and leuco-malachite green in ﬁshery industry. International Food
Research Journal Volume: 20 Issue: 4 Pages: 1511–1519 Published: 2013
Lopez-Gutierrez, Noelia; Romero-Gonzalez, Roberto; Martinez Vidal, Jose Luis; Garrida-Frenich
Antonia, 2013. Analysis of triphenylmethane dyes in seafood products: a review of extraction methods
and determination by liquid chromatography coupled to mass spectrometry. ANALYTICAL METHODS
Volume: 5 Issue: 14 Pages: 3434–3449 Published: 2013.
Hashimoto, Juliana Campos; Rizzato Paschoal, Jonas Augusto; De Queiroz, Julio Ferraz; Reyes
Reyes, Felix Guillermo, 2011. Considerations on the Use of Malachite Green in Aquaculture and
Analytical Aspects of Determining the Residues in Fish: A Review. JOURNAL OF AQUATIC FOOD
PRODUCT TECHNOLOGY Volume: 20 Issue: 3 Pages: 273–294 Published: 2011
These four reviews were used to identify papers on chemistry and methods of analysis. In addition,
a literature search was conducted to identify the most recent papers published since 2012, as
described below.
A.1.1.1. Web of Science
Used search string: TOPIC: (“malachite green” OR “leucomalachite green”) AND TOPIC: (chemistry
OR analysis OR determination OR detection OR ELISA OR immune* OR GC OR GC-MS OR HPLC OR
LC-MS OR ICP-MS) NOT TOPIC: (“waste water*” OR waste OR wastewater* OR adsorp* OR degradat*
OR decoloriz* OR Ichthyophthirius OR mycobacterium OR tile OR ceramic OR pottery OR Saprolegnia
OR salmonella OR coli); Reﬁned by: RESEARCH AREAS: (CHEMISTRY OR FOOD SCIENCE
TECHNOLOGY OR SPECTROSCOPY OR INSTRUMENTS INSTRUMENTATION OR AGRICULTURE OR
VETERINARY SCIENCES OR FISHERIES); Timespan=2012-2015; Search language=Auto
Result in Web of Science: 267
A.1.1.2. PubMed
Used search string: (((((“malachite green” OR “leucomalachite green”)) AND (chemistry OR analysis
OR determination OR detection OR elisa OR immune* OR GC OR gc-ms OR hplc OR lc-ms OR icp-ms))
AND (“2012/01/01”[PDAT]: “3000”[PDAT]))) NOT (“waste water*” OR waste OR wastewater* OR
adsorp* OR degradati* OR decoloriz* OR ichthyophthirius OR mycobacterium OR tile OR ceramic OR
potter OR saprolegnia OR salmonella OR coli)
Results in PubMed: 251
A.1.2. Occurrence and exposure
A search in Web of Science and PubMed was conducted to identify papers on occurrence and
exposure by using the following search strings:
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A.1.2.1. Web of Science
Used search string: TOPIC: (“malachite green” OR “leucomalachite green”) AND TOPIC: (occurrence
OR exposure OR assessment OR levels OR concentrate* OR beverage OR food OR vegetable* OR
fruit* OR grain OR cereal OR poultry OR meat OR eggs OR milk OR seafood OR ﬁsh OR shrimp
OR prawns OR crustacean) NOT TOPIC: (“waste water” OR waste OR wastewater OR adsorp* OR
degradati* OR decoloriz* OR Ichthyophthirius OR mycobacterium OR tile OR ceramic OR pottery OR
Saprolegnia OR salmonella OR coli); Reﬁned by: RESEARCH AREAS: (CHEMISTRY OR FOOD SCIENCE
TECHNOLOGY OR VETERINARY SCIENCES OR FISHERIES OR SPECTROSCOPY OR INSTRUMENTS
INSTRUMENTATION OR AGRICULTURE); Timespan=2002-2015;Search language=Auto
Result in Web of Science: 475
A.1.2.2. PubMed
Used search string: ((((“malachite green” OR “leucomalachite green”)) AND (occurrence OR
exposure OR assessment OR levels OR concentrate* OR beverage OR food OR vegetable* OR fruit*
OR grain OR cereal OR poultry OR meat OR eggs OR milk OR seafood OR ﬁsh OR shrimp OR prawns
OR crustacean)) AND (“2002/01/01”[Date - Publication]: “3000”[Date - Publication])) NOT (“waste
water” OR waste OR wastewater OR adsorp* OR degradati* OR decoloriz* OR ichthyophthirius OR
mycobacterium OR tile OR ceramic OR potter OR saprolegnia OR salmonella OR coli OR soil)
Results in PubMed: 166
A.1.3. Occurrence due to illegal use as a food colouring agent
A search in Web of Science and PubMed was conducted to identify papers regarding the occurrence
due to the illegal use of MG as a food colouring agent by using the following search strings:
A.1.3.1. Web of Science
Used search string: TOPIC: (“malachite green”) AND TOPIC: ((adulteration or “food colour*” or
“food color*”)); Timespan=2002-2015; Search language=Auto
Result in Web of Science: 13
A.1.3.2. PubMed
Used search string: ((“malachite green”) AND (adulteration or “food colour*” or “food color*”)) AND
(“2002/01/01”[Date - Publication]: “3000”[Date - Publication])
Results in PubMed: 2
A.1.4. Processing
A search in Web of Science and PubMed was conducted to identify papers on processing by using
the following search strings:
A.1.4.1. Web of Science
Used search string: TOPIC: (“malachite green” OR “leucomalachite green”) AND TOPIC: (cooking
OR roasting OR frying OR boiling OR baking OR “thermal processing”) NOT TOPIC: (“waste water” OR
waste OR wastewater OR decolor* OR biodegrad* OR photocatal* OR photodegrad* OR adsorp* OR
Ichthyophthirius OR mycobacterium OR tile OR ceramic OR pottery OR Saprolegnia OR salmonella
OR coli); Reﬁned by: RESEARCH AREAS: (CHEMISTRY OR VETERINARY SCIENCES OR AGRICULTURE
OR FOOD SCIENCE TECHNOLOGY OR FISHERIES); Timespan=All years; Search language=Auto
Result in Web of Science: 29
A.1.4.2. PubMed
Used search string: (((“malachite green” OR “leucomalachite green”)) AND (processing OR cooking
OR roasting OR frying OR boiling OR baking OR “thermal processing” OR sterilization))
Results in PubMed: 16
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A.1.5. Metabolism and kinetics
A search in Web of Science and PubMed was conducted to identify papers on metabolism and
kinetics by using the following search strings:
A.1.5.1. Web of Science
Used search string: TOPIC: (“malachite green” OR “leucomalachite green”) AND TOPIC:
(toxicokinetic* OR metabolism* OR distribution OR excretion OR “mode of action” OR absorption OR
biomarker OR biotransformation) NOT TOPIC: (“waste water*” OR ﬂuorogen OR waste OR “surface
plasmon resonance” OR SPR OR “light scattering” OR ﬁlm* OR wastewater* OR soil* OR humic OR
humus OR nano* OR decolor* OR biodegrad* OR photocatal* OR photodegrad* OR adsorp*
OR Ichthyophthirius OR mycobacterium OR tile OR ceramic OR pottery OR Saprolegnia OR salmonella
OR coli); Reﬁned by: RESEARCH AREAS: (CHEMISTRY OR BIOCHEMISTRY MOLECULAR BIOLOGY OR
PHARMACOLOGY PHARMACY OR TOXICOLOGY OR CELL BIOLOGY OR ENDOCRINOLOGY METABOLISM
OR VETERINARY SCIENCES); Timespan=All years; Search language=Auto
Result in Web of Science: 557
A.1.5.2. PubMed
Used search string: (((“malachite green” OR “leucomalachite green”)) AND (toxicokinetic* OR
metabolism* OR distribution OR excretion OR “mode of action” OR absorption OR biomarker OR
biotransformation)) NOT (“waste water*” OR ﬂuorogenic OR waste OR “surface plasmon resonance”
OR SPR OR “light scattering” OR ﬁlm* OR wastewater* OR soil* OR humic OR humus OR nano* OR
decolor* OR biodegrad* OR photocatal* OR photodegrad* OR adsorp* OR ichthyophthirius OR
mycobacterium OR tile OR ceramic OR potter OR saprolegnia OR salmonella OR coli)
Result in PubMed: 301
A.1.6. Toxicity
A search in Web of Science and PubMed was conducted to identify papers on toxicity by using the
following search strings:
A.1.6.1. Web of Science
Used search string: TOPIC: (“malachite green” OR “leucomalachite green”) AND TOPIC: (toxicity OR
toxi* OR mutagen* OR teratogen* OR carcinogen* OR carcino* OR genotox* OR reprotox* OR
nephrotox* OR neurotox* OR hepatotox* OR immunotox* OR haemotox* OR hematotox* OR cytotox*
OR “develop* toxicity” OR endocri*) NOT TOPIC: (“waste water*” OR ﬂuorogen OR waste OR “surface
plasmon resonance” OR SPR OR “light scattering” OR ﬁlm* OR wastewater* OR soil* OR humic OR humus
OR nano* OR decolor* OR biodegrad* OR photocatal* OR photodegrad* OR adsorp* OR Ichthyophthirius
OR mycobacterium OR tile OR ceramic OR pottery OR Saprolegnia); Reﬁned by: RESEARCH
AREAS: (TOXICOLOGY OR CARDIOVASCULAR SYSTEM CARDIOLOGY OR ANATOMY MORPHOLOGY OR
PHARMACOLOGY PHARMACY OR OPHTHALMOLOGY OR BIOCHEMISTRY MOLECULAR BIOLOGY OR LIFE
SCIENCES BIOMEDICINE OTHER TOPICS OR DERMATOLOGY OR HEMATOLOGY OR GERIATRICS
GERONTOLOGY OR ONCOLOGY OR UROLOGY NEPHROLOGY OR CELL BIOLOGY OR PATHOLOGY OR
RHEUMATOLOGY OR ENDOCRINOLOGY METABOLISM OR RESPIRATORY SYSTEM OR ORTHOPEDICS OR
OBSTETRICS GYNECOLOGY OR NEUROSCIENCES NEUROLOGY OR DEVELOPMENTAL BIOLOGY
OR GASTROENTEROLOGYHEPATOLOGYORDENTISTRYORAL SURGERYMEDICINEOR IMMUNOLOGYOR
REPRODUCTIVE BIOLOGY OR ALLERGY OR PEDIATRICS OR PUBLIC ENVIRONMENTAL OCCUPATIONAL
HEALTH); Timespan=All years; Search language=Auto
Result in Web of Science: 555
A.1.6.2. PubMed
Used search string: (((((“malachite green” OR “leucomalachite green”)) AND (toxicity OR toxi* OR
mutagen* OR teratogen* OR carcinogen* OR carcino* OR genotox* OR reprotox* OR nephrotox* OR
neurotox* OR hepatotox* OR immunotox* OR haemotox* OR hematotox* OR cytotox* OR “develop*
toxicity” OR endocri*))) NOT (“waste water*” OR ﬂuorogen* OR waste OR ﬁlm* OR wastewater* OR
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soil* OR humic OR humus OR nano* OR decolor* OR biodegrad* OR photocatal* OR photodegrad* OR
adsorp* OR Ichthyophthirius OR mycobacterium OR tile OR ceramic OR pottery OR Saprolegnia))
Result in PubMed: 132
A.1.7. Human studies
A search in Web of Science and PubMed was conducted to identify papers on human data by using
the following search strings.
A.1.7.1. Web of Science
Used search string: TOPIC: (“malachite green” OR “leucomalachite green”) AND TOPIC: (epidemiology
OR biomarker OR cohort OR “case control” OR “case stud*” OR “adverse effect*”) NOT TOPIC: (“waste
water*” OR ﬂuorogen OR waste OR “surface plasmon resonance” OR SPR OR “light scattering” OR ﬁlm*
OR wastewater* OR soil* OR humic OR humus OR nano* OR decolor* OR biodegrad* OR photocatal* OR
photodegrad* OR adsorp* OR Ichthyophthirius OR mycobacterium OR tile OR ceramic OR pottery OR
Saprolegnia); Reﬁned by: RESEARCH AREAS: (TOXICOLOGY OR HEMATOLOGY OR PHARMACOLOGY
PHARMACY OR DEVELOPMENTAL BIOLOGY OR ANATOMY MORPHOLOGY OR UROLOGY NEPHROLOGY
OR SURGERY OR PEDIATRICS OR RHEUMATOLOGY OR BIOCHEMISTRY MOLECULAR BIOLOGY OR
IMMUNOLOGY OR RESPIRATORY SYSTEM OR PUBLIC ENVIRONMENTAL OCCUPATIONAL HEALTH OR
DERMATOLOGY OR RESEARCH EXPERIMENTAL MEDICINE OR CARDIOVASCULAR SYSTEM CARDIOLOGY
OR REPRODUCTIVE BIOLOGY OR OPHTHALMOLOGY OR ONCOLOGY OR PATHOLOGY OR GERIATRICS
GERONTOLOGY OR GASTROENTEROLOGY HEPATOLOGY OR CELL BIOLOGY OR ANESTHESIOLOGY OR
DENTISTRY ORAL SURGERY MEDICINE OR ENDOCRINOLOGY METABOLISM); Timespan=All years;
Search language=Auto
Result in Web of Science: 63
A.1.7.2. PubMed
Used search string: (((“malachite green” OR “leucomalachite green”)) AND (epidemiology OR
biomarker OR cohort OR “case control” OR “case stud*” OR “adverse effect*”)) AND (“waste water*”
OR ﬂuorogen* OR waste OR ﬁlm* OR wastewater* OR soil* OR humic OR humus OR nano* OR
decolor* OR biodegrad* OR photocatal* OR photodegrad* OR adsorp* OR Ichthyophthirius OR
mycobacterium OR tile OR ceramic OR pottery OR Saprolegnia)
Result in PubMed: 11
A.2. Exclusion criteria for abstracts
The references, resulting from the literature search described in Section A.1, were imported and
saved using reference manager software (EndNote18), which allows effective management of
references and citations. After deletion of duplicate references, a list of about 1,500 references was
obtained. The titles and abstracts of these references were screened to identify the relevant papers.
Papers on the following subjects were excluded:
• Papers related to the use as dye (e.g. colouring of plastics or clothes)
• Papers related to environmental science (e.g. wastewater treatment)
• Papers related to ornamental plants/plant varieties/plant health
• Papers related to the efﬁcacy of the drug/treatment of infections
• Papers related to feed (occurrence and analytical methods)
• Papers related to the use of MG for the detection of other compounds/spectrophotometric
characteristics of MG
• Toxicity studies in non-mammalian animals, except for studies related to the mode of action
and toxicokinetics
• Papers related to microbiological methods and general microbiology
• Case reports on pets.
A.3. EFSA guidance documents applied for the risk assessment
• EFSA (European Food Safety Authority), 2005. Opinion of the Scientiﬁc Committee on a request
from EFSA related to a harmonised approach for risk assessment of substances which are both
genotoxic and carcinogenic. EFSA Journal 2005;3(10):282, 31 pp. doi:10.2903/j.efsa.2005.282
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• EFSA (European Food Safety Authority), 2006. Guidance of the Scientiﬁc Committee on a
request from EFSA related to uncertainties in Dietary Exposure Assessment. EFSA Journal
2006;4(12):438, 54 pp. doi:10.2903/j.efsa.2007.438
• EFSA (European Food Safety Authority), 2009a. Guidance of the Scientiﬁc Committee on use of
the benchmark dose approach in risk assessment. EFSA Journal 2009;7(6):1150, 72 pp.
doi:10.2903/j.efsa.2009.1150
• EFSA (European Food Safety Authority), 2009b. Guidance of the Scientiﬁc Committee on
transparency in the scientiﬁc aspects of risk assessments carried out by EFSA. Part 2: General
principles. EFSA Journal 2009;7(5):1051, 22 pp. doi:10.2903/j.efsa.2009.1051
• EFSA (European Food Safety Authority), 2010. Management of left-censored data in dietary
exposure assessment of chemical substances. EFSA Journal 2010;8(3):1557, 96 pp.
doi:10.2903/j.efsa.2010.1557
• EFSA (European Food Safety Authority), 2011a. Use of the EFSA Comprehensive European
Food Consumption Database in Exposure Assessment. EFSA Journal 2011;9(3):2097, 34 pp.
doi:10.2903/j.efsa.2011.2097
• EFSA (European Food Safety Authority), 2011b. Evaluation of the FoodEx, the food
classiﬁcation system applied to the development of the EFSA Comprehensive European Food
Consumption Database. EFSA Journal;9(3):1970, 22 pp. doi:10.2903/j.efsa.2011.1970
• EFSA (European Food Safety Authority), 2011c. Report on the development of a food
classiﬁcation and description system for exposure assessment and guidance on its
implementation and use. EFSA Journal;9(12):2489, 438 pp. doi:10.2903/j.efsa.2011.2489
• EFSA (European Food Safety Authority), 2011d. Use of BMDS and PROAST software packages
by EFSA Scientiﬁc Panels and Units for applying the Benchmark Dose (BMD) approach risk
assessment. Technical Report. EFSA Supporting Publications 2011, EN-113, 190 pp.
• EFSA (European Food Safety Authority), 2011e. Overview of the procedures currently used at
EFSA for the assessment of dietary exposure to different chemical substances. EFSA Journal
2011;9(12):2490, 33 pp. doi:10.2903/j.efsa.2011.2490
• EFSA Scientiﬁc Committee, 2011. Scientiﬁc Opinion on genotoxicity testing strategies applicable
to food and feed safety assessment. EFSA Journal 2011;9(9):2379, 69 pp. doi:10.2903/
j.efsa.2011.2379
• EFSA Scientiﬁc Committee, 2012a. Guidance on selected default values to be used by the EFSA
Scientiﬁc Committee, Scientiﬁc Panels and Units in the absence of actual measured data. EFSA
Journal 2012;10(3):2579, 32 pp. doi:10.2903/j.efsa.2012.2579
• EFSA Scientiﬁc Committee, 2012b. Scientiﬁc Opinion on Risk Assessment Terminology. EFSA
Journal 2012;10(5):2664, 43 pp. doi:10.2903/j.efsa.2012.2664
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Appendix C – Benchmark dose analysis
The CONTAM Panel performed benchmark dose (BMD) analyses on
• the incidence of hepatocellular adenomas and carcinomas in female B6C3F1 mice exposed to
leucomalachite green (LMG) in feed for 2 years (NTP, 2005; Culp et al., 2006) (see Table C.1);
• increased absolute liver weight in female F344 rats exposed to malachite green (MG) in feed
for 28 days (Culp et al., 1999; NTP, 2004) (see Table C.3);
• increased absolute liver weight in male F344 rats exposed to LMG in feed for 2 years (NTP,
2005; Culp et al., 2006) (see Table C.6);
• decreased body weight in male and female F344 rats exposed to MG or LMG in feed for
2 years (NTP, 2005; Culp et al., 2006) (see Table C.9).
For quantal endpoints, the BMD/L values were calculated by means of the software BMDS v.2.4. All
models for dichotomous (quantal) data available were selected for the BMD analysis using the default
benchmark response (BMR) of 10% extra risk as advised by the EFSA guidance on the use of
benchmark dose (EFSA, 2009b). In the ﬁrst instance, all models were run without restrictions.
Acceptance of a model (and its benchmark dose lower conﬁdence limit (BMDL)) was deﬁned through
the log-likelihood value and its goodness-of-ﬁt test with a p > 0.05. The lowest BMDL of all accepted
models ﬁtted to the data of one endpoint and one dose–response data set was determined as the
BMDL of that data set.
For continuous endpoints, the BMD/L values were calculated by means of the software PROAST
(v26). The exponential and Hill models were selected for the BMD analysis using the default
benchmark response (BMR) of 5% extra risk as advised by the EFSA guidance on the use of
benchmark dose (EFSA, 2009b). Acceptance of a model (and its BMDL) was deﬁned through the log-
likelihood value and its goodness-of-ﬁt test with a p > 0.05. The lowest BMDL of all accepted models
ﬁtted to the data of one endpoint and one dose–response data set, was determined as the BMDL of
that data set.
C.1. Hepatocellular adenomas and carcinomas in female B6C3F1 mice
exposed to leucomalachite green
The incidences of hepatocellular adenomas and carcinomas in female mice exposed to LMG are
shown in Table C.1.
The results of the BMD analysis are shown in Table C.2. The CONTAM Panel noted the small (non-
signiﬁcant) difference between the log-likelihood values for the null and full model, indicating that both
models do not differ signiﬁcantly. The CONTAM Panel noted the very large BMD/BMDL ratio for the
gamma model and the disparity between the lower 95% conﬁdence limit for a benchmark response of
10% extra risk (BMDL10) obtained for the gamma model and the BMDL10 values obtained from other
models. Therefore, the gamma model was not considered further. It was also noted that no BMDL10
was calculated for several models. Based on these observations, restricted models were also evaluated
(see Table C.2).
From this BMD analysis, a lowest BMDL10 of 13.1 mg/kg body weight (bw) per day was identiﬁed
(Table C.2, Figure C.1).
Table C.1: Incidence of hepatocellular adenomas and carcinomas in female B6C3F1 mice exposed
to leucomalachite green for 2 years (NTP, 2005)
Dose reported by NTP
(mg/kg bw per day)
Number of animals
Number of animals with hepatocellular
adenoma or carcinoma
0 47 3
13 48 6
31 47 6
63 47 11
NTP: National Toxicology Program; bw: body weight.
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C.2. Increased absolute liver weight in female F344 rats exposed to
malachite green in a 28-day study
The data on increased liver weight in female rats exposed to MG are shown in Table C.3. The
results of the BMD analysis are shown in Tables C.4 and C.5 and in Figure C.2.
From this BMD analysis, a lowest BMDL05 of 5.9 mg/kg bw per day was identiﬁed (Table C.4,
Figure C.2).
Table C.2: Results from the benchmark dose analysis of the data on incidences of hepatocellular
adenomas and carcinomas in female mice exposed to leucomalachite green for 2 years
Models Restriction
Number of
parameters
Log-
likelihood
p-Value Accepted
BMD10
(mg/kg bw
per day)
BMDL10
(mg/kg bw
per day)
Full n.a. 4 72.77 – – – –
Null n.a. 1 75.70 – – – –
Gamma None 3 72.94 0.5586 Yes 34.6 9.5E-43
Logistic n.a. 2 72.97 0.8138 Yes 43.1 31.2
LogLogistic None 3 72.94 0.5492 Yes 34.6 n.c.
LogProbit None 3 72.97 0.522 Yes 33.5 n.c.
Multistage None 3 72.93 0.5611 Yes 36.8 13.1
Multistage-
Cancer
n.a. 3 72.93 0.5611 Yes 36.8 20.1
Probit n.a. 2 72.96 0.8223 Yes 41.9 29.5
Weibull None 3 72.94 0.558 Yes 34.8 n.c.
Quantal-Linear n.a. 2 72.94 0.8417 Yes 35.4 20.1
Gamma Default 2 72.94 0.8417 Yes 35.4 20.1
LogLogistic Default 3 72.94 0.5492 Yes 34.6 18.5
LogProbit Default 2 73.18 0.6589 Yes 46.5 30.4
Multistage Default 3 72.93 0.5611 Yes 36.8 20.1
Weibull Default 2 72.94 0.8417 Yes 35.4 20.1
BMD10: benchmark dose for a benchmark response of 10% extra risk; BMDL10: the lower 95% conﬁdence limit for a benchmark
response of 10% extra risk; n.a.: not applicable; n.c.: not calculated by BMDS software.
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Figure C.1: Dose–response data and ﬁtted Multistage model (unrestricted) for the incidence of
hepatocellular adenomas and carcinomas in female mice exposed to leucomalachite
green
Malachite green in food
www.efsa.europa.eu/efsajournal 74 EFSA Journal 2016;14(7):4530
Table C.4: Benchmark dose values on increased liver weight in female F344 rats exposed to
malachite green for 28 days
Model BMDL05 (mg/kg bw per day) BMD05 (mg/kg bw per day) BMDU05 (mg/kg bw per day)
Exponential 5.9 9.1 13.9
Hill 11.4 17.1 33.7
bw: body weight; BMD05: benchmark dose for a response of 5% extra risk; BMDL05: lower 95% conﬁdence limit for a benchmark
response of 5% extra risk; BMDU05: upper 95% conﬁdence limit for a benchmark response of 5% extra risk.
Table C.3: Liver weight in female F344 rats exposed to malachite green for 28 days (Culp et al.,
1999; NTP, 2004)
Dose reported by NTP
(mg/kg bw per day) Number of animals Liver weight (g) Standard deviation
0 8 4.257 0.104
3 8 4.491 0.233
12 8 4.457 0.221
40 8 4.924 0.148
75 8 4.996 0.089
190 8 4.953 0.116
NTP: National Toxicology Program; bw: body weight.
Table C.5: Results from the benchmark dose analysis of the data on increased liver weight in
female F344 rats exposed to malachite green for 28 days
Exponential model(a)
Model Converged npar loglik
Full 1 7 95.50
m1- 1 2 59.18
m2- 1 3 71.39
m3- 1 4 85.25
m4- 1 4 90.20
m5- 1 5 91.01
m4- 1 4 90.20
Hill model(b)
Model Converged npar loglik
Full 7 95.50
m1- 1 2 59.18
m2- 1 3 70.94
m3- 1 4 85.10
m4- 1 4 88.61
m5- 1 5 90.82
m4- 1 5 90.82
(a): The chosen exponential model was m4-.
(b): The chosen Hill model was m5-.
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C.3. Increased absolute liver weight in male F344 rats exposed to
leucomalachite green in a long-term study
The data on increased liver weight in male rats exposed to LMG are shown in Table C.6. The results
of the BMD analysis are shown in Tables C.7 and C.8, and in Figure C.3.
From this BMD analysis, a lowest BMDL05 of 7.2 mg/kg bw per day was identiﬁed (Table C.7,
Figure C.3).
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Figure C.2: Dose–response data and ﬁtted exponential and Hill model for a benchmark response of
5% for the liver weight in female rats exposed to malachite green
Table C.6: Liver weight in male F344 rats exposed to leucomalachite green for 2 years (NTP, 2005)
Dose reported by NTP
(mg/kg bw per day) Number of animals Liver weight (g) Standard deviation
0 23 14.73 0.52
5 29 14.81 0.69
15 34 17.18 0.67
30 29 19.29 0.69
NTP: National Toxicology Program; bw: body weight.
Table C.7: Benchmark dose values on increased liver weight in male F344 rats exposed to
leucomalachite green for 2 years
Model BMDL05 (mg/kg bw per day) BMD05 (mg/kg bw per day) BMDU05 (mg/kg bw per day)
Exponential 7.3 9.9 12.9
Hill 7.2 9.5 12.6
bw: body weight; BMD05: benchmark dose for a response of 5% extra risk; BMDL05: lower 95% conﬁdence limit for a benchmark
response of 5% extra risk; BMDU05: upper 95% conﬁdence limit for a benchmark response of 5% extra risk.
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C.4. Decreased body weight in male and female F344 rats exposed to
leucomalachite green or malachite green in a long-term study
Both MG and LMG caused a decreased body weight in rats and the data are shown in Table C.9.
MG was only tested in male rats while LMG was tested in both sexes. The data from both compounds
and both sexes were combined for BMD analysis, using substance and sex as covariate. As MG and
LMG have a different molecular weight, the doses were expressed as mmol/kg bw per day for the BMD
analysis. The results from the BMD analysis were then converted to mg LMG/kg bw per day. Table C.10
shows the BMD(L/U) values both expressed as mmol/kg bw per day and mg LMG/kg bw per day.
Table C.8: Results from the benchmark dose analysis of the data on increased liver weight in male
F344 rats exposed to leucomalachite green for 2 years
Exponential model(a)
Model Converged npar loglik
Full 1 5 210.18
m1- 1 2 83.56
m2- 1 3 196.14
m3- 1 4 196.15
m4- 0 4 196.89
m5- 1 5 210.18
m5- 1 5 210.18
Hill model(b)
Model Converged npar loglik
Full 5 210.18
m1- 1 2 83.56
m2- 1 3 193.95
m3- 1 4 194.66
m4- 0 4 196.81
m5- 1 5 210.18
m5- 1 5 210.18
(a): The chosen exponential model was m5-.
(b): The chosen Hill model was m5-.
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Figure C.3: Dose–response data and ﬁtted exponential and Hill model for a benchmark response of
5% for the liver weight in male rats exposed to leucomalachite green
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The results of the BMD analysis are shown in Tables C.10 and C.11 and in Figure C.4.
From this BMD analysis, a lowest BMDL05 of 5.8 mg/kg bw per day was identiﬁed (Table C.10,
Figure C.4).
Table C.9: Body weight in female and male F344 rats exposed to malachite green or
leucomalachite green (NTP, 2005)
Substance
Dose (mg/kg bw
per day)
Dose (mmol/kg bw
per day)
Number of
animals
Sex
Body
weight (g)
Standard
deviation
MG
0 0 28 F 315 7
7 0.0192 23 F 312 10
21 0.0575 32 F 287 9
43 0.1178 25 F 277 10
LMG
0 0 38 F 312 7
6 0.0182 36 F 299 7
17 0.0514 35 F 277 7
35 0.1059 33 F 240 7
0 0 23 M 432 8
5 0.0151 29 M 424 10
15 0.0454 34 M 397 10
30 0.0908 29 M 377 10
bw: body weight; LMG : leucomalachite green: MG: malachite green.
Table C.10: Benchmark dose values from the analysis of the data on decreased body weight in
female and male F344 rats exposed to malachite green or leucomalachite green for
2 years using substance and sex as covariate
Values expressed as mmol/kg bw per day
Model BMDL05 BMD05 BMDU05
LMG female
Exponential 0.01766 0.0201 0.0227
Hill 0.01794 0.0204 0.02298
LMG male
Exponential 0.02903 0.0325 0.03627
Hill 0.02992 0.0335 0.03720
MG female
Exponential 0.03753 0.0429 0.04899
Hill 0.03852 0.044 0.05018
Values expressed as mg LMG/kg bw per day
Model BMDL05 BMD05 BMDU05
LMG female
Exponential 5.8 6.6 7.5
Hill 5.9 6.7 7.6
LMG male
Exponential 9.6 10.7 12.0
Hill 9.9 11.1 12.3
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Table C.11: Results from the benchmark dose analysis of the data on decreased body weight in
female and male F344 rats exposed to malachite green or leucomalachite green for
2 years
Exponential model(a)
Model Converged loglik npar
Full 1 813.21 13
Full-v 1 817.15 15
m1-v 1 224.34 4
m2-v 1 383.36 5
m2-av 1 707.75 7
m2-bv 1 553.01 7
m2-abv 1 796.37 9
m3-abv 1 796.45 10
m4-abv 1 796.37 10
m5-abv 1 796.45 11
m5-bv 1 525.41 9
m5-av 1 717.04 9
m5-abv 1 796.45 11
Hill model(b)
Model Converged loglik npar
Full-v 817.15 15
m1-v 1 224.34 4
m2-v 1 361.39 5
m2-av 1 709.98 7
m2-bv 0 523.71 7
m2-abv 1 794.53 9
m3-abv 1 795.28 10
m4-abv 1 794.53 10
m5-abv 1 795.28 11
m5-bv 1 524.36 9
m5-av 1 716.88 9
m5-abv 1 795.28 11
(a): The chosen exponential model was m5-abv.
(b): The chosen Hill model was m5-abv.
Values expressed as mg LMG/kg bw per day
Model BMDL05 BMD05 BMDU05
MG female
Exponential 13.7 15.7 17.9
Hill 14.1 16.1 18.3
bw: body weight; BMD05: benchmark dose for a response of 5% extra risk; BMDL05: lower 95% conﬁdence limit for a benchmark
response of 5% extra risk; BMDU05: upper 95% conﬁdence limit for a benchmark response of 5% extra risk; LMG: leucomalachite
green: MG: malachite green.
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The red line indicates male rats exposed to LMG, the green line female rats exposed to MG and the black line
female rats exposed to LMG.
Figure C.4: Dose–response data and ﬁtted exponential and Hill model for the body weight in male (m)
and female (f) rats exposed to malachite green (MG) or leucomalachite green (LMG) (dose
expressed as mmol/kg bw per day) for a benchmark response of 5% (substrate and sex
were analysed as covariate)
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